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Abstract 
The aim of this project was to covalently link chemically modified organic dyes, 
such as methylene blue, toluidine blue O, or crystal violet, to the surface of a 
polymer, via a 1,3-dipolar cycloaddition reaction.  
The synthesis of variants of methylene blue and toluidine blue O was 
attempted; unfortunately, we were unable to synthesise any analogues from 
phenothiazine or from the dyes themselves.  
The synthesis of a crystal violet analogue via a double Grignard reaction was 
investigated. We were unable to isolate the desired product in the final step. 
Instead, two leucocrystal violet analogues were prepared by reacting 
appropriately functionalised tertiary anilines with Michler’s hydrol. Another 
leucocrystal violet analogue was prepared by reacting 4-(prop-2-yn-1-
yloxy)benzaldehyde with two equivalents of N,N-dimethylaniline. The 
leucocrystal violet analogues were oxidised to give the corresponding crystal 
violet analogues, which were incorporated into polyurethane by a dip-coating 
process. The antibacterial activities of the resultant polymer films were 
assessed: each displayed differing antibacterial properties when illuminated 
(no activity was observed in the dark).  
We were unable to covalently attach any crystal violet analogues to the surface 
of pre-functionalised silicone, polyurethane, or poly(vinyl chloride) (PVC).  
Considering the differences that were observed between the antibacterial 
activities of the crystal violet analogues, the antibacterial activity of silicone 
incorporated with commercially available ethyl violet was compared with that 
of the same material containing crystal violet. The superiority of crystal violet 
over ethyl violet as a photobactericidal agent was demonstrated. 
Several porphyrins and metalloporphyrins were synthesised and incorporated 
into silicone. The resultant films were characterised by measuring their UV-
Vis, IR, and fluorescence spectra. Unfortunately, due to time constraints, the 
antibacterial properties of these polymers were not assessed. 
Finally, we were unable to synthesise polyurethane with covalently attached 
crystal violet moieties via a polymerisation reaction.  
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1 Introduction 
The development of bacterial biofilms on polymeric surfaces is a serious cause 
for concern, particularly in places such as hospitals, where the chance of 
immunocompromised patients contracting infections is greatly heightened. 
Despite the implementation of rigorous cleaning protocols, hospital surfaces 
are continuously subjected to further bacterial contamination. Moreover, and 
perhaps more alarmingly, medical implant devices such as catheters are 
frequently colonised by bacteria, regardless of whether medical staff adhere 
strictly to proper insertion techniques. This results in the proliferation of 
malignant infections within the hospital environment, which can lead to the 
death of patients in some instances. The development of robust antibacterial 
polymeric surfaces that prevent the attachment of bacteria and subsequent 
biofilm formation, would therefore appear to be an excellent strategy to combat 
this problem.  
In recent years, numerous antibacterial polymeric surfaces have been 
developed. Broadly speaking, antibacterial surfaces can be divided into three 
categories: those that kill bacteria, those that resist the adhesion of bacteria, 
and those that release attached bacteria.1 The main focus of this project was 
the development of light-activated antibacterial surfaces that kill bacteria; 
therefore, those that resist bacterial adhesion, or release attached bacteria, 
will not be discussed here. For more information about surfaces with these 
properties, the reader is directed towards a number of publications and 
reviews that discuss a range of topics including quorum sensing inhibition,2,3 
the use of biosurfactants to disperse bacterial biofilms,4 surface 
micropatterning,5 the utility of zwitterionic coatings,6,7 and the development of 
either super-hydrophobic or highly hydrophilic surfaces.8-11 In addition, there 
are a number of broader reviews that discuss these topics, and many others, 
in excellent detail.12-16  
In the following sections, the antibacterial properties of a variety of different 
antibacterial surfaces, prepared in a number of different ways, will be 
discussed. The utility of light-activated antibacterial surfaces is considered in 
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significant detail, as the production of such materials was the main focus of 
this project. 
1.1 Bacterial biofilms: a brief overview 
A bacterial biofilm is a sessile bacterial community encased within a hydrated 
polymeric matrix, which consists of proteins, polysaccharides, teichoic acids, 
and extracellular DNA. The first stage of biofilm formation involves the 
attachment of planktonic bacteria to a surface by various means, such as with 
pili, which are proteinaceous outer membrane structures. Once attached to the 
surface, some bacteria are capable of secreting “slimes” that engulf the 
bacteria present, and effectively bind them irreversibly to the surface. The 
bacterial colonies that form within this biofilm matrix are extremely difficult to 
eradicate: they are up to 1000 times more resistant to biocides than planktonic 
bacteria. The intermittent release of planktonic bacteria from a mature biofilm 
means that new biofilms can form elsewhere, or it can result in a persistent 
infection where indwelling devices, such as catheters, are concerned (Figure 
1).17-20 
 
Figure 1. A simplified schematic detailing each phase of biofilm development. 
1.2 Antibiotics 
The most common way of preventing, or combatting, medical device related 
infections involves the use of antibiotics such as penicillin, rifampicin, 
minocycline, vancomycin, and cefoxitin. An antibiotic is a compound that is 
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either a bactericide, which means that it works by killing bacteria directly; or a 
bacteriostatic, which means that it works by preventing bacteria from 
reproducing, and hence proliferating. The term “antibiotic” is often used 
loosely, and incorrectly, to refer to any compounds that eliminate microbes of 
any type, such as viruses. Such compounds should be labelled as 
“disinfectants” or “antimicrobials”, and will be discussed in section 1.3. 
There are a number of different ways in which antibiotics can be employed to 
prevent the bacterial colonisation of polymeric surfaces. The most common 
strategy involves impregnating, or coating, the polymer with such compounds. 
Alternatively, antibiotics can be covalently attached to the surface of a 
polymer, to biodegradable thin-film coatings, or to surface adsorbed vesicles. 
In the case of catheter associated infections, the catheter can be flushed with 
antibiotics to eliminate bacterial colonies that have already developed – this 
process is known as “antibiotic lock therapy”. In the next few sections these 
differing strategies, including their pros and cons, will be discussed. 
1.2.1 Antibiotic lock therapy 
In 1988, Messing et al.21 developed a new strategy to eliminate catheter-
related infections. In a clinical trial, a highly concentrated antibiotic solution in 
isotonic saline was injected into the lumen of the contaminated catheter of 
each participant, who was suffering from a catheter-related infection, every 
twelve hours for two weeks. The group found that catheter removal wasn’t 
required to cure the eleven patients who participated in this clinical trial, and 
concluded that this method could be utilised in the future to successfully 
combat catheter-related infections.  
Up until 1998, a number of clinical trials had indicated that antibiotic lock 
therapy was effective at curing catheter-related infections that were caused by 
a variety of different bacteria; however, limited in vitro laboratory experiments 
had been performed.22-28 Andris et al.29 investigated the efficacy of a number 
of different antibiotic systems for the elimination of a range of microbial 
colonies. They found that different antibiotics exhibited varying levels of 
effectiveness against different strains of bacteria. For example, nafcillin, 
ceftriaxone, and vancomycin caused a significant decrease in colonisation of 
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the intraluminal membrane by various staphylococcal species. On the other 
hand, aztreonam, ceftriaxone, and gentamicin were all highly efficacious 
against Gram-negative bacteria. Moreover, it was shown that amphotericin 
and fluconazole were effective against two different yeast species: C. albicans 
and C. tropicalis. 
The use of antibiotic lock therapy is well documented; it has been shown on 
numerous occasions that it is an effective tool when it comes to eradicating 
catheter-related infections.30 There are, however, three discrete 
disadvantages associated with this approach. Firstly, there is a chance that a 
blockage might occur in the interior of the catheter lumen, caused by 
precipitation of the active agent. Secondly, exposure to high concentrations of 
antibiotics is often associated with localised toxicity and/or undesired side-
effects. Finally, and most importantly, the patient is already suffering from a 
catheter-related infection, as a result of prior catheter contamination.30 In 
addition, although not a disadvantage of the technique itself, the use of this 
method is limited exclusively to catheters. 
Clearly, a preventative approach would be better than a reactive one, as 
patients would not have to endure the trauma of becoming infected in the first 
place. In the next two sections, the ability of antibiotics to prevent the bacterial 
colonisation of polymeric surfaces will be explored. 
1.2.2 The impregnation or coating of polymeric medical devices with 
antibiotics 
There is a vast amount of literature describing the impregnation, or coating, of 
different polymeric materials with a range of antibiotics. Throughout the 1990s, 
many groups incorporated a multitude of different antibiotics into a range of 
different medical devices. The effectiveness of such devices in preventing 
bacterial colonisation has been demonstrated in in vitro and in vivo 
experiments.31 
A variety of different methods were developed to facilitate the physical 
adsorption of different antibiotics to the surfaces of various medical devices. 
One approach involved the pre-treatment of a polymeric device with a cationic 
surfactant, tridodecylmethylammonium chloride, in ethanol. This allowed for 
James Rudman 
13 
 
the non-covalent binding of a negatively charged antibiotic, such as cefoxitin 
or vancomycin, to the surface.32,33 
Many groups utilised the ability of polymers such as silicone and polyurethane 
to swell in certain solvent systems. They dissolved the antibiotic(s) in a solution 
that also caused the polymer to swell. After a certain amount of time the 
solvent was removed and the polymer returned to its original size, with the 
antibiotics encapsulated within the polymer matrix.34-37 
A few highly original techniques were also developed. For example, DiTizio et 
al.38 produced a hydrogel-coated catheter that contained embedded 
liposomes, which were loaded with the antibiotic ciprofloxacin. Presumably, it 
was expected that the liposomes would be able to store more of the active 
compound than the polymeric matrix, thus giving rise to a more efficacious 
antibacterial surface with an extended shelf-life. The modified catheter 
resisted colonisation by P. aeruginosa for one week in an in vitro experiment. 
In a similar vein, Marconi et al.39 generated a sulfated polyurethane, which was 
able to sequester large amounts of the antibiotics cefamandole and 
vancomycin. The resultant polymer was effective at eliminating S. epidermidis 
in an in vitro study. Although both of these methods of generating antibacterial 
surfaces are clearly very interesting, it’s impossible to compare the 
effectiveness of these polymers with ones that were less technically 
demanding to generate. 
Commonly, a combination of two or more antibiotics with different modes of 
action are incorporated: this reduces the risk of resistant bacterial strains 
developing, as bacteria are very unlikely to undergo two simultaneous 
mutations that make them resistant to both antibiotics at once.40 Moreover, 
combinations of antibiotics have frequently been shown to act in synergy.33,41 
This is often because the mode of action of one antibiotic causes the bacterium 
in question to become less resistant to the other.  
There are a number of commercially available medical devices incorporated 
with antibiotics that have been shown, in numerous clinical trials, to 
significantly reduce the onset of catheter-related infections.42-44 For example, 
in 1999 Darouiche et al.45 conducted a large clinical trial, where they 
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established that the use of catheters incorporated with a combination of 
minocycline and rifampicin resulted in a statistically significant reduction in the 
amount of patients acquiring catheter-related infections. Interestingly, in 2014, 
Jamal et al.46 coated a minocycline-rifampicin catheter with the disinfectant, 
chlorhexidine, and demonstrated that it was significantly more effective than 
the unmodified variant. This indicates that there may be good reason to 
combine antibiotics with disinfectants, as this seems to improve the 
antibacterial properties of the resultant polymer. More recently, Fisher et al.47 
produced a urinary catheter impregnated with a mixture of rifampicin, 
sparfloxacin, and the disinfectant triclosan, and found that it too was highly 
effective at inhibiting microbial contamination. 
The coating, or incorporation, of polymers with antibiotics is a proven strategy 
for preventing the occurrence of device related infections. The major issue 
associated with this method is a consequence of the way that antibiotic 
incorporated medical devices prevent bacterial contamination. Over time, 
antibiotics diffuse into the surrounding medium. The rate at which this occurs 
depends upon the antibiotic(s) used, the composition of the surrounding 
medium, and the composition of the polymer. The rate of diffusion from the 
device is correlated with how effective it is, as well as its shelf-life. After a 
certain period of time, the concentration of antibiotic that diffuses from the 
polymeric matrix into the surrounding medium will be sub-inhibitory. Not only 
does this mean that no further antibacterial activity is observed, but also that 
the chance of resistant strains of bacteria developing is greatly increased. 
1.2.3 Surface-bound antibiotics 
In the previous section, surfaces that release physically adsorbed antibiotics 
passively into their surroundings were discussed. In this section, examples of 
the covalent linkage of antibiotics to various surfaces, or surface coatings, will 
be discussed. This approach offers a far greater degree of control, as the 
antibiotic in question could either be permanently bound to the surface, or 
released in the presence of bacteria if cellular uptake is required for it to be 
active. In both cases, the antibiotics would only be depleted as and when they 
are needed.   
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In 2007, the Urban group developed a method for covalently attaching 
penicillin to the surface of expanded polytetrafluoroethylene (ePTFE).48,49 
Initially, an argon plasma discharge was generated in a microwave in the 
presence of ePTFE and maleic anhydride. This resulted in the formation of a 
reactive surface containing carboxylic acid functional groups. The modified 
surface was then reacted with a poly(ethylene glycol) (PEG) linker, and this 
was followed by subsequent attachment of the antibiotic penicillin (Scheme 1). 
 
Scheme 1. Attachment of penicillin (PEN) to the surface of functionalised ePTFE. 
The penicillin-functionalised polymer surface was shown to retard the growth 
of S. aureus (a Gram-positive bacterium), but was ineffective against P. 
aeruginosa (a Gram-negative bacterium).48,49 Penicillin is a β-lactam antibiotic 
that inhibits the action of DD-transpeptidase, an enzyme that catalyses the 
formation of cross-links between peptidoglycan units in the cell wall of Gram-
positive bacteria. This creates an imbalance, as enzymes that hydrolyse these 
links remain active: the result is degradation of the cell wall and subsequent 
cell death. Conversely, Gram-negative bacteria have an outer membrane that 
consists of lipopolysaccharides and phospholipids. The inability of penicillin to 
penetrate this layer renders it inactive against Gram-negative bacteria. 
The Urban group demonstrated that penicillin is active when bound to the 
surface of ePTFE, and speculated that the mixed molecular weight PEG 
linkers probably facilitated this. They noted that, after one day in phosphate 
buffered saline (PBS) solution, 32% of the originally bound penicillin had been 
released from the surface due to hydrolysis of the ester linkage between the 
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PEG linker and penicillin; however, even after this loss of active compound, 
the resultant polymer was still able to resist bacterial contamination 
effectively.48,49 The uncontrollable release of penicillin from the surface due to 
some hydrolysis is not ideal, but this approach is clearly a major improvement 
on previously designed surfaces where the antibiotic is only physically 
adsorbed. 
In more recent work conducted by the same group, Aumsuwan et al.50 
attached ampicillin to the surface of ePTFE by a similar method to that which 
is described above. Although ampicillin is a β-lactam, and has a similar mode 
of action to penicillin, it has a broader spectrum of activity and is active against 
some Gram-negative bacteria. The Urban group showed that this new surface 
was effective against a variety of Gram-positive and Gram-negative bacteria, 
including S. aureus, B. thuringiensis, E. faecalis, E. coli, P. putida, and S. 
enterica. They also showed that approximately 90% of the originally bound 
ampicillin was present after exposure to different bacterial solutions for one 
day. 
In 2009, Aumsuwan et al.51 used the same synthetic strategy, as detailed in 
scheme 1, to attach both penicillin and gentamicin (active against Gram-
negative bacteria) to the surface of polypropylene. They demonstrated that 
this surface was effective against the Gram-positive bacterium S. aureus, and 
the Gram-negative bacterium P. putida. 
In the following year, another group devised a method for covalently attaching 
levofloxacin to a functionalised poly(methylhydro-co-dimethyl)siloxane coating 
(Scheme 2).52 
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Scheme 2. Covalent attachment of levofloxacin to a modified siloxane surface. 
In this instance, slow hydrolysis is desirable and gives rise to “free” 
levofloxacin, which is responsible for the observed antimicrobial activity. The 
modified polymer had a more uniform distribution of covalently bound 
levofloxacin, and showed a higher initial kill, as well as sustained antimicrobial 
activity, relative to a polysiloxane coating that had simply been blended with 
levofloxacin.  
In 2012, Komnatny et al.53 covalently attached ciprofloxacin to the surface of 
(4-hydroxymethylbenzoic acid)-linked ChemMatrix polymer beads via a lipase-
sensitive anhydride linkage (Scheme 3). They found that, in the presence of a 
strain of P. aeruginosa that produces lipases, ciprofloxacin was released from 
the beads and this resulted in complete eradication of the bacterial population 
within four hours. On the other hand, when lipase-defective mutants were used 
an insignificant decrease in the bacterial population was observed. To show 
that release of the antibiotic was vital, they attached ciprofloxacin to the 
polymer beads by an amide linkage, which is not susceptible to the action of 
lipases. In the presence of these beads, the population of lipase-producing P. 
aeruginosa was unaffected. 
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Scheme 3. Covalent attachment of ciprofloxacin to the surface of (4-hydroxymethylbenzoic acid)-linked ChemMatrix 
polymer beads by an anhydride linkage. 
Despite ongoing improvements in this area, producing polymeric surfaces with 
covalently bound antibiotics is still technically challenging. On the other hand, 
the generation of surfaces with physically adsorbed antibiotics is often 
relatively simple. There is one major problem with all the aforementioned 
antibiotic-loaded polymers: the antibacterial activity is not permanent. Once 
the antibiotics have served their function and/or have been released from the 
polymer surface, they are not replaced. 
1.2.4 The future of antibiotics 
Throughout this section, the ability of antibiotics to prevent the colonisation of 
various polymeric surfaces has been discussed. Despite all the research that 
has been carried out in this area, the use of antibiotics has a major 
disadvantage in that they commonly have a very specific mode of action. This 
means that the effectiveness of antibiotics is in rapid decline due to growing 
resistance as a result of their overuse in various applications.54,55 Moreover, 
the low discovery rate of new antibiotic drug classes compounds this problem: 
over thirty years passed between the approval of nalidixic acid in 1967 and 
linezolid in the year 2000.40  
One way of combatting the development of antibiotic resistant bacterial strains 
might involve the use of carefully selected combinations of antibiotics, perhaps 
even along with adjuvants that enhance their activity. The premise behind this 
strategy is that, as previously mentioned, bacteria are less likely to undergo 
more than one mutation at the same time. As a result, every bacterium within 
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a colony will be susceptible to the mode of action of at least one of the 
antibiotics; therefore, the chance of resistant strains developing is greatly 
reduced.40 
In recent times the isolation and development of new antibiotics appears to be 
heading towards a new golden era, but who knows how long this will last?56,57 
Considering the slow supply of new antibiotics, the rapid development of 
antibiotic-resistant strains of bacteria, and the fact that the antibacterial activity 
of antibiotic-incorporated surfaces can only ever be finite, new and improved 
methods for preventing the bacterial colonisation of polymeric surfaces need 
to be developed. 
1.3 Non-metallic disinfectants 
In addition to antibiotics, a huge variety of disinfectants and other organic 
natural products have been incorporated into, or covalently bound to the 
surface of, various polymers. Unlike antibiotics, these compounds are often 
extremely harmful towards humans, which means that their potential to be 
used in indwelling medical devices, such as catheters, is somewhat limited; 
however, the covalent attachment of disinfectants, such as quaternary 
ammonium salts, to the surface of an indwelling device, may prevent them 
from being toxic towards the human host. In any case, their use in external 
surfaces, where cytotoxicity is not an issue, should not cause any problems. 
In the ensuing sections, the utility of numerous disinfectants in preventing the 
adhesion of bacteria to a range of different surfaces is considered. 
1.3.1 N-Halamines 
An N-halamine is a compound that contains at least one nitrogen-halogen (N-
X) bond. They are formed by the halogenation of an N-H bond of an imide, 
amine, or amide. The N-H bond can be halogenated by a variety of different 
reagents, including X2, HOX, and OX−, where X symbolises a halogen atom. 
The resultant N-halamines are potent biocides because the halogen atom is 
in the +1 oxidation state. In essence, they are a source of X+, which can be 
released into cells upon contact and induce cell death. Alternatively, 
dissociation of the N-X bond can give rise to free X+ in the surrounding 
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environment, which results in a zone of inhibition around the polymer in 
question. The evidence appears to suggest that both processes occur to some 
extent. The inactivation of bacteria by X+ is accompanied by reformation of the 
corresponding N-halamine precursor, and a subsequent loss of antibacterial 
activity over time. To overcome this, the precursor can be recharged by 
halogenation, as described above.58 
The stability of N-halamines is reduced by the presence of an α-hydrogen 
atom, as dehydrohalogenation can take place (Scheme 4). In fact, very few N-
halamines actually contain an α-hydrogen because of this decomposition 
pathway.58 
 
Scheme 4. The mechanism of dehydrohalogenation. 
The stability of the N-X bond towards hydrolysis increases as the nitrogen 
atom becomes more electron rich. This means that, in general, the rate of 
dissociation of N-X bonds decreases in the following order: imides > amides > 
amines. Unsurprisingly, an inverse trend is observed when the biocidal 
activities of the N-halamines are compared, as dissociation of the N-X bond is 
required for these compounds to effect bacterial kill. It is important to consider 
both the stability and the associated antimicrobial activity of the resultant N-
halamine incorporated polymer when attempting to design an antimicrobial 
surface. If one wishes to produce a polymer surface that exhibits long-term 
activity, without the need for frequent “recharging”, then it would be wise to 
utilise amine N-halamine compounds. On the other hand, if a high level of 
activity is required in short, intermittent bursts, imide N-halamine compounds 
should be used.58 
There are numerous strategies for producing antimicrobial N-halamine-
functionalised polymers. One method used involves the grafting of an N-
halamine precursor onto a commercially available, occasionally pre-
functionalised, polymer surface.58-69 Alternatively, a polymer containing 
reactive groups can be spin-coated onto the surface of a chemically inert 
polymer, either prior to the covalent attachment of an N-halamine precursor, 
or with an N-halamine precursor already bound.70-73 The N-H bond can then 
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be “activated” by treatment with an appropriate halogenating agent. Another 
strategy that has been invoked involves polymerisation of an N-halamine 
monomer with, or without, other monomeric units to give a homo-, or 
copolymer respectively.58,74-76 
The fact that N-halamine-functionalised polymers are rechargeable (by 
treatment with a halogenating agent, as discussed above) is a disadvantage: 
the surface must undergo frequent maintenance to ensure that it continues to 
exhibit antimicrobial activity. Clearly, this might not be very practical for 
medical implant devices such as catheters, or in other applications where 
access to the surface in question is restricted; however, for their use in most 
fields this shouldn’t pose too much of a problem. In most cases, the N-
halamine moiety is either part of, or covalently attached to, the polymer; 
therefore, toxicity is not considered to be an issue, as there is little to no chance 
of it being released into the surrounding environment. Surfaces that are 
modified with N-halamines have been shown to be extremely effective at 
significantly reducing bacterial contamination in numerous areas, such as in 
water disinfection, due to their potent bactericidal properties.58 
1.3.2 Quaternary ammonium compounds (QACs)  
For a number of years, it has been known that QACs, like N-halamines, are 
potent, broad spectrum bactericides which act against both Gram-positive and 
Gram-negative bacteria. The exact mechanism of antimicrobial action is still 
debated, though it is generally accepted that QACs kill bacteria, as well as 
other microorganisms, on contact. It is believed that the positively charged 
QAC disrupts the charge distribution of the bacterial cell membrane, which 
results in loss of low molecular weight components from the cell and 
subsequent necrosis.77,78 
In 1935, Domagk first demonstrated that benzalkonium chloride is a highly 
effective disinfectant; since then, QACs have been used extensively in this 
role (Figure 2).79 Throughout the 1990s, a number of groups investigated the 
efficacy of a range of different catheters coated with benzalkonium chloride to 
prevent bacterial adhesion by a killing mechanism.80-84 The results were 
varied, with some groups reporting that the resultant catheters demonstrated 
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excellent long-term activity, whilst others found them to be ineffective. The fact 
that different types of catheter were impregnated with benzalkonium chloride 
does not make a comparative account easy, though. In 2010, a woman 
reportedly suffered anaphylactic shock following insertion of a catheter that 
was coated with benzalkonium chloride; however, once again it is impossible 
to say whether or not this was actually caused by benzalkonium chloride.85 
Clearly, more research is required to ascertain the effectiveness of 
benzalkonium chloride, and whether it is even safe to use. 
 
Figure 2. Benzalkonium chloride is a mixture of alkylbenzyldimethylammonium chlorides. 
Many research groups have investigated whether chitosan, a linear 
polysaccharide containing amine moieties, could be exploited in a number of 
different applications where materials with antibacterial properties are desired 
(Figure 3). It is produced by the de-acetylation of naturally occurring chitin 
under basic conditions. The conjugate acid of the amino substituents of 
chitosan have a pKa of ~6.5, so are protonated to some extent under mildly 
acidic conditions. Its use as a food packaging material is of particular interest, 
due to the fact that it is both biodegradable and non-toxic.86 It can also be 
covalently bound, or physically adsorbed, to the surface of various polymeric 
surfaces, thus rendering them antibacterial.87,88   
 
Figure 3. Chitosan, produced by the de-acetylation of chitin. 
Many research groups have synthesised a wide variety of polymeric materials 
with covalently bound QACs. In 1977, Rembaum et al.89 demonstrated that a 
series of ionenes, which are polymers that have ionic groups as part of the 
main chain, were biocidal. In this case, the main chain was composed of a 
sequence of quaternary ammonium centres. The preparation of ionenes 
containing QACs, or of polymers with a pendant QAC moiety can be achieved 
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by the polymerisation of an appropriately functionalised QAC monomer, or by 
the copolymerisation of a QAC monomer with other compounds.78,90-99 If the 
QAC is unstable to the polymerisation conditions, a precursor, i.e. a tertiary 
amine, or an alkyl halide, can be used. Then once the desired polymer has 
been produced, the quaternary centres can be generated. These types of 
polymer have exhibited excellent antibacterial properties, regardless of 
whether the quaternary ammonium centre is located in the main chain, or is 
part of a pendant moiety.78,100  
Instead of conducting polymerisation reactions, many other groups have used 
various surface grafting methods, plasma polymerisation, or layer-by-layer 
deposition, to attach QACs, or their precursors, to the surface of a 
polymer.78,100,101 In many of these instances, inert polymers were used; 
therefore, surface modification (e.g. ozonolysis, argon plasma discharge) was 
necessary for the subsequent covalent attachment of a QAC.102-104 
Alternatively, preparation of a closely related polymer that incorporated 
reactive groups (e.g. a silicone polymer containing Si-H bonds), also proved 
to be an effective tactic.105-107 
Ongoing research in this area has led to some interesting observations 
regarding the characteristics of different QACs. In 2010, Sharma et al.108 
investigated the effect of changing the counter-ion of poly(4-vinyl 2-
hydroxyethyl pyridinium) chloride on the antimicrobial activity. They found that 
the polymer with hydroxide as the counter-ion was the most efficacious at 
killing both bacteria (B. coagulans) and fungi (A. niger and M. circenelliods). 
In another study, Garg et al.109 showed that, for poly[1-vinyl-3-(2-sulfoethyl 
imidazolium betaine)], varying the anion had a profound effect on the biocidal 
activity against different types of bacteria. For example, the polymer with the 
hydroxide counter-ion was the most effective against a Gram-positive 
bacterium; whereas against a Gram-negative bacterium, it was found that 
fluoride, sulphide, and nitrate were the best anions to have. The effect of 
changing the counter-ion on the antibacterial activity of the polymer appears 
to depend quite heavily on the type of bacterium used in the study, as well as 
on the structure of the QAC and the rest of the polymer. 
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It has been shown by many research groups that changing the length of the 
substituted alkyl chain of a QAC can have a drastic effect on its effectiveness 
as a bactericide. It is thought that the hydrophobic alkyl chain facilitates binding 
to the bacterial cell membrane; thus QACs with a longer alkyl chain are often 
found to be more biologically active.90,101,102 If the chain length is too long, 
however, then one would expect aggregation of the hydrophobic chains and a 
subsequent loss of activity: this has also been demonstrated by a number of 
research groups.91,101 This clearly demonstrates that a balance between 
hydrophobicity and hydrophilicity is required, as both the positive charge and 
the length of the alkyl chain are important with regards to the antibacterial 
activity of QACs.100,101 
Though they demonstrate excellent antimicrobial properties, there are 
concerns regarding the cytotoxicity of polymers containing QACs; however, 
this shouldn’t be an issue if they are covalently bound to a surface. These 
concerns do not extend to the semi-synthetic polymer chitosan, though. In 
addition to concerns about toxicity, there is also evidence of bacteria becoming 
less susceptible to the mode of action of QACs, which appears to be 
associated with increased efflux pump activity.77 That said, there is certainly 
potential for the use of surfaces with covalently bound QACs in almost any 
conceivable application, including for the development of medical implant 
devices. 
1.3.3 Quaternary phosphonium compounds (QPCs) 
In almost every respect, from the way they are prepared through to their mode 
of action against bacteria, QPCs are identical to QACs.100 A number of 
research groups have compared the antibacterial activities of structurally 
related polymers containing QPCs and QACs; in almost every case it was 
found that QPCs are more effective biocides than their QAC counterparts.110-
116 The larger atomic radius of phosphorus means that the association 
between the anion and the cation of a QPC is weaker than would be observed 
for an analogous QAC. It is believed that this results in improved binding of 
QPSs to bacterial cell membranes.100 
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The use of QPCs to prevent the bacterial colonisation of polymeric surfaces 
appears to have many advantages, even over the formidable QACs; however, 
due to the susceptibility of their phosphine precursors towards reduction, 
QPCs are somewhat more difficult to produce.100 This would appear to explain 
why the development of surfaces containing QPCs is relatively much less 
advanced than for those with incorporated QACs.   
1.3.4 Antimicrobial peptides (AMPs) 
In recent years, a number of research groups have physically adsorbed or 
covalently attached a variety of naturally occurring AMPs to different polymeric 
surfaces. They are broad-spectrum antimicrobial agents that constitute an 
important part of the immune system of many different types of organisms, 
including humans.78 As they contain cationic amino acid residues, it is perhaps 
no surprise that their mode of action is thought to be very similar to that of the 
previously described QACs: it has been proposed that they kill bacteria by 
disrupting the charge distribution of the cell membrane, resulting in cell 
permeabilisation and subsequent necrosis.117 
The methods used to produce surfaces containing AMPs are, somewhat 
unsurprisingly, very similar to those used for the generation of surfaces that 
contain QACs/QPCs. The use of layer-by-layer assembly is very popular, and 
a number of other research groups have utilised the fact that AMPs tend to be 
highly functionalised by covalently linking them to commercially available, or 
pre-functionalised, polymeric surfaces.117  
Since they exist in living organisms, there is unlikely to be an issue with 
regards to cytotoxicity, which has been highlighted as a potential drawback of 
synthetically produced QACs and QPCs. On the other hand, due to their 
structural complexity, AMPs are notoriously difficult to synthesise; therefore, 
for their use to become widespread, more practical and cost-effective synthetic 
routes need to be elucidated. Alternatively, biological production methods 
could be improved.  
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1.3.5 Nitric oxide (NO)  
Even though NO is not biocidal in its own right, the fact that its mode of action 
induces the killing of bacteria, albeit indirectly, is the reason it will be discussed 
herein. It has been known since the 1980s that NO is an important signalling 
molecule, which is involved in various physiological processes, including 
cardiovascular homeostasis, immune response, bone metabolism, and 
neurotransmission. Several research groups have tried to develop 
biomaterials that release NO, as it is felt that they could be used to prevent 
various complications (e.g. thrombus formation, neointimal hyperplasia, 
cerebral vasospasms, or blood perfusion) which arise because of the 
implantation of medical devices such as cardiovascular grafts. As well as their 
use in other applications, including the treatment of female sexual dysfunction 
and in wound healing, it has also been proposed that polymers which can 
release NO might be effective at preventing unwanted microbial 
contamination. This is because it is believed that an additional supply of NO 
should enhance the immune system’s response to the presence of foreign 
microorganisms, which would lead to their subsequent eradication.118 
In the last fifteen years, Schoenfisch and co-workers have developed an NO-
releasing sol-gel coating, which has been shown to prevent bacterial adhesion 
in a range of different in vitro and in vitro experiments.119-124 The coating 
contains nitrogen-based diazeniumdiolates, which can be hydrolysed under 
physiological conditions to generate NO (Scheme 5). 
 
Scheme 5. Synthesis of a generic nitrogen-based diazeniumdiolate, as described by Schoenfisch and co-
workers.119  
Unfortunately, the oxidative decomposition of nitrogen-based 
diazeniumdiolates can also result in the generation of carcinogenic 
nitrosamines; therefore, Engelsman et al.125 devised a novel carbon-based 
NO-releasing coating (Scheme 6). They applied this coating to surgical 
meshes, and found that it was effective at preventing the adhesion of S. 
aureus, E. coli, and P. aeruginosa in in vitro experiments; however, they found 
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the modified meshes were not effective when subcutaneously tested in mice. 
It was observed that the rate of NO release from the carbon-based coating 
was six times less than that of the nitrogen-based coating; therefore, the 
amount of NO that was released might have been too low to prevent microbial 
colonisation in vivo. 
 
Scheme 6. Synthesis of a functionalised poly(ethylene-vinylacetate) coating containing carbon-based 
diazeniumdiolate moieties.125 
Though NO-releasing materials have demonstrated efficacy in in vitro and in 
in vivo studies, there is scope to improve their storage efficiency, as well as 
their antibacterial lifetimes. Moreover, particularly with regards to coatings that 
contain nitrogen-based diazeniumdiolates, the release of potentially cytotoxic 
compounds, including nitrosamines, and their subsequent effect, needs to be 
taken into consideration. The way by which NO is released from the surface 
coatings that have been discussed also implies that their use is probably 
restricted to indwelling medical devices.    
1.3.6 Crystal violet 
In 1883, Kern and Caro described the first synthesis of crystal violet. Firstly, 
N,N-dimethylaniline was reacted with phosgene to give 4,4’-
bis(dimethylamino)benzophenone (otherwise known as Michler’s ketone). 
This was then reacted with N,N-dimethylaniline and phosphorus oxychloride 
under acidic conditions. Finally, the colourless, reduced form of crystal violet 
(known as leucocrystal violet) was oxidised in the presence of hydrochloric 
acid (Scheme 7).126 Since 1883, a number of different syntheses of crystal 
violet have been described, though they will not be discussed here.127 
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Scheme 7. The first described synthesis of crystal violet. 
In 1912, Churchman et al.128 found crystal violet to be an effective antibacterial 
agent against Gram-positive bacteria in both in vitro and in vivo experiments. 
It was, however, found that crystal violet was somewhat less effective against 
Gram-negative bacteria: this is thought to be related to its mode of action. It is 
known that the cell wall of a typical Gram-positive bacterium contains more 
acidic components than that of a Gram-negative bacterium; therefore, the cell 
wall of a Gram-positive bacterium tends to have a lower isoelectric point and 
thus binds to crystal violet more readily.129 In any case, crystal violet was used 
widely for the treatment of various ailments, including trench mouth, thrush, 
impetigo, burns, pinworm, and cutaneous and systemic fungal infections; 
however, the discovery of penicillin in 1928, and the subsequent mass 
production of antibiotics in the 1940s, resulted in a decline in its popularity.130  
In 1992, Bakker et al.131 were on the hunt for an antimicrobial drug that was 
inexpensive, simple to prepare, chemically stable, and active in low 
concentrations. This led to crystal violet being revisited as a potential 
antimicrobial. The group found that it was a highly effective biocide against 
several different species’ Gram-positive bacteria, as well as against C. 
albicans, in an in vitro experiment. 
In more recent times, a number of research groups have demonstrated that 
polymeric surfaces that have been coated with gendine, which is a 
combination of crystal violet and chlorhexidine, are highly effective at 
preventing bacterial adhesion and the subsequent development of biofilms, in 
both in vitro and in vivo studies.132-134 It is not clear whether this combination 
James Rudman 
29 
 
of antiseptics acts in synergy, as appropriate control experiments were not 
conducted. 
Despite its extensive use in various clinical applications, there are concerns 
regarding the toxicity of crystal violet. In particular, it is known to be 
carcinogenic due to its ability to interact with intracellular DNA.135 That said, 
large amounts of crystal violet were used in studies which have shown this; 
therefore, one might argue that if this substance was to be used sparingly, 
then it should not pose a significant risk to human health.130 
1.3.7 Triclosan 
 
Figure 4. Triclosan. 
Since the 1960s, triclosan has been utilised in numerous applications, owing 
to it being a potent broad-spectrum antimicrobial agent.136 Its incorporation 
into various polymeric materials has often resulted in the generation of 
surfaces that are resistant to the adhesion of bacteria and subsequent biofilm 
formation.137,138 There have, however, been instances where the modified 
polymers have not functioned as hoped, with little to no antimicrobial activity 
observed.139,140  
Until 1998, it was presumed that triclosan killed bacteria by interacting with 
multiple cellular sites; however, it has since been shown that it targets a 
specific fatty acid biosynthetic enzyme, enoyl-[acyl-carrier protein] reductase. 
There are thus serious concerns regarding its widespread use, as resistant 
strains of bacteria can evolve in much the same way as they do when 
antibiotics are over-used. Moreover, a number of laboratory based studies 
have shown that bacterial strains which are resistant to triclosan are also not 
affected by some antibiotics: in essence, cross-resistance has been 
observed.136 That said, the use of triclosan in the clinical environment over the 
last few decades has not given rise to a single reported incidence of bacterial 
resistance.138  
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1.3.8 Other non-metallic biocides 
In addition to the previously discussed non-metallic biocidal agents, many 
other disinfectants have been incorporated into, or covalently bound to the 
surface of, various polymers. Three recent examples are given to highlight the 
seemingly limitless range of possibilities with regards to producing effective 
antibacterial surfaces. 
In 2010, Luo et al.141 prepared polyurethane films that were incorporated with 
iodine, a well-known disinfectant. The resultant films demonstrated excellent 
antibacterial, antifungal, and antiviral properties. In the past, other groups have 
developed iodine containing polymers and obtained similar results.31 Luo et 
al.141 showed that iodine containing polyurethane is toxic towards mammalian 
cells when the iodine content is greater than, or equal to, 3.46%. Conversely, 
when the polymer had an iodine content of less than, or equal to, 0.96%, no 
toxicity was observed. Further in vivo studies are required to assess the 
suitability of iodine containing polymers for use as antibacterial surfaces, or as 
medical devices. 
In 2013, Piotto et al.142 synthesised a novel azobenzene compound (Scheme 
8), which they incorporated into polypropylene and low-density polyethylene. 
They discovered that the resultant polymeric films had excellent antibacterial 
and antifungal properties. They found that this was true even when the 
concentration of the azobenzene dye was below 0.01%. 
 
Scheme 8. Synthesis of a novel azobenzene compound.  
In the same year, Tran et al.143 coated poly(vinyl chloride) (PVC), 
polyurethane, and silicone with selenium nanoparticles. They demonstrated 
that the growth of S. aureus was significantly reduced on the surfaces of these 
polymers, when compared with the unmodified control samples.   
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1.3.9 The future of non-metallic disinfectants 
The use of broad-spectrum antimicrobial disinfectants, whether they are 
commercially available or newly synthesised, certainly seems to be a sensible 
strategy that has been employed for the defence of polymeric surfaces from 
bacterial colonisation; however, as is the case for all the aforementioned 
examples, the safety of polymers which have been modified with disinfectants 
should be rigorously assessed. This is particularly true of polymers that are 
incorporated with novel compounds, such as the azobenzene compound 
which was discussed in the previous section. That said, one might argue that 
if the disinfectant in question is covalently bound to the surface of a polymer, 
or if the polymer is not part of some indwelling medical device, then the 
potential toxicity of the antimicrobial agent towards humans is irrelevant. 
1.4 Metallic disinfectants 
For thousands of years, countless civilisations have utilised the antimicrobial 
properties of metals, such as silver, copper, and lead, in numerous 
applications, including water disinfection and food preservation. The Romans, 
for example, built their water pipes out of lead; the Phoenicians stored water 
in silver containers to prevent spoilage. Though these ancient civilisations may 
have been blissfully unaware of the existence of microbes, they can be 
credited with producing the earliest known antimicrobial materials. The ability 
of polymers containing silver/copper salts or nanoparticles to prevent bacterial 
contamination will be evaluated in this section. 
1.4.1 Silver 
Prior to the discovery and subsequent industrial-scale production of 
antibiotics, silver salts were commonly used to prevent the onset of infections 
that can arise if an open wound becomes contaminated with bacteria.144 In 
recent times, many research groups have begun to investigate whether silver, 
either in the form of a salt, or as the metal itself, is effective at preventing the 
microbial contamination of polymeric surfaces.144-147 
Metals, such as silver, are commonly referred to as “non-essential” – that is, 
they have no known biological function. The observed antimicrobial activity of 
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silver is due to the release of Ag(I) ions, as silver itself is chemically inert. It is 
generally accepted that Ag(I) ions can bring about the death of a 
microorganism through a combination of different mechanisms, though none 
of these has been identified as dominant.  
It has been shown by transmission electron microscopy (TEM) that Ag(I) ions 
interact with the cell wall of bacteria, leading to eventual loss of the cellular 
membrane and subsequent cell death.148 One theory is that Ag(I) ions bind 
with sulfhydryl groups present in the cell wall, causing disruption to the 
bacterial electron transport chain. It has also been proposed that Ag(I) ions 
are able to disrupt the chemiosmotic potential of the membrane, by interfering 
with ion transport processes.149 Either way, the end result is death of the cell 
in question. As well as showing binding with the cell wall, TEM has been used 
to demonstrate that Ag(I) ions are able to enter bacterial cells and bind with 
DNA, enzymes, and proteins.148 The binding of Ag(I) ions to DNA, for example, 
causes the DNA to become densely packed, or condensed, thereby 
preventing replication and cell division. It should be noted, however, that it is 
impossible to discern whether the processes that are observed lead to cell 
death, or occur due to the death of the cell.149 
There is also evidence to suggest that reactive oxygen species (ROS), which 
can kill bacteria via a multi-site attack, accumulate in toxic amounts in the 
presence of Ag(I) ions, and that these have a significant effect on the 
antimicrobial activity. It has been shown that the antimicrobial activity of Ag(I) 
ions is enhanced under aerobic conditions, and diminishes when ROS 
scavengers are present;150,151 however, some research groups have obtained 
results that suggest that ROS contribute negligibly to the observed 
antimicrobial activity.152,153 The generation of excess ROS in the presence of 
Ag(I) ions is likely due to: the destruction of Fe-S clusters in the cell, which 
results in the release of Fe(II) ions that can partake in the Fenton reaction 
(Scheme 9);154 and the depletion of thiol-containing anti-oxidant reserves, 
such as glutathione. These processes occur due to the fact that Ag(I) ions are 
“soft” acids, which are able to bind strongly with the sulfur-containing residues 
that are present within the cell.149 
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Fe2+ + H2O2 → Fe3+ + HO− + HO● 
Fe3+ + H2O2 → Fe2+ + HOO● + H+ 
Scheme 9. The iron-catalysed generation of hydroxyl and hydroperoxyl radicals: two potent ROS. 
Up until this point, silver nanoparticles (particles which are less than 100 nm 
in size) have not been mentioned, as their mode of action is thought to be a 
little more complex. Their activity has been shown to be affected by their 
size,155-157 shape,158 and surface charge.159,160  It is known that they kill 
bacteria by releasing Ag(I) ions from the surface, or by binding directly to the 
cellular sites mentioned above. They are of great interest due to the ease with 
which they can be embedded into polymeric matrices,161 and the fact that they 
often exhibit enhanced antibacterial properties.162  
A number of research groups have shown that pre-oxidised silver 
nanoparticles are more effective as antibacterial agents.159,163 In 2011, Xiu et 
al.164 demonstrated that silver nanoparticles that were synthesised and tested 
under anaerobic conditions were non-toxic. Based on this discovery, they 
inferred that Ag(I) ions are solely accountable for any observed antimicrobial 
activity, regardless of whether they are released from the surface of the 
nanoparticle, or remain surface-bound. There are a number of proposed 
mechanisms for the oxidative generation of Ag(I) ions at the surface of silver 
nanoparticles in situ, which means that silver nanoparticles that haven’t been 
pre-oxidised are still effective biocidal agents.153,165,166  
A number of research groups have shown that smaller silver nanoparticles are 
more toxic towards microorganisms than their larger counterparts. It is 
believed that this is due to the fact that smaller nanoparticles have a far greater 
surface area to volume ratio, which means that they are able to generate a 
higher number of Ag(I) ions by mass at the surface.145,159 A major concern for 
these research groups is the potential for aggregation of the silver 
nanoparticles they develop; unsurprisingly, their effectiveness as antibacterial 
agents diminishes with increasing aggregation.163,167 
A number of biomaterials incorporated with silver compounds or nanoparticles 
are commercially available, including wound dressings,168,169 endotracheal 
tubes,170,171 prostheses,172 catheters,45,80,173-176 vascular grafts,177,178 and 
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dental devices;179 however, conflicting results regarding their effectiveness are 
concerning.144,145 Nonetheless, many research groups have developed new 
silver-incorporated polymeric materials, with the expectation that they should 
display superior antibacterial properties.145-147,161,180-185 One popular method 
that’s been employed to achieve this goal involves the encapsulation of silver 
compounds or nanoparticles into polymeric hydrogel coatings. This results in 
the steady release of Ag(I) ions into the surrounding environment over time. A 
more advanced method involves the incorporation of the active silver agent 
into biodegradable coatings. The Ag(I) ions are released upon degradation of 
the coating, which preferably occurs in the presence of bacteria. There is also 
a growing interest in generating combination coatings, with a particular focus 
on combining silver with the previously discussed antibacterial polymer, 
chitosan.       
Even though silver-containing polymeric materials have generally been shown 
to possess favourable antibacterial properties, there are concerns that silver-
resistant bacterial strains could become more widespread. There are two 
mechanisms of resistance that are known to exist. The first involves the 
formation of insoluble silver compounds within the cell, including Ag2S. In this 
way, toxic Ag(I) ions are effectively “mopped up”, and stored as harmless 
salts.145 The second mechanism involves the active removal of Ag(I) ions from 
the cell through efflux pumps.186 It should be noted that neither of these 
mechanisms confer absolute resistance, and will be essentially useless if the 
Ag(I) ion concentration is too high.  
In addition to the development of silver-resistant bacterial strains, there are 
also concerns regarding the toxicity of silver towards mammalian cells; in 
particular, silver nanoparticles have been shown to be toxic towards 
mammalian cells in in vitro and in vivo experiments.187-192 Moreover, although 
Ag(I) ions are commonly regarded as being significantly less toxic towards 
mammalian cells than they are towards bacterial cells,193 there is conflicting 
evidence that suggests that this simply isn’t true.194 Clearly, the toxicity of 
different silver compounds or nanoparticles can only be considered 
individually.  
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Like some strains of bacteria, mammalian cells can sequester Ag(I) ions, 
resulting in the formation of insoluble silver salts. If this occurs in the skin cells, 
this can result in the skin turning a greyish colour. This condition is known as 
argyria. Though not life-threatening, it is certainly not aesthetically pleasing 
either. 
If the use of silver-containing polymeric materials is to be continued, then it 
must be demonstrated that they are both safe to use and effective. The safety 
of indwelling medical devices containing silver, particularly newly-developed 
silver nanoparticles that exhibit enhanced antibacterial properties, should be 
rigorously assessed to ensure that the Ag(I) ion concentration isn’t toxic for 
mammalian cells. Moreover, the use of silver-containing polymeric materials 
for any application should be carefully controlled to ensure that the chance of 
silver-resistant bacterial strains developing is minimised. 
1.4.2 Copper 
Unlike silver, copper is an essential trace element in plants, animals, and 
aerobic microorganisms. It is required for a number of different functions, 
including immune response, tissue repair, and radical scavenging within 
cells.195,196 Despite its importance, it can also be fatally toxic above a certain 
threshold concentration, which is dependent on the organism in question. It is 
thought that Cu ions, particularly Cu(II) ions, are responsible for the observed 
antibacterial activity of copper salts and nanoparticles. Like silver, they can 
bind with various sulfur, oxygen, or nitrogen containing residues that are either 
(i) part of the cell wall, or (ii) part of various intracellular structures, such as 
proteins, enzymes, or DNA. If the cellular environment allows for the 
generation of Cu(I) ions, then these can participate in Fenton-like reactions to 
generate ROS. Through a combination of different mechanisms, which are 
very similar to those that are observed with Ag(I) ions, they are able to induce 
cell death (see section 1.4.1).147,149   
A number of research groups have attempted to produce copper-incorporated 
antibacterial surfaces.147 Recently, for example, Sehmi et al.197 embedded 
silicone and polyurethane with copper nanoparticles via a swell-encapsulate-
shrink process. This involved dissolving the copper nanoparticles in an 
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aqueous solution containing ascorbic acid, and then combining this solution 
with acetone in the ratio 1:9. Immersion of silicone and polyurethane films into 
these solutions caused swelling of the polymer matrix, which facilitated the 
uptake of the copper nanoparticles. Removal of the films from the solution and 
subsequent air-drying overnight resulted in them returning to their original size 
and shape, with the copper nanoparticles embedded in the polymer matrix. 
The copper-incorporated polymers both demonstrated potent biocidal activity 
against methicillin-resistant S. aureus and E. coli. In addition, recent clinical 
studies have shown that frequently touched surfaces that are coated with 
copper or copper alloys, such as door handles, bathroom fixtures, and bed 
rails, are effective at preventing the proliferation of microbes.196 
As for silver, the use of copper should be carefully controlled to ensure that 
copper-modified surfaces are both safe towards humans and effective at 
preventing microbial contamination. The incorporation of materials with copper 
is somewhat less well documented than for silver. This might be because silver 
is easier to handle as, in its metallic form, it is chemically inert. On the other 
hand, copper is prone to oxidation and the formation of potentially unwanted 
CuO. Nonetheless, further investigations into the usefulness of copper-
incorporated materials is warranted, since copper is significantly cheaper and 
more common than silver.  
1.5 Light-activated antibacterial surfaces 
It has long been known that light can cause the destruction of microorganisms 
indirectly, via the activation of certain types of molecules or materials. This 
type of process was first reported in 1900, when Raab et al.198 found that 
acridine hydrochloride exhibited antibacterial properties against P. caudatum 
in the presence of light (Figure 5). In the following sub-sections, the 
bactericidal properties of photocatalytic surfaces, and of surfaces containing 
photosensitiser molecules, will be explored. 
 
Figure 5. Acridine hydrochloride. 
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1.5.1 Photocatalytic surfaces 
A number of semi-conductors, in particular TiO2, have demonstrated 
outstanding self-sterilising properties due to their ability to kill bacteria via a 
photocatalytic mechanism. A semi-conductor has an electronic band structure: 
the lower energy band is filled with electrons, and is known as the valence 
band; the higher energy band is unfilled, and is known as the conduction band. 
The minimum energy required for photoexcitation of an electron from the 
valence band to the conduction band is known as the band gap. The result of 
photoexcitation is the generation of positive “holes” in the valence band (h+vb), 
and the accumulation of excess electrons in the conduction band (e−cb). These 
so called “electron-hole pairs” can recombine rapidly; alternatively, they can 
be “trapped” by suitable electron (3O2) or positive charge (H2O) scavengers, 
thus initiating photocatalytic reactions. The result of these photocatalytic 
reactions is the production of various ROS, including hydroxyl and 
hydroperoxyl radicals (Schemes 10 and 11).199-201 
O2 + e−cb → O2●− 
O2●− + H+ → HOO● 
HOO●− + H+ → HOOH 
HOOH + e−cb → HO● + HO− 
Scheme 10. The photoinduced formation of hydroxyl and hydroperoxyl radicals from oxygen. 
H2O + h+vb → HO● + H+ 
HO− + h+vb → HO● 
Scheme 11. The photoinduced formation of hydroxyl radicals from water. 
The ROS that are generated can oxidise various organic components of 
bacterial cells, particularly of the cell wall or membrane, thereby inducing cell 
death. As numerous cellular sites are targeted, the chance of resistant 
bacterial strains developing is minimal (Scheme 12).199,202 
HO● + RH → R● + H2O 
R● + HO● → ROH 
ROH + HO● → RO● + H2O 
Scheme 12. The oxidation of organic components by hydroxyl radicals. 
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It has also been proposed that organic components could be directly oxidised 
by the electron-hole pairs (Scheme 13).202-206 
RH + h+vb → R● + H+ 
R● + O2 → ROO● 
ROO● + RH → ROOH + R● 
ROOH + e−cb → RO● + HO− 
Scheme 13. The oxidation of organic components by electron-hole pairs. 
Over a period of time, organic matter adhered to the surface will undergo 
complete oxidation to form CO2 and H2O. This means that photocatalytic 
surfaces are self-cleaning, as well as being self-sterilising.199,202 
It is known that biomedical materials that have been manufactured with Ti 
alloys demonstrate excellent antibacterial and antiadhesive properties. This is 
due to the development of a nanometric TiO2 layer on the surface of such 
alloys, which results from spontaneous oxidation.207 There is thus a growing 
interest in coating different materials, from stainless steel to silicone, with TiO2, 
using numerous techniques, including a sol-gel process,208-211 anodic 
oxidation (Ti alloys only),207 electrophoretic deposition,212 chemical vapour 
deposition,213,214 plasma immersion ion implantation,215-218 and plasma 
spray.219 In the vast majority of cases, the materials that have been produced 
have proven to be effective at preventing the adhesion and subsequent 
formation of bacterial colonies.220 Some research groups have even coated 
indwelling medical devices, such as catheters, with TiO2. For example, 
Sekiguchi et al.221 investigated the efficacy of TiO2-coated catheters in an in 
vivo experiment, and found them to be highly effective with regards to 
preventing microbial adhesion.   
The photocatalytic activity of TiO2-coated surfaces can be altered by changing 
the proportions of the three main polymorphs of TiO2 (rutile, anatase, and 
brookite). Although rutile has the smallest band gap, anatase is considered to 
be the most photochemically active phase. A number of studies have 
demonstrated that mixed phases (e.g. anatase and rutile, or anatase and 
brookite) are more active than anatase alone.222,223  
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Another strategy to improve the photocatalytic efficacy of TiO2-coated surfaces 
involves doping with another metal or non-metal.224-230 In particular, many 
research groups are interested in producing composites that have a smaller 
band gap than pure TiO2 coatings, which would enable them to utilise the 
energy of visible light. In this area, there has been a lot of interest in N-doped 
TiO2 thin films, as they are generally cheap and easy to produce.224   
The ability of materials coated with photocatalytic compounds, particularly 
TiO2, to prevent bacterial contamination is well documented. In the case of 
TiO2, it is both inexpensive and non-toxic; therefore, it is easy to envisage its 
utilisation in a huge range of different applications where antibacterial and 
antiadhesive properties are desirable.231 The mechanisms by which TiO2-
coated surfaces kill bacteria means that the likelihood of resistant bacterial 
strains developing is small.202 Despite these advantages, the vast majority of 
TiO2-coated surfaces require activation with UV light. The use of efficient UV 
light generating sources can be impractical, and in some cases wholly 
inappropriate (for example, with regards to the de-contamination of indwelling 
medical devices).220 Though a number of groups have tried to decrease the 
band gap of TiO2 by altering the chemical properties of these materials,224,225 
the incorporation of polymeric materials with photosensitiser molecules that 
absorb light in the visible region of the electromagnetic spectrum might prove 
to be a more sensible strategy for overcoming this limitation. 
1.5.2 Surfaces incorporated with photosensitiser molecules 
In 1973, Blossey et al.232 reported the covalent attachment of the 
photosensitiser Rose Bengal to chloromethylated polystyrene beads via an 
SN2 reaction. It should be noted, however, that the only evidence for 
successful covalent attachment was that the dye does not wash off the 
surface. This observation may simply imply that Rose Bengal is physically 
adsorbed to the surface. Nonetheless, in 1978 Bezman et al.233 demonstrated 
that polystyrene beads with covalently attached Rose Bengal moieties, as 
prepared by Blossey et al.,232 were able to effect the photoinactivation of E. 
coli with visible light and oxygen. Since these studies were carried out, a 
number of research groups have investigated different methods for preparing 
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polymers with incorporated photosensitiser dyes, including various porphyrins, 
crystal violet, methylene blue, toluidine blue O, and Rose Bengal. Their 
findings will be discussed in detail below. These molecules tend to contain at 
least one heterocyclic ring, and have extensive conjugated π-systems (Figure 
6).234 
 
Figure 6. Examples of different types of photosensitiser molecules. 
The mechanism of bacterial kill via the light-activation of a photosensitiser 
molecule is best described with the help of a Jablonski diagram (Figure 7). The 
first step involves absorption of a photon of light, which results in promotion of 
the photosensitiser molecule from its ground state (S0) to an excited singlet 
state (S1). This is immediately followed by vibrational relaxation to the lowest 
energy vibrational state. A radiationless process known as intersystem 
crossing (ISC) then occurs, which results in the molecule being in an excited 
triplet state (T1). The triplet state has a longer life time as relaxation to the 
singlet ground state is spin forbidden. If the molecule doesn’t undergo internal 
conversion or phosphorescence first, it can transfer an electron or energy to 
surrounding molecules, such as water and oxygen. Electron transfer 
processes are referred to as type I, while energy transfer processes are 
designated type II. The type I process requires the interaction of the excited 
state molecule with another molecular substrate, such as water. The outcome 
of this is the formation of a variety of ROS, like those that are generated in the 
TiO2 photocatalytic process. The type II process involves quenching with 
molecular oxygen in the environment, which affords the very reactive singlet 
oxygen species. The combination of ROS, including singlet oxygen, unleashes 
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a multi-site attack mechanism against microorganisms. The prospect of 
developing bacterial resistance is therefore minimal, as the chance of bacteria 
developing more than one type of resistance gene simultaneously is very 
small.234 
 
Figure 7. A Jablonski diagram outlining the mechanism of light-activation of a generic photosensitiser. 
1.5.2.1 Porphyrins 
Polymers with incorporated dyes have exhibited excellent bacterial kill, and 
have also proven to be highly successful at preventing the formation of, or 
destroying, bacterial biofilms on the surface when exposed to a visible light 
source.234 There has been a growing interest in the ability of porphyrins to 
protect polymeric surfaces from bacterial contamination in recent years.235 In 
addition, they have been utilised in a number of other applications,236 most 
notably photodynamic therapy.235,237,238 
There are several different methods by which porphyrins, amongst other dyes, 
might be incorporated into a polymer. In 1993, Bonnett et al.239 utilised three 
different techniques to generate a series of porphyrin-incorporated polymer 
films: impregnation, by immersion of the polymer in a solution of the porphyrin; 
co-dissolution of the polymer and the dye, followed by casting; and co-
polymerisation of porphyrin containing monomers to generate polymers with 
covalently bound porphyrins. They noticed that the charge of the porphyrin 
was often important; for example, regenerated cellulose showed a greater 
affinity for cationic porphyrins over neutral or anionic porphyrins. Clearly, the 
best porphyrin in a given situation might prove to be completely ineffective in 
different circumstances. 
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In recent years, there has been increasing interest in the development of 
polymers with covalently bound porphyrins.240-249 In 2003, the Michielsen 
group covalently grafted protoporphyrin IX and zinc protoporphyrin IX to the 
surface of nylon-6,6 films.240,241 They first grafted poly(acrylic acid) to the 
surface, and then reacted the modified surface with ethylene diamine 
derivatives of the aforementioned porphyrins (Scheme 14). The group then 
demonstrated that both modified surfaces were active against S. aureus and 
E. coli in the presence of a light source. Of the two materials, that which 
contained zinc protoporphyrin IX was the more effective. 
 
Scheme 14. The preparation of modified nylon films with covalently grafted (zinc) protoporphyrin IX, as described 
by Sherrill et al.240 
Since 2003, many other research groups from around the world have 
covalently attached different types of porphyrins to a variety of different 
polymers. A number of groups have utilised the intrinsic reactivity of polymers 
such as cellulose,243-249 which contains hydroxyl groups; and chitosan,242 
which contains amino groups, in order to achieve their goals. Meanwhile, other 
research groups have conducted polymerisation reactions with,250 or in the 
presence of,251,252 appropriately functionalised porphyrins in order to generate 
the corresponding polymers. In many cases, it has been demonstrated that 
the resultant materials exhibit antibacterial properties in the presence of light. 
It has, however, been noted that porphyrin-incorporated materials are 
significantly more active against Gram-positive bacteria than they are against 
Gram-negative bacteria.241  
In 2011 Ringot et al.247 demonstrated that a surface-bound cationic porphyrin 
was more photoactive against S. aureus than a surface-bound neutral 
porphyrin, which was itself more active than a surface-bound anionic 
porphyrin. The relative effectiveness of cationic porphyrins as 
photobactericidal agents has been alluded to elsewhere, so this result is 
perhaps not entirely surprising.253-255 Though a number of different research 
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groups have investigated the biological activity of porphyrins with different 
charges, few studies have been carried out to explore the effect of more subtle 
structural changes.   
The effect of combining porphyrins, or related compounds, with metal 
nanoparticles, has been investigated in recent years. For example, Lyutakov 
et al.256 demonstrated that polymethylmethacrylate films that were doped with 
meso-tetraphenylporphyrin and silver nanoparticles were more efficacious at 
killing bacteria than those which were incorporated with only one or the other. 
1.5.2.2 Phenothiazinium dyes 
The ability of polymers that are incorporated with dyes other than porphyrins 
to resist bacterial contamination has also been extensively studied. In 
particular, there have been a number of investigations into the usefulness of 
phenothiazinium dyes, such as methylene blue and toluidine blue O. These 
cationic dyes, which are derived from phenothiazine, have frequently exhibited 
excellent antibacterial properties, both in solution and when incorporated into 
a polymer. In 1997, Wainwright et al.257 tested the relative photobactericidal 
activities of the following phenothiazinium dyes: toluidine blue O, methylene 
blue, methylene green, and dimethyl methylene blue. They compared the 
activities of these dyes with two acridine photosensitisers: acridine orange and 
proflavine. They discovered that, in general, the photobactericidal activities of 
the phenothiazinium dyes were more pronounced. Of the phenothiazinium 
dyes, toluidine blue O was shown to be the most effective photosensitiser 
against the following strains of bacteria: P. aeruginosa, E. coli, and E. faecalis.  
In 2003, Wilson et al.258 demonstrated that cellulose acetate films which were 
incorporated with toluidine blue O were effective at killing S. aureus and P. 
aeruginosa after one day of white light illumination. Three years later, the same 
group incorporated cellulose acetate with a combination of toluidine blue O 
and Rose Bengal, an anionic dye.259 It was shown that cellulose acetate films 
containing toluidine blue O and Rose Bengal could reduce the viable count of 
several different bacterial strains (S. aureus, methicillin-resistant S. aureus, C. 
difficile, and E. coli) to below the detection limit after white light illumination for 
up to sixteen hours. They were also effective at killing suspensions of S. 
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aureus that were sprayed onto the surface.260 Further studies have 
demonstrated the ability of cellulose acetate coatings that contain toluidine 
blue O and Rose Bengal to reduce the levels of bacterial contamination in a 
clinical environment.261 
In 2009, the photobactericidal properties of silicone films incorporated with 
combinations of either methylene blue and gold nanoparticles, or toluidine blue 
O and gold nanoparticles, were investigated.262,263 It should be noted that gold 
nanoparticles do not display any antibacterial properties; moreover, unless 
otherwise stated, the gold nanoparticles that were used were 2 nm in diameter. 
The Parkin group found that gold nanoparticles enhanced the ability of 
methylene blue-incorporated silicone films to kill bacteria in the presence of 
light, but that this effect was not observed with silicone films that were 
incorporated with toluidine blue O. It was, however, apparent that silicone films 
that were incorporated with toluidine blue O were vastly more effective at killing 
bacteria than those which contained methylene blue, with or without gold 
nanoparticles. The latter observation is perhaps not surprising when one takes 
into consideration the previous observations of Wainwright et al.,257 discussed 
above. The observation that methylene blue in the presence of gold 
nanoparticles displays enhanced light-induced antibacterial properties is 
rather more intriguing, and has been the subject of further studies. In 2012, 
Noimark et al.264 conducted a series of time-resolved electron paramagnetic 
resonance experiments with PVC films that had been incorporated with 
methylene blue and gold nanoparticles. The results suggested that methylene 
blue triplet state production is enhanced by the presence of the gold 
nanoparticles. Further studies have shown that larger gold nanoparticles (5 
nm or 20 nm) do not enhance the activity of methylene blue.265 In addition, 
silicone films that were embedded with a combination of methylene blue and 
gold nanoparticles were effective at preventing the formation of bacterial 
biofilms,266 killing S. aureus when illuminated with a white light source (as 
opposed to a laser light of a particular wavelength),267 and preventing the 
bacterial contamination of hospital surfaces in a clinical trial.268 
In all the previously discussed examples, toluidine blue O or methylene blue 
was incorporated into the polymer in question via a swell-encapsulate-shrink 
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process, and was thus physically adsorbed to the polymeric matrix. In 2009, 
Piccirillo et al.269 produced two different silicone polymers with covalently 
bound methylene blue, or toluidine blue O, moieties. They first functionalised 
the surface of silicone with (MeHSiO)n in the presence of triflic acid. This 
afforded them a polymer with Si-H bonds, which was then reacted with a 
functionalised PEG linker containing an allyl ether in a hydrosilylation reaction. 
The resultant polymer was treated with methylene blue or toluidine blue O in 
PBS solution (Scheme 15). The dye-functionalised polymers exhibited 
excellent photobactericidal activities against E. coli and S. epidermidis. 
Unfortunately, the use of expensive and/or harsh reagents throughout this 
synthesis, such as platinum-divinyltetramethyldisiloxane complex or triflic acid, 
means that it is not industrially viable. There is thus an interest in developing 
new and improved routes towards light-activated antibacterial surfaces with 
covalently bound phenothiazinium dyes. 
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Scheme 15. The synthesis of a silicone polymer with covalently attached toluidine blue O moieties, as described by 
Piccirillo et al.269 
1.5.2.3 Crystal violet 
In 2013, Noimark et al.270 incorporated silicone with crystal violet, and when 
they exposed the resultant polymer to laser light, discovered that it was 
significantly more effective at killing bacteria (S. epidermidis and E. coli) than 
silicone which was incorporated with methylene blue and gold nanoparticles. 
As with methylene blue, they found that gold nanoparticles enhanced the 
photobactericidal properties of crystal violet. More recently, it was also 
demonstrated that a crystal violet-incorporated silicone film was able to kill S. 
aureus and E. coli in the presence of a white light source.271 A year later, 
Noimark et al.272 produced a silicone film which was incorporated with a 
combination of crystal violet, methylene blue, and gold nanoparticles. They 
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showed that it was even more potent at killing bacteria (S. epidermidis and E. 
coli) than a silicone film which contained only crystal violet and gold 
nanoparticles. Moreover, they found that this new polymer could kill bacteria 
in the dark, although it was markedly less efficacious under these conditions. 
The usefulness of this polymer has been demonstrated practically: Page et 
al.273 developed photobactericidal mobile phone and tablet screen protectors 
by incorporating them with methylene blue, crystal violet, and gold 
nanoparticles.  
In further studies, the ability of zinc nanoparticles to improve the antibacterial 
properties of crystal violet-incorporated silicone films was investigated.274,275 It 
was found that the film containing both crystal violet and zinc nanoparticles 
was more effective than films containing only crystal violet or zinc 
nanoparticles. In 2015, Sehmi et al.276 observed similar results with crystal 
violet-incorporated polyurethane films; however, they also found that the 
polymer containing crystal violet and zinc nanoparticles killed 99.9% of S. 
aureus (after two hours) and E. coli (after four hours) in the dark. The polymer 
demonstrated even more impressive kill rates when exposed to white light. 
Considering the outstanding performance of this polymer, and the excellent 
activity that has been observed when crystal violet is combined with methylene 
blue and gold nanoparticles, it would surely be prudent to assess the 
photobactericidal properties of polymers containing the following 
combinations: (i) crystal violet, methylene blue, and zinc nanoparticles; and (ii) 
crystal violet, methylene blue, zinc nanoparticles, and gold nanoparticles.  
Although crystal violet has been incorporated into different polymers on a 
number of separate occasions, it has never been covalently attached to a 
polymer surface. The main reason for this is that crystal violet does not contain 
any reactive functional groups that enable its modification; therefore, to enable 
its covalent attachment to a polymer surface, one would have to synthesise a 
suitably functionalised crystal violet derivative. 
The effectiveness of various light-activated antibacterial agents at reducing the 
bacterial load on surfaces has been highlighted in this section. As they are 
able to kill bacteria by the generation of ROS when illuminated, there are no 
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concerns regarding the development of bacterial strains that are resistant to 
this method of eradication; however, ROS can oxidise the dye molecules 
themselves, in a process which is known as photobleaching.277 That said, 
photobleaching has not been reported as being a problem with the previously 
described dye-incorporated polymer systems; therefore, the incorporation of 
polymers with light-activated antibacterial agents would appear to be an 
excellent strategy to combat bacterial contamination.     
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2 Results and discussion 
One of the main goals of this project was to covalently attach small organic 
dye molecules, which exhibit antibacterial activity by light-activation, to the 
surface of a polymer. It was proposed that there would be two major 
advantages associated with having dyes covalently attached to a polymer 
surface, instead of them being physically adsorbed; both of which are due to 
the fact that the dye should not be lost from the surface over time. Firstly, the 
toxicity of various dyes towards mammalian cells would be irrelevant. 
Secondly, one would expect that the antibacterial lifetime of the surface should 
be greatly extended. Of course, a major disadvantage could be that chemical 
modification of a polymer surface might give it undesirable physical properties; 
however, if only a small percentage of the surface is modified it is thought that 
any changes would have a negligible effect on the physical properties of the 
bulk polymer.278 
There are a number of reports in the literature describing the covalent linkage 
of alkyne or azide containing molecules to the surface of an appropriately 
functionalised polymer surface, via a 1,3-dipolar cycloaddition reaction 
(Scheme 16).9,103,246,248,279-284  
 
Scheme 16. A generic 1,3-dipolar cycloaddition reaction between an azide-functionalised polymer surface and an 
alkyne-functionalised antimicrobial molecule (AM).  
It was felt that this approach could be utilised for the preparation of 
antimicrobial polymers with covalently bound photosensitiser molecules of the 
triarylmethane and phenothiazine classes, such as crystal violet and 
methylene blue respectively. In the past, compounds such as these have been 
shown to be highly effective at preventing the bacterial colonisation of various 
polymeric surfaces.234 There is, however, only one known publication that 
describes the covalent attachment of both methylene blue and toluidine blue 
O to the surface of a silicone polymer. The disadvantages of the route used 
by Piccirillo et al.269 are described extensively in the introduction (See section 
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1.5.2.2). At the time of writing, there are no known examples describing the 
covalent grafting of crystal violet, or closely related analogues, to the surface 
of any polymer. 
2.1 Preparation of alkyne-functionalised dyes, and their 
antibacterial activities 
In the following sections, the attempts to synthesise a variety of analogues of 
methylene blue, toluidine blue O and crystal violet are described. In every 
case, it was intended that the final product would contain an alkyne substituent 
that would allow for its covalent attachment to a pre-modified polymer which 
contained azide functionality. It was felt that alkyne-containing small molecules 
would be easier to handle than those containing azides, which have the 
potential to be explosive.  
The direct chemical modification of dyes such as crystal violet and methylene 
blue was not deemed to be a feasible approach. These compounds have no 
reactive functional groups that could be manipulated to generate analogues 
containing alkyne substituents. In addition, it was decided that a good 
approach would involve the formation of the charged, modified dye in the final 
step of the synthesis. This is because both methylene blue and crystal violet 
are water soluble, thus it was felt that the purification of the modified dyes 
might prove to be challenging. 
2.1.1 Methylene blue analogues 
 
Figure 8. Methylene blue. 
In 2007, Wischik et al.285 described the synthesis of a number of different 
phenothiazine salts, as well as their precursors. It was thus postulated that a 
variety of methylene blue analogues could be accessed by the following route, 
which is outlined in the retrosynthetic analysis below (Scheme 17). 
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Scheme 17. The proposed synthetic route towards different methylene blue analogues. 
The first step of the proposed synthesis involves the di-nitration of 
commercially available phenothiazine to give di-nitro compound 1. This is 
followed by acetylation to give the corresponding acetylated di-nitro compound 
2, and then reduction of the nitro substituents to generate diamine 3. It was 
hoped that mono-alkylation at one of the amino positions could then be 
achieved, with a pre-prepared or commercially available alkyne, to give mono-
alkylated diamine 4. Finally, methylation of the remaining positions, de-
acetylation, and oxidation would afford methylene blue analogue 5. In theory, 
methylene blue analogue 5 could be covalently attached to an azide-
functionalised polymer surface by a 1,3-dipolar cycloaddition, as described 
above. Of course, the reduced form of the methylene blue analogue in 
question could be linked to a pre-functionalised polymeric surface before 
undergoing oxidation, if the former approach was unsuccessful.  
The di-nitration of phenothiazine with NaNO2 in acetic acid and 
dichloromethane (DCM) to give 3,7-dinitrophenothiazine 1 did not work as 
described by Wischik et al.285 initially. When the reaction was left for three 
hours, as specified in the literature, the crude yield of di-nitro compound 1 was 
only 20%. It was thought that this was due to the reaction not going to 
completion, as only di-nitro compound 1 was expected to precipitate out of the 
reaction mixture (See section 4.2). Further experiments were thus attempted, 
where the number of equivalents of NaNO2 was increased from six to eight, 
and the reaction time was extended to six hours. No notable increase in 
product yield was obtained, so the original reaction conditions were re-
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investigated. In this instance, more satisfactory yields of up to 52% were 
obtained (Scheme 18).285 
 
Scheme 18. Di-nitration of phenothiazine. 
The acetylation of di-nitro compound 1 using acetic anhydride in N,N-
dimethylformamide (DMF) with triethylamine gave the corresponding 
acetylated di-nitro compound 2 in yields of up to 75% (Scheme 19).286  
 
Scheme 19. Acetylation of di-nitro compound 1. 
The reduction of acetylated di-nitro compound 2 with SnCl2.2H2O in ethanol 
afforded diamine 3 in moderate yields of up to 63% (Scheme 20).285 
 
Scheme 20. Reduction of acetylated di-nitro compound 2. 
Prior to attempting to attach an alkyne motif to diamine 3, two model systems 
were tested to try to discern the best method for mono-alkylation of one or both 
of the amine substituents.287,288 The SN2 reactions of aniline and 4-
aminobenzoic acid with benzyl bromide were investigated: low to moderate 
yields were obtained in all cases. The di-alkylated product was always 
observed, along with other unidentifiable by-products. Sadly, the attempted 
alkylation of diamine 3 gave complex mixtures under two different sets of 
conditions (Table 1). 
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Table 1. Attempted mono-alkylation of aniline, 4-aminobenzoic acid, and diamine 3. 
It was proposed that a slightly different approach might overcome this problem. 
In theory, the conversion of diamine 3 to an imine, followed by reduction and 
then methylation, would give the corresponding leucomethylene blue 
analogue. The reaction between diamine 3 and benzaldehyde to give the 
corresponding imine 7, followed by reduction with sodium borohydride to give 
secondary diamine 8, and finally methylation with methyl iodide to give 
leucomethylene blue analogue 9, was attempted, and gave a complex mixture 
(Scheme 21). Unfortunately, it was not possible to isolate any of the 
intermediates. 
 
Scheme 21. Attempted reductive alkylation of diamine 3. 
Finally, the formation of 10-acetyl-3,7-bis(dimethylamino)phenothiazine 10 
was attempted, as described in the literature, but only a 3% crude yield of the 
desired product was obtained (Scheme 22).285 At this point, attempts to 
prepare alkyne-functionalised methylene blue analogues were abandoned.  
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Scheme 22. Attempted synthesis of 10-acetyl-3,7-bis(dimethylamino)phenothiazine 10. 
2.1.2 Toluidine blue O analogues 
 
Figure 9. Toluidine blue O. 
Considering the difficulties encountered in the attempted synthesis of 
methylene blue analogues, and the fact that both methylene blue and toluidine 
blue O contain the same phenothiazine motif, the proposed route to synthesise 
analogues of toluidine blue O was by starting with the dye itself (Scheme 23). 
In this instance, it was felt that direct functionalisation might be possible 
because toluidine blue O contains a primary aniline substituent, which can 
participate in chemical reactions. 
 
Scheme 23. Proposed synthesis of toluidine blue O analogues. 
The reduction of toluidine blue O to form the corresponding leuco dye 11 was 
attempted using two different methods, but no product was obtained in either 
case (Table 2).286,289 
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Table 2. Attempted reduction of toluidine blue O. 
Instead of trying to isolate leuco dye 11, a one-pot reaction was attempted 
where reduction under basic conditions was followed immediately by alkylation 
with propargyl bromide to give mono-alkylated leuco dye 12 (Scheme 24).286 
Once again, the desired product was not obtained. 
 
Scheme 24. Attempted synthesis of mono-alkylated leuco dye 12. 
Rather than continuing to investigate phenothiazine based dyes, it was 
decided to attempt the formation of alkyne-functionalised crystal violet 
analogues. In a recent publication, Noimark et al.270 had showed that crystal 
violet incorporated into medical grade silicone exhibited excellent 
photobactericidal properties, and also induced significant reduction in the 
numbers of bacterial colonies in the dark.  
2.1.3 Crystal violet analogues via a Grignard reaction 
 
Figure 10. Crystal violet. 
In 1996, Taber et al.290 demonstrated that it was possible to synthesise crystal 
violet and malachite green via a Grignard reaction (Scheme 25). 
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Scheme 25. Synthesis of malachite green and crystal violet, as described by Taber et al.290 
It was postulated that similar conditions could be used to synthesise an alkyne-
containing crystal violet analogue. To achieve this, the synthesis of an alkyne-
functionalised tertiary amino benzoate was proposed. This could then be 
reacted with the Grignard reagent, 4-(N,N-dimethylamino)phenyl magnesium 
bromide, which is prepared from commercially available 4-bromo-N,N-
dimethylaniline, to give the desired crystal violet analogue. The 
aminobenzoate could be prepared in three steps, beginning with the 
esterification of 4-aminobenzoic acid to give methyl 4-aminobenzoate 13. This 
would be followed by mono-methylation of the amino position to give methyl 
4-(methylamino)benzoate 14. Finally, alkylation with an alkyne-containing 
alkyl halide would give the desired alkyne-functionalised tertiary 
aminobenzoate. The retrosynthetic analysis is detailed below (Scheme 26). 
 
Scheme 26. Proposed synthesis of crystal violet analogues. 
The first step involved the acid-catalysed esterification of 4-aminobenzoic acid 
with methanol to give methyl 4-aminobenzoate 13 in yields of up to 70% 
(Scheme 27).291 
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Scheme 27. Esterification of 4-aminobenzoic acid. 
The most direct route towards an alkyne-functionalised crystal violet analogue 
would have involved mono-methylation of the primary amino substituent in the 
next step. The conditions of Gray et al.287 did not give as good a yield of methyl 
4-(methylamino)benzoate 14 as hoped (Scheme 28). The reaction was 
sluggish: even after thirty-six hours a 3:1 mixture of starting material to product 
was obtained. Another issue that was encountered was that the addition of 
extra methyl iodide gave rise to methyl 4-(dimethylamino)benzoate 
exclusively: an undesired by-product. 
 
Scheme 28. Attempted mono-methylation of methyl 4-aminobenzoate 13. 
Instead, a two-step route towards methyl 4-(methylamino)benzoate 14, 
involving reductive amination, was investigated. The first step involved 
formylation of methyl 4-aminobenzoate 13 to afford the corresponding 
formamide 15. Initially, two sets of conditions were explored for this reaction: 
one involved the use of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC), a carboxyl activating agent, with formic acid; the other 
involved the formation of formic acetic anhydride by the reaction of formic acid 
and acetic anhydride, which was then reacted with methyl 4-aminobenzoate 
13. Unfortunately, both reactions gave low yields of 16% and 17% respectively 
(Scheme 29). 
 
Scheme 29. Formylation of methyl 4-aminobenzoate 13. 
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As EDC is quite expensive relative to acetic anhydride and formic acid, 
attempts to optimise the latter reaction were undertaken. In the above reaction, 
diethyl ether was added to formic acetic anhydride, and methyl 4-
aminobenzoate 13 was added to this mixture as a solution in DCM. It was 
decided to repeat the reaction in DCM instead of using diethyl ether. Once the 
reaction was complete, the reaction mixture was concentrated in vacuo, before 
removal of any impurities by dissolution of the residue in diethyl ether and 
subsequent removal of insoluble impurities by filtration. This gave vastly 
improved yields of up to 64% (Scheme 30). In some cases, where it proved 
difficult to remove residual acetic acid, the resultant product was washed with 
water. The desired product was obtained as a mixture of rotamers in a ratio of 
3:1. 
 
Scheme 30. Synthesis of formamide 15. 
The reduction of formamide 15 using BH3-THF, dissolved in tetrahydrofuran 
(THF), gave methyl 4-(methylamino)benzoate 14 in yields of up to 84% 
(Scheme 31). It was found that the intermediate boron species was quenched 
by the dropwise addition of methanol, and that refluxing this species in 6M HCl 
(the method used by another research group for a much more complex 
compound), gave no product.292 
 
Scheme 31. Reduction of formamide 16. 
The next step in the synthesis required the alkylation of methyl 4-
(methylamino)benzoate 14 with a pre-synthesised, or commercially available, 
alkyne motif. The alkylation was tested using benzyl bromide and the 
conditions of Srivastava et al.,288 and tertiary aminobenzoate 16 was obtained 
in a moderate yield of 57% (Scheme 32). 
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Scheme 32. Alkylation of methyl 4-(methylamino)benzoate 14. 
The proposed double-Grignard reaction was attempted with tertiary 
aminobenzoate 16: 4-bromo-N,N-dimethylaniline was reacted with 
magnesium turnings in THF to generate the Grignard reagent 17, to which was 
added tertiary aminobenzoate 16 (Scheme 33). 
 
Scheme 33. Attempted synthesis of crystal violet analogue 18. 
It was not possible to isolate the product 18 from this reaction, if it was formed 
at all. After an aqueous work-up, a small amount of blue solid was isolated, 
which was an unidentifiable mixture of compounds. At this stage, another route 
towards alkyne-functionalised crystal violet analogues had been identified, 
and was deemed to be worthy of further exploration. 
2.1.4 Leucocrystal violet analogues from Michler’s hydrol 
A different route, involving the synthesis of a leucocrystal violet analogue, was 
postulated as being a better method for preparing a variety of crystal violet 
analogues. It was proposed that the leuco dye could be attached to the surface 
before being oxidised to the photoactive coloured form. Any difficulties 
associated with the purification of charged dyes would thus be overcome as, 
in theory, any by-products from the oxidation reaction could simply be washed 
from the surface. 
The proposed synthesis of a variety of different leucocrystal violet analogues 
involved two steps, not including the formation of an appropriately 
functionalised tertiary aniline. Firstly, bis(4-(dimethylamino)phenyl)methanone 
James Rudman 
60 
 
(Michler’s ketone) 19 would be reduced to bis(4-
(dimethylamino)phenyl)methanol (Michler’s hydrol) 20. Secondly, an acid-
catalysed reaction between Michler’s hydrol 20 and a pre-prepared tertiary 
aniline alkyne motif would give the corresponding leucocrystal violet analogue 
(Scheme 34).293,294 
 
Scheme 34. Proposed synthesis of leucocrystal violet analogues. 
The preparation of Michler’s hydrol 20 was more problematic than originally 
anticipated. Costero et al.295 previously claimed that the reduction of Michler’s 
ketone 19 with NaBH4 gave Michler’s hydrol 20 in an excellent yield of 95%. 
The reaction was attempted as described, and also with subtle changes to the 
reaction conditions. In addition, other reducing agents were tested, but only 
conversions of up to 40% were achieved (Table 3). 
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Table 3. Reduction of Michler’s ketone 19. 
The results indicate that the reaction was very sensitive to the batch of NaBH4 
that was used. Moreover, the concentration of the reaction mixture, as well as 
the presence or absence of air, were found to be important factors. The use of 
ethanol seemed to improve the % conversion significantly over the use of 
methanol or THF. The greater reactivity of LiBH4 over NaBH4, due to the more 
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strongly polarising Li+ ion that coordinates with the carbonyl in the rate 
determining step, was apparent.  
Fortunately, it was discovered that the powerful reducing agent, LiAlH4, gave 
complete conversion after one hour. The crude product could be recrystallized 
from benzene to give Michler’s hydrol 20 in yields of up to 79%; however, the 
capricious nature of this reaction meant that the purity of the crude product 
was variable and thus yields could vary quite dramatically (Scheme 35). 
 
Scheme 35. Reduction of Michler’s ketone 19 using LiAlH4. 
Having successfully synthesised Michler’s hydrol 20, two different alkyne-
containing tertiary anilines 21 and 22 were identified as target compounds 
(Figure 11). One of the substrates contains an alkyne moiety that is conjugated 
with an aromatic ring, the other contains an isolated alkyne. It was 
hypothesised that they would both therefore have differing levels of reactivity 
when, in the future, attempts would be made to react them with an azide-
functionalised surface. 
 
Figure 11. Two tertiary anilines 21 and 22, that were identified as target compounds. 
The reaction between N-methylaniline and propargyl bromide in dimethyl 
sulfoxide (DMSO) with potassium carbonate gave the corresponding tertiary 
aniline 21 in yields of up to 75%. Once again, the procedure of Srivastava et 
al.288 was used (Scheme 36). 
 
Scheme 36. Synthesis of tertiary aniline 21. 
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It was proposed that the other tertiary aniline 22 could be prepared in four 
steps via the following route (Scheme 37). 
 
Scheme 37. Proposed synthesis of tertiary aniline 22. 
The first step of the synthesis involved a Sonogashira cross-coupling reaction 
between an aryl halide and trimethylsilylacetylene to give the corresponding 
trimethylsilyl-protected alkyne 23. Initially, 4-bromotoluene was reacted with 
trimethylsilylacetylene in different solvent systems, and with two different 
palladium catalysts: Pd(PPh3)4 and Pd(PPh3)2Cl2. It was found, however, that 
the yield of trimethylsilyl-protected alkyne 23 was always less than or equal to 
10% after two days of heating under reflux (Table 4; see the first seven 
entries). It was decided that the issue was the poor reactivity of 4-
bromotoluene, so instead 4-iodotoluene was employed as the coupling 
partner. It is known that 4-iodotoluene is more reactive than 4-bromotoluene 
due to the C-I bond being weaker than the C-Br bond. Once again, both 
Pd(PPh3)4 and Pd(PPh3)2Cl2 were tested as catalysts, but only the dichloride 
showed a reasonable level of activity. In addition, various amines were 
screened as solvents, and the best proved to be triethylamine, which 
consistently gave rise to yields of greater than 50% (Table 4; see the final six 
entries). Further improvements to the experimental procedure meant that 
yields of up to 89% could be achieved for this reaction. 
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Table 4. Sonogashira cross-coupling reaction to form trimethylsilyl-protected alkyne 23. 
In nearly every case, the Glaser coupling product 26 was observed in the 
crude 1H NMR spectra and is represented by a singlet at 0.18 ppm,296 but it 
was easily separated from the product by flash column chromatography 
(Figure 12). The Glaser coupling is facilitated by copper (I) salts in the 
presence of oxygen, so the reaction was performed under an inert atmosphere 
of argon. In addition, trimethylsilylacetylene was used in excess to 
accommodate for the occurrence of the Glaser coupling. 
 
Figure 12. Glaser coupling product 26. 
Having successfully synthesised trimethylsilyl-protected alkyne 23, mono-
bromination at the benzylic position was attempted. Initially, the reaction was 
performed in carbon tetrachloride with N-bromosuccinimide (NBS) as the 
brominating agent, and dibenzoyl peroxide as the radical initiator (Scheme 
38). 
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Scheme 38. Mono-bromination of trimethylsilyl-protected alkyne 23. 
It was soon decided that it would be beneficial to find a more suitable solvent 
system for this reaction, due to restrictions in place that make it difficult to 
obtain carbon tetrachloride: it is highly toxic and known to effect ozone 
depletion. Several solvents were screened and the best proved to be 
benzotrifluoride, both in terms of % conversion and with regards to its low 
toxicity (relative to 1,2-dichloroethane, for example). Therefore, 
benzotrifluoride was used in place of carbon tetrachloride for all future repeats 
of this reaction (Table 5). 
 
Table 5. Mono-bromination reaction to form benzylic bromide 24. 
It was later established that performing this reaction in the presence of an IQ 
group floodlight in addition to heating under reflux gave rise to isolated yields 
of up to 60%, as opposed to 30% in the absence of a light source (Scheme 
39). 
 
Scheme 39. Synthesis of benzylic bromide 24. 
The SN2 reaction between benzylic bromide 24 and N-methylaniline in DMSO 
with potassium carbonate gave a mixture of trimethylsilyl-protected tertiary 
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aniline 25 and the desired final product, tertiary aniline 22 (Scheme 40). Once 
again, the procedure of Srivastava et al.288 was used. 
 
Scheme 40. Alkylation of mono-brominated, trimethylsilyl-protected alkyne 24. 
Instead of attempting to isolate trimethylsilyl-protected tertiary aniline 25, 
which was inseparable from tertiary aniline 22 by flash column 
chromatography, the crude product was subjected to proto-desilylation 
conditions. The overall yield across the two steps was 82% (Scheme 41). 
 
Scheme 41. Two-step synthesis of tertiary aniline 22. 
Having synthesised all the required precursors, the preparation of tris(4-
dimethylaminophenyl)methane (leucocrystal violet) 27 was investigated. The 
procedure of Yang et al.294 was tried to begin with, and involved the reaction 
between Michler’s hydrol 20 and N,N-dimethylaniline in toluene in the 
presence of an acid catalyst, p-toluenesulfonic acid. Unfortunately, 
leucocrystal violet 27 was not isolated using these conditions. The procedure 
was investigated and modified, with adjustments being made to the number of 
equivalents of Michler’s hydrol 20 relative to N,N-dimethylaniline, or the crude 
work up.  
By chance, it was noticed that some of the purple solid that was obtained from 
one experiment appeared to be partially soluble in methanol. Immersion of the 
solid in methanol resulted in the formation of a purple solution and an 
insoluble, colourless solid. It transpired that the colourless solid was in fact 
pure leucocrystal violet 27. Based on this discovery, the reaction was 
attempted in methanol as opposed to toluene. The desired product 
precipitated out of the reaction mixture as it formed. It was isolated by filtration, 
washed with methanol, and dried under suction in the dark. It was found that 
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no further purification was necessary, and the reaction gave yields of up to 
81% (Scheme 42).  
 
Scheme 42. Synthesis of leucocrystal violet 27. 
Using the same conditions, Michler’s hydrol 20 was reacted with tertiary aniline 
alkyne precursors 21 and 22, to afford the corresponding leucocrystal violet 
analogues 28 and 29 (Figure 13). 
 
Figure 13. Novel leucocrystal violet analogues 28 and 29. 
The yield for both reactions was poor, which might be because leucocrystal 
violet analogues 28 and 29 are more susceptible to various decomposition 
pathways than leucocrystal violet 27 itself. It is not clear why this should be, 
though. Alternatively, leucocrystal violet analogues 28 and 29 might be more 
soluble in methanol than leucocrystal violet 27; however, none of the 
compounds appeared to dissolve when attempts were made to solubilise 
them. 
2.1.5 Leucocrystal violet analogues from aryl aldehydes 
Having successfully synthesised two novel leucocrystal violet analogues, it 
was decided that it would be interesting to replace one of the nitrogen atoms 
with another heteroatom (for example, O or S). It was anticipated that this 
would give rise to a crystal violet analogue with a significantly different UV-Vis 
absorption profile compared to that of crystal violet itself, thus one would 
expect it to demonstrate altered photobactericidal properties.  
James Rudman 
68 
 
A different route was investigated, involving a reaction between an aryl 
aldehyde and two equivalents of N,N-dimethylaniline to afford the 
corresponding leucocrystal violet motif (Scheme 43).127 
 
Scheme 43. A different approach towards leucocrystal violet analogues. 
Initially, the literature reaction between N,N-dimethylaniline and benzaldehyde 
to give bis(4-dimethylaminophenyl)phenylmethane (leucomalachite green) 30 
was repeated as proof of principle.297 The reaction gave a complex mixture 
when attempted in air, but gave leucomalachite green 30 in a 41% yield when 
conducted under an inert atmosphere of argon (Scheme 44). 
 
Scheme 44. Synthesis of leucomalachite green 30. 
Having synthesised leucomalachite green 30, two aryl aldehyde alkyne motifs 
were identified as suitable synthetic targets (Figure 14). They were chosen 
since they are structurally similar to the tertiary anilines 21 and 22, that were 
prepared previously. 
 
Figure 14. Two alkyne-functionalised aryl aldehydes 31 and 32, that were chosen as synthetic targets. 
The synthesis of the first aryl aldehyde 31 proceeded as reported in the 
literature by Hoogendoorn et al.,298 with yields of up to 79% obtained after 
purification by flash column chromatography. The crude product could, 
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however, be used without purification; crude yields were up to 95% (Scheme 
45).  
 
Scheme 45. Synthesis of aryl aldehyde 31.  
The synthesis of aryl aldehyde 32 was analogous to that which successfully 
yielded tertiary aniline 22 (See section 2.1.4). The previously synthesised 
benzylic bromide 24 was reacted with 4-hydroxybenzaldehyde and potassium 
carbonate in acetone, as described by Hoogendoorn et al.298 The crude 
product was then subjected to basic conditions to remove the trimethylsilyl-
protecting group. The desired product, aryl aldehyde 32, was obtained in yields 
of up to 46% over the two steps (Scheme 46). 
 
Scheme 46. Two-step preparation of aryl aldehyde 32. 
Having successfully synthesised the desired aryl aldehyde alkyne motifs 31 
and 32, attention was turned to the production of the two corresponding 
leucocrystal violet analogues. 
Initially, the conditions of Szent-Gyorgyi et al.297 were used for the preparation 
of leucocrystal violet analogue 33, which was obtained in a low yield of 34%. 
The reaction was attempted using different conditions to try and improve the 
yield (Table 6). 
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Table 6. Synthesis of leucocrystal violet analogue 33. 
Intriguingly, it was found that a higher yield was obtained when an old bottle 
of ZnCl2 was used, instead of a freshly opened one (Table 6; see the first two 
entries). The old “ZnCl2” that was used was very obviously wet, due to the 
absorption of water from the atmosphere over time. Its improved reactivity may 
have been due to the fact that it was predominantly composed of highly acidic 
tetrahedral ZnClχ(OH2)(4 – χ) complexes, which are essentially a source of H+ 
ions and are thus Brønsted acids.299 The reaction was therefore attempted 
with a catalytic amount of acetyl chloride, which was expected to react with 
ethanol to generate hydrochloric acid in situ, in addition to ZnCl2. Under these 
conditions an improved yield of 48% was obtained. The reaction was also 
attempted with a catalytic amount of acetyl chloride only, but poor conversion 
(21%) was achieved after one day. The reaction was then attempted with two 
equivalents of acetyl chloride and the desired product, leucocrystal violet 
analogue 33, was obtained in a moderate yield of 62% (Table 6). These 
conditions were thus used in future repeats of the above reaction. 
Attempts to synthesise the other desired leucocrystal violet analogue from aryl 
aldehyde 32 via an analogous reaction with N,N-dimethylaniline were not 
initially successful. Unfortunately, the attempted attachment of the previously 
synthesised leucocrystal violet analogues to the surface of a polymer had 
failed at this time (See section 2.2). It was decided to focus on oxidising the 
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leucocrystal violet analogues that had already been prepared, and to 
subsequently assess their efficacy as light-activated antimicrobial compounds. 
2.1.6 Oxidation of leucocrystal violet analogues 
Oxidation of the three alkyne-functionalised leucocrystal violet analogues 28, 
29, and 33 was explored. The photobactericidal properties of the resultant 
crystal violet analogues were assessed when incorporated into polyurethane. 
Initially, the oxidation of leucocrystal violet 27 was investigated, as this can be 
synthesised easily from Michler’s hydrol 20 and N,N-dimethylaniline (See 
section 2.1.4). In preliminary studies, it was found that the use of a mild 
oxidant, MnO2, was unsuccessful: no product was obtained using various 
conditions and work-up procedures. Instead, a modified procedure of Szent-
Gyorgyi et al.,297 who oxidised another crystal violet analogue in ethyl acetate 
with chloranil, gave the desired product, crystal violet analogue 34 (Scheme 
47). 
 
Scheme 47. Synthesis of crystal violet analogue 34. 
It was found that extraction with ethyl acetate was not necessary as, upon 
cooling the reaction mixture to r.t., the product precipitated out of the reaction 
mixture. Simply washing the resultant solid with cold ethyl acetate (0 ºC) and 
diethyl ether afforded the desired product.  
Having successfully synthesised crystal violet analogue 34, the other crystal 
violet analogues 35-37 were prepared from the corresponding leuco dyes 28, 
29, and 33 using the same conditions (Figure 15). Unfortunately, it was found 
that one of the products, crystal violet analogue 36, contained ethyl acetate as 
an irremovable impurity (<3% by mass). 
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Figure 15. Crystal violet analogues 35-37. 
The counter-ion, 2,3,5,6-tetrachloro-4-hydroxyphenolate, doesn’t give a 1H 
NMR signal; however, it was identified by negative ion mass spectrometry for 
each of the crystal violet analogues. Signals corresponding to other possible 
anions such as chloride, which was reported as being the counter-ion by 
Szent-Gyorgyi et al.,297 were not observed. 
Each of the above compounds was dissolved in ethanol (1 × 10−5 M); UV-Vis 
absorbance spectra were acquired, and are shown below (Figure 16). 
Unsurprisingly, crystal violet analogues 34-36 each give rise to near identical 
spectra: one peak with a poorly defined shoulder is observed, and the 
absorbance maximum arises between 589-590 nm in each instance. It should 
be noted that the spectra recorded correlate well with those obtained for crystal 
violet itself in the past (λmax at 590 nm in ethanol, for example).300 For the other 
crystal violet analogue 37, where one of the nitrogen atoms is substituted with 
an oxygen atom, a spectrum with two distinct peaks is obtained: one of the 
peaks is red-shifted with an absorbance maximum at 611 nm; the other is blue-
shifted with an absorbance maximum at 459 nm. The drastically different 
spectrum obtained for the latter compound is not unexpected as one would 
expect the introduction of a different heteroatom to have a pronounced effect 
on the electronic properties of the triarylmethyl cation segment of the molecule. 
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Figure 16. UV-Vis absorbance spectra of crystal violet analogues 34-37 dissolved in ethanol. 
2.1.7 Physical and biological characterisation of crystal violet-
polyurethane samples 
Three crystal violet analogues 35-37, whose syntheses are described in the 
previous sections, were incorporated into polyurethane using a simple dip-
coating technique, which had been used previously by Noimark et al.270 This 
involved immersing 1 cm × 1 cm films, which had been cut from a sheet of 
polyurethane, in aqueous solutions of each dye (1 × 10−3 M), and leaving them 
for four days in the dark. The samples were then washed with distilled water, 
dried with paper towels, and air dried in the dark overnight (Figure 17).  
 
Figure 17. Polyurethane samples that were incorporated with crystal violet analogues 35, 36, and 37 (from left to 
right). 
The dye-incorporated samples were analysed by FT-IR and UV-Vis 
absorbance spectroscopy. 
No significant differences between the FT-IR spectra of unmodified 
polyurethane, and of the dye-incorporated polymer samples, were observed. 
This indicates that the incorporation process did not result in any significant 
changes to the chemical structure of the polyurethane. Only peaks associated 
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with the polyurethane polymer matrix were observed. The absence of peaks 
corresponding to the presence of the dye molecules can be attributed to the 
low concentration of dye present relative to the bulk polymer. 
The UV-Vis absorbance spectra of the dye-incorporated polymer samples 
were obtained (Figure 18). As expected, unmodified polyurethane does not 
absorb visible light. The polyurethane samples incorporated with crystal violet 
analogues 35 and 36 gave rise to peaks with absorbance maxima at 600 ± 5 
nm. Additionally, shoulder peaks at roughly 550 nm can be seen. For the 
sample incorporated with crystal violet analogue 37, a stronger absorption 
maximum at 620 ± 5 nm was observed, along with a smaller peak at 465 ± 5 
nm. The spectral values obtained are close to those obtained from the solution 
phase measurements for each of the dyes dissolved in ethanol (See section 
2.1.6). A bathochromic shift of roughly 10 nm was observed in each instance 
for the dyes when incorporated into polyurethane. 
 
Figure 18. UV-Vis absorbance spectra of polyurethane samples that were incorporated with crystal violet analogues 
35-37. 
Further physical and biological characterisation was carried out by Ekrem 
Ozkan. The contact angles of the unmodified and dye-incorporated 
polyurethane samples are displayed below (Table 7). The surface of 
unmodified polyurethane is moderately hydrophobic, with a water contact 
angle of 103.2º. The incorporation of crystal violet analogues 35 and 36 did 
not cause any significant change in the hydrophobicity of the surface; however, 
0
0.5
1
1.5
2
2.5
3
3.5
400 450 500 550 600 650 700 750 800
A
b
so
rb
an
ce
Wavelength, nm
35
36
37
James Rudman 
75 
 
a more hydrophilic surface, with a water contact angle of 91.2º, was obtained 
when polyurethane was incorporated with crystal violet analogue 37. 
 
Table 7. Water contact angles for each of the polymer samples (± SD). 
The photobactericidal activities of the samples were investigated against a 
Gram-positive bacterium, S. aureus 8325-4. A General Electric 28 W Watt 
MiserTM T5 2D compact fluorescent lamp, like those commonly found in UK 
hospitals, was used as the light source. In addition, a set of control samples 
were incubated in the dark, to determine whether any antibacterial activity 
observed was photoinduced.  
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Figure 19. The number of S. aureus colony forming units (CFU) per mL on the surfaces of the polymer samples 
after white light illumination, or incubation in the dark for 3 hours. D = dark, L = light; * indicates that the bacteria 
count was below the detection limit of 100 CFU mL−1. 
As expected, none of the polymer samples tested caused a reduction in the 
numbers of bacteria after incubation in the dark for three hours (Figure 19). In 
addition, no bacterial kill was observed for the unmodified polyurethane (L-
Polymer), or for the sample incorporated with crystal violet analogue 37 (L-37) 
after irradiation with white light for three hours. Illumination of the sample 
incorporated with crystal violet analogue 36 (L-36), however, produced an 
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almost two log reduction (P = 0.004) in the number of viable bacteria after 
three hours. The sample that was incorporated with crystal violet analogue 35 
(L-35) was highly effective at killing S. aureus after three hours of white light 
illumination, reducing bacterial numbers to below the detection limit (> 4 log 
reduction; P = 0.002). The differences between the antibacterial activities of 
the polymers incorporated with crystal violet analogues 35-37 could be 
attributed to the variation in the amount of dye present on the surface in each 
sample, as well as intrinsic chemical and/or physical differences between the 
dyes. 
In this study, it was established that the crystal violet analogue 35, when 
incorporated into polyurethane, was the most effective photosensitiser of the 
three analogues that were tested. 
2.2 Attempted grafting of alkyne-functionalised dyes to a 
variety of polymer surfaces 
Three synthetic routes towards polymer surfaces with covalently attached 
photosensitiser molecules were proposed, which all involved a 1,3-dipolar 
cycloaddition as a key step: a reaction between an azide-functionalised 
polymer surface with an alkyne-functionalised dye; a reaction between an 
azide-functionalised poly(ethylene glycol) (PEG) linker with an alkyne-
functionalised dye, followed by attachment of the linker to a polymer surface; 
and a reaction between an azide-functionalised PEG linker with a polymer 
surface, followed by attachment of an alkyne-functionalised dye (Figure 20). 
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Figure 20. Proposed routes towards a functionalised polymer surface. 
It was felt that the use of a PEG linker could be beneficial, as various types 
have been shown to resist the adhesion of bacteria and other biological 
material in the past.1,13 Moreover, the use of a polymeric spacer might prevent 
the aggregation of the surface-bound antibacterial agent. On the other hand, 
the PEG linker might prove to be highly susceptible to oxidative degradation, 
which could result in bond cleavage and subsequent loss of the covalently 
attached photosensitiser to the surrounding medium. 
In the following sections, all the proposed routes towards functionalised 
polymer surfaces are explored in the quest to prepare a photobactericidal 
polymer film. 
2.2.1 Synthesis of a mono-amine, mono-azide-terminated PEG linker 
The synthesis of a suitable PEG linker that could be attached to a polymer 
surface and subsequently undergo a 1,3-dipolar cycloaddition with an alkyne-
functionalised dye molecule, or vice versa, was proposed. In 2009, Susumu et 
al.301 successfully synthesised a mono-amine, mono-azide-terminated PEG 
linker 39 via a two-step sequence, starting from PEG. The first step involved 
mesylation of the two hydroxyl substituents, followed by displacement via an 
SN2 reaction with sodium azide to afford the corresponding di-azide-
terminated PEG compound 38. The di-azide-terminated PEG compound 38 
was then reacted with triphenylphosphine in a bi-phasic mixture of 1M HCl(aq) 
and ethyl acetate. The Staudinger reduction only occurs at one end of the PEG 
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chain as the ammonium salt formed under acidic conditions dissolves into the 
aqueous phase and is effectively removed from the reaction mixture. Two 
mono-amine, mono-azide-terminated PEG linkers 39 were synthesised in 
accordance with the literature protocol (Scheme 48): one that was 
polydisperse, from PEG-400; and another that was monodisperse, from PEG-
6. 
 
Scheme 48. Synthesis of mono-amine, mono-azide-terminated PEG linker 39. 
2.2.2 Attempted 1,3-dipolar cycloaddition reaction between a PEG linker 
and an alkyne-functionalised dye 
Initially, the 1,3-dipolar cycloaddition reaction between N-methyl-N-phenyl-
propargylamine 21, synthesised previously (See section 2.1.4), and PEG 
linker 39 was investigated. A brief review of the literature uncovered 
CuBr(PPh3)3 as a suitable catalyst, particularly because of its solubility in 
various organic solvents.302 A number of different solvents and conditions were 
screened (Table 8).  
 
Table 8. 1,3-dipolar cycloaddition reaction between alkyne 21 and PEG linker 39. 
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The best solvent was found to be DCM, and performing the reaction under an 
inert atmosphere of argon was found to be important. The latter observation is 
perhaps not surprising, as oxidation of the active Cu(I) species is undesirable. 
The crude 1H NMR spectra showed that a single isomer was present, 
presumably the 1,4-disubstituted product, which is the expected product of any 
Cu(I)-catalysed 1,3-dipolar cycloaddition reaction.302-304 The attempted 
purification of the resultant triazole 40 via flash column chromatography led to 
partial conversion to another product with very similar 1H NMR characteristics. 
It was speculated that the new compound, which was obtained as the major 
product in a 2:1 ratio, may be one of the structural isomers shown below 
(Figure 21). There is, however, no literature precedent for isomerisation 
occurring with molecules of this type, and the mechanism for this 
transformation is not clear. Moreover, it was not possible to assign fully the 
connectivity of any of the compounds that were formed. 
 
Figure 21. Three possible structural isomers of a generic 1,2,3-triazole. 
Nonetheless, attempts were made to react PEG linker 39 with leucocrystal 
violet analogue 33, which was synthesised previously (See section 2.1.5). The 
reaction was tried in both DCM and acetone; once again DCM proved to be 
the superior alternative (86% versus 71% conversion). The attempted 
purification of triazole 41 by flash column chromatography resulted in complete 
isomerisation of the original product this time around. The resultant product 
was not pure and so a yield hasn’t been quoted (Scheme 49).  
 
Scheme 49. Attempted synthesis of triazole 41. 
It was discovered that leaving the original isomer open to the air on the bench 
for one day did not result in any isomerisation occurring. On the other hand, 
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isomerisation was found to occur to some extent after one day of being 
dissolved in deuterated chloroform, or after exposure to silica gel. It can thus 
be inferred that the isomerisation that is occurring might be acid-catalysed, 
and a mechanism has been suggested below (Scheme 50). The first step 
involves protonation of one of the nitrogen atoms to give a positively charged 
species. This allows the migration of the PEG linker onto an adjacent nitrogen. 
Finally, de-protonation gives rise to a new isomeric form. As far as this writer 
is aware, the acid-catalysed isomerisation of 1,4-disubstituted 1,2,3-triazoles 
has not been reported elsewhere. 
 
Scheme 50. Suggested mechanism for the acid-catalysed isomerisation of a general 1,2,3-triazole. A similar 
mechanism can be invoked to explain the migration of the “R” substituent onto any N atom. 
The attempted oxidation of triazole 41 with chloranil in ethyl acetate was 
unsuccessful, and gave a complex mixture of products.297 Considering the 
problems encountered, it was decided that performing the 1,3-dipolar 
cycloaddition on the surface of a polymer would be a better approach as, in 
theory, any un-wanted by-products could simply be washed from the surface 
using an appropriate solvent system. 
2.2.3 Attempted modification of silicone 
The possibility of covalently attaching a modified dye molecule to the surface 
of a silicone elastomer was investigated. The use of silicone elastomers in 
various medical and pharmaceutical applications is well documented because 
of their chemical inertness and biocompatibility.305 Despite this, there are 
various methods for introducing reactive groups to the surface, including 
ozonolysis, and plasma treatments.306-308 Ozonolysis was particularly 
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appealing due to its relative simplicity, low cost, and easy access to an ozone 
generator. Ozonolysis treatment gives rise to peroxide groups on the surface 
of the polymer, which collapse to form highly reactive oxygen radicals with 
sufficient heating (60 ºC).307 Previously, di-amine-terminated PEG has been 
covalently grafted to the surface of ozonolysed polyurethane and silicone films 
via a two-step coupling reaction (Scheme 51).307 It was thus hypothesised that 
if mono-amine, mono-azide-terminated PEG linker 39 could be attached to the 
surface of silicone using this method, then covalent attachment of an alkyne-
functionalised dye could proceed via a 1,3-dipolar cycloaddition reaction. 
 
Scheme 51. Coupling of di-amine-terminated PEG to the surface of silicone or polyurethane, as described by Ko et 
al.307  
Sheets of medical grade silicone were cut into discs using a standard sized 
hole punch, and ozone was passed over the discs for varying periods of time 
(up to one hour). After treatment, the films were put under vacuum overnight 
to remove any traces of ozone trapped within the polymer matrix. 
To begin with, experiments were performed to establish the number of 
peroxides introduced as a result of ozone treatment, if any. One way of 
measuring the number of peroxides present is via the iodometric method. This 
involves suspending the polymer films in a mixture of sodium iodide and a 
catalyst, such as ferric chloride, in a mixture of benzene and isopropanol at 60 
ºC for ten minutes, with occasional swirling.308 The oxidation of I− to I3− is 
effected by peroxides, and the concentration of I3− can be measured by UV-
Vis absorbance spectroscopy (λmax = 360 nm). Unfortunately, no λmax signal 
indicating the presence of I3−  was detected. It was concluded that the 
iodometric method was not sensitive enough and so a different colorimetric 
assay was investigated. 
When a solution of ammonium ferrous sulfate and xylenol orange in acidified 
methanol comes into contact with peroxides, Fe(II) is oxidised to Fe(III). The 
formation of a purple coloured Fe(III)-xylenol orange complex ensues 
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(Scheme 52). The concentration of this complex can be elucidated by using 
UV-Vis absorbance spectroscopy (λmax = 560 nm).309 
 
Scheme 52. Formation of the Fe(III)-xylenol orange complex. 
The number of peroxides present in a test sample can be calculated from a 
plot of A560 against the number of moles of tert-butyl hydroperoxide in a series 
of calibration experiments. A known amount of tert-butyl hydroperoxide was 
mixed with an excess of the Fe(II)/xylenol orange reagent for thirty minutes, 
and this was repeated for a number of different concentrations of tert-butyl 
hydroperoxide. The UV-Vis absorbance spectrum of each sample was then 
obtained and the corresponding values for A560 were plotted against the 
number of nmoles of tert-butyl hydroperoxide per reaction volume (Figure 22). 
A measurement of the UV-Vis absorbance spectrum of the Fe(II)-xylenol 
orange reagent after exposure to the test sample should give a value for A560 
which corresponds to a point on the curve. The number of moles of peroxides 
present in the test sample can then be deduced. 
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Figure 22. Graph of A560 against the number of nmoles of tert-butyl hydroperoxide per reaction volume. 
Once again, silicone discs were exposed to ozone for varying periods of time 
(up to one hour), after which they were put under vacuum overnight, before 
being exposed to the Fe(II)-xylenol orange reagent. The control samples that 
had not been exposed to ozone gave the same amount of oxidation of Fe(II) 
to Fe(III) as those samples which had supposedly undergone ozonolysis. This 
indicates that the ozonolysis was unsuccessful, and at this stage, the 
investigation into the functionalisation of polyurethane was begun. 
2.2.4 Attempted modification of polyurethane 
There are a number of examples of polyurethane modification in the literature, 
most of which involve ozonolysis or plasma treatment, as discussed 
above.307,308,310 In addition to these techniques, deprotonation of the amide 
moiety of polyurethane followed by an SN2 reaction with an appropriate 
electrophile can give rise to a variety of modified surfaces. For example, 
Alferiev et al.311 successfully attached acetylthio groups to the surface of 
polyurethane via  treatment with LiOC(CH3)3 and 1,4-dibromobutane in N,N-
dimethylacetamide, followed by SN2 displacement of the remaining bromide 
with thioacetic acid (Scheme 53). 
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Scheme 53. Chemical modification of polyurethane, as described by Alferiev et al.311 
It was proposed that the above conditions could be used to produce modified 
polyurethane with pendant PEG or azide groups, by using the previously 
synthesised PEG linker 39 or sodium azide instead of thioacetic acid in the 
second step. 
Initially, a solution of polyurethane in N,N-dimethylacetamide was treated with 
LiOC(CH3)3 and 1,4-dibromobutane, using the conditions previously 
described. According to the 1H NMR spectrum of the modified polyurethane in 
DMF-d6, no bromobutyl groups were present. Moreover, the polyurethane film 
that was obtained did not bear any structural or visual resemblance to the 
starting material prior to being solubilised in N,N-dimethylacetamide: rather 
than being hard and flexible, the product was much softer and more brittle. 
The reaction was thus tried in toluene instead of N,N-dimethylacetamide, as it 
was felt that using a solvent that only swelled the polymer and didn’t dissolve 
it would give a product that bore a greater resemblance to the starting material. 
This was indeed the case, and was unsurprising with hindsight since no 
reaction had occurred according to the 1H NMR spectrum of the product 
dissolved in DMF-d6. 
2.2.5 Attempted covalent attachment of a PEG linker to PVC 
Recently, Ameer et al.312 claimed that they reacted PVC with a variety of 
different amines to afford the corresponding modified polymers. The 
previously synthesised PEG linker 39 (See section 2.2.1) was subjected to the 
same reaction conditions (Scheme 54). It was hoped that a PEG-
functionalised PVC film could be obtained by simply removing the solvent in 
vacuo. 
 
Scheme 54. Attempted generation of PEG-functionalised PVC. 
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The FT-IR spectrum of the resultant polymer did not contain any peaks that 
were attributable to the presence of any azide moieties, which indicated that 
the reaction hadn’t been successful. 
The reaction was then tried with a PVC film (See section 4.3.2 for preparation) 
in the presence of potassium carbonate, and in a variety of solvents, including 
isopropanol, ethanol, methanol, and acetonitrile. In every instance, no peaks 
in the FT-IR spectrum of the product corresponding to the presence of any 
azide moieties were detected. Moreover, it was noticed that the films were 
highly discoloured in every instance, presumably due to de-
hydrochlorination.313  
To try and overcome this problem, the reaction was attempted at a lower 
temperature of 60 ºC, with the same solvents that had been used previously. 
In addition, the concentration of PEG linker 39 was doubled. Unfortunately, 
none of these alterations resulted in the covalent attachment of PEG linker 39 
to the surface of a PVC film, and attempts to produce a PEG-functionalised 
PVC film were not pursued. 
2.2.6 Modification of PVC with sodium azide   
In 1969, Takeishi et al.314 demonstrated that by reacting a solution of PVC with 
sodium azide in DMF at 60 ºC, it was possible to generate PVC with covalently 
bound azide moieties. Later, Sacristán et al.315 showed that the reaction could 
be done heterogeneously with a PVC film in a mixture of DMF and water. It 
was shown that the degree of chloride displacement by sodium azide was 
dependent on the ratio of DMF:water used. It was also claimed that the azide 
groups were homogenously distributed throughout the polymer film when this 
technique was used, so one might expect chemical modification of the bulk 
polymer as well as the surface. 
Initially, modification of a piece of PVC catheter was attempted, using the 
conditions of Sacristán et al.315 The PVC was immersed in a solution of sodium 
azide (0.5 M) in DMF:water (6:1) for two days at 60 ºC (Scheme 55).  
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Scheme 55. Formation of azide-functionalised PVC.315 
The FT-IR spectrum of the resultant polymer did not contain any peaks that 
corresponded to the presence of an azide moiety; therefore, the reaction was 
tried using PVC powder instead of the catheter polymer film. A prominent peak 
in the FT-IR spectrum at 2105 cm−1 was observed, which was indicative of the 
presence of azide; however, it was impossible to discern whether or not this 
was covalently bound to the polymer matrix.315 The reaction was then tried 
with a PVC film, which was generated from PVC powder (See section 4.3.2): 
once again azide functionality was detectable by FT-IR. The absence of any 
azide moieties when the modification was attempted with the catheter segment 
is hard to explain, as the exact chemical composition of the catheter segment 
that was used isn’t known.  
It was noticed that the reaction was not particularly reliable: in every instance 
the PVC film that was generated was a different colour, from pale yellow to 
dark brown. It was decided that the issue might be the concentration of the 
sodium azide solution, so a 0.1 M solution was used instead of a 0.5 M 
solution. This appeared to improve the consistency as visually similar PVC 
films were obtained from every separate reaction performed. 
Having solved the issue with visual consistency, a more rigorous washing 
sequence was implemented as DMF was still present in the previously 
prepared PVC samples (as indicated by the presence of a peak at 1672 cm−1 
in the FT-IR spectrum). Instead of simply rinsing the samples with water and 
diethyl ether, the azide containing PVC films were immersed in solutions of 
acetone:water 6:4 for one day, and the process was repeated three times. The 
acetone:water solution caused polymer swelling, so it was hoped that any 
unreacted sodium azide and DMF trapped in the polymer matrix would be 
removed in the washing process.  
It was found that the DMF was removed from the polymer matrix, but was 
replaced by acetone (as indicated by a peak at 1710 cm−1 in the FT-IR 
spectrum). Moreover, the presence of acetone instead of DMF caused a shift 
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in the peak corresponding to the presence of azide to 2110 cm−1 (from 2105 
cm−1). This can be attributed to changes in the physical properties of the 
polymer film due to the incorporation of acetone instead of DMF. 
Having improved the washing technique, evidence was obtained to confirm 
that the azide was covalently linked to the polymer film. An FT-IR spectrum of 
the azide-functionalised film was obtained prior to washing: two peaks 
corresponding to the presence of azide were observed at 2110 and 2027 cm−1 
(Figure 23). 
 
Figure 23. The FT-IR spectrum of an azide-functionalised PVC film prior to washing. 
After washing, only the peak at 2110 cm−1 was present (Figure 24). It can thus 
be deduced that the peak at 2027 cm−1 corresponds to the presence of free, 
unbound sodium azide, which is removed in the washing process. 
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Figure 24. The FT-IR spectrum of the same azide-functionalised PVC film after washing. 
Although the visual consistency of the resultant product had been improved 
by altering the reaction conditions, some data to quantify the amount of azide 
present was desired. Lafarge et al.103 used X-ray photoelectron spectroscopy 
(XPS) to ascertain the percentage substitution of chloride substituents with 
azide moieties. The relative intensity of the peaks corresponding to the 
presence of N and Cl atoms was used to calculate the percentage of chloride 
displacement, using the formula shown below: 
% (𝐶ℎ𝑙𝑜𝑟𝑖𝑑𝑒 𝑑𝑖𝑠𝑝𝑙𝑎𝑐𝑒𝑚𝑒𝑛𝑡) =  
%𝑁
3
%𝐶𝑙 +  
%𝑁
3
 ×100 
The effect on the consistency of the reaction was investigated by making 
alterations to the scale, as well as the concentration of sodium azide (from 0.1-
0.5 M). It was found that the reaction was very inconsistent: even films 
immersed in the same reaction solution were subject to vastly different levels 
of chloride displacement, which was particularly noticeable when the reaction 
was scaled up (Table 9). It was felt that one issue could have been the amount 
of time each PVC disc spent in contact with the wall of the reaction vessel. 
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According to Sacristán et al.,315 however, sodium azide is able to penetrate 
the polymer bulk, so this shouldn’t have an effect in theory. 
 
Table 9. Percentage of chloride displacement values for each polymer film. 
It was felt that using PVC powder instead of a film might result in the reaction 
being more consistent, so a similar set of experiments were tried. For each 
powder sample, spread evenly across carbon fibre tape, the XPS spectrum 
was measured five times at different locations. The average percentage of 
chloride displacement under different reaction conditions is shown below, 
along with the original five measurements for each sample (Table 10). 
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Table 10. Average percentage of chloride displacement as calculated from the XPS data that was obtained. 
The peak corresponding to N in the XPS spectrum was barely visible when the 
concentration of sodium azide was less than or equal to 0.3 M. The calculated 
values for percentage of chloride displacement have a large associated error 
for these samples. When PVC powder was exposed to higher concentrations 
of sodium azide (0.4 and 0.5 M), the percentage of chloride displacement was 
measured as being anywhere between 13% and 16%, and 14% and 19% 
respectively. 
Of course, as might be expected, the PVC powders that had been exposed to 
more concentrated solutions of sodium azide were highly discoloured, which 
was not desirable. Moreover, the reaction had not been shown to be 
remarkably consistent at these concentrations, and it’s impossible to suggest 
whether the reaction is more consistent at lower concentrations as the XPS 
data for these samples is unreliable. Nonetheless, attempts to graft various 
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alkynes to an azide-functionalised PVC film, as prepared in this section, are 
described below.  
2.2.7 Attempted grafting of an alkyne to an azide-functionalised PVC film 
via a 1,3-dipolar cycloaddition 
As discussed at the beginning of the results and discussion (Section 2.1), a 
number of groups have utilised the 1,3-dipolar cycloaddition reaction to 
covalently graft a variety of compounds or polymers to a polymer surface. A 
few of these groups have described the covalent attachment of various alkyne-
functionalised moieties to azide-functionalised PVC.9,103,279-281 
Initially the physical properties of the PVC film that had been generated (See 
section 4.3.2) were investigated after immersion in a range of different 
solvents. A solvent that induced swelling without permanent changes to the 
size and physical properties of the polymer was desired as a medium for the 
proposed 1,3-dipolar cycloaddition reaction. It was found that the structure of 
the film was unaltered, and no swelling was induced, after immersion in water, 
alcoholic solvents, and diethyl ether. On the other hand, solvents such as 
DCM, chloroform, acetone, and DMSO effected significant swelling, which 
resulted in the permanent deformation of the polymer film. In addition, DMF 
and THF were found to dissolve PVC. It was found that acetonitrile, as well as 
toluene, caused only minor swelling and after drying the polymer film returned 
to its original size and shape. The more volatile solvent, acetonitrile, was 
chosen for most of the experiments. 
To produce the azide-functionalised PVC used in these reactions, PVC films 
were immersed in 0.1 M solutions of sodium azide. The XPS data obtained 
cannot be relied upon extensively, but it was apparent that chloride 
displacement by sodium azide was significantly less than 10% when the 
reaction was conducted at this concentration. It was therefore decided that the 
amount of coupling partner that was required should be calculated on the basis 
that the percentage of chloride displacement was 10%. Moreover, to drive the 
reaction to completion with respect to azide consumption, 1.5 equivalents of 
alkyne-functionalised leucocrystal violet analogue 28 (See section 2.1.4) were 
used. The complete disappearance of the azide peak in the FT-IR spectrum 
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of the resultant polymer would be indicative of a successful reaction. 
Conversely, if the dye was used as the limiting reagent, it would be more 
difficult to prove that it was covalently bound to the polymer and not just 
physically adsorbed to the surface, as an azide peak would still be present in 
the FT-IR spectrum even if the reaction were successful. 
The reaction between azide-functionalised PVC and leucocrystal violet 
analogue 28 was tried predominantly in acetonitrile with a variety of different 
copper catalysts: CuSO4.5H2O/sodium ascorbate, CuI, CuBr, CuCl, 
CuBr(PPh3)3, Cu(OAc)2.H2O/sodium ascorbate, Cu(0) powder, and 
CuSO4.5H2O/Cu(0) powder. In every instance the reaction was performed in 
the presence of triethylamine. Control reactions were tried in the absence of 
triethylamine, and in toluene instead of acetonitrile, with the catalyst 
CuBr(PPh3)3. In addition, a control reaction with no copper catalyst was 
conducted (Table 11). 
 
Table 11. Attempted 1,3-dipolar cycloaddition reaction between azide-functionalised PVC and leucocrystal violet 
analogue 28. 
Once the PVC discs had been subjected to the above-mentioned conditions 
for one day, they were immersed in acetonitrile with the intention of washing 
away any unbound components. The latter process was repeated three times, 
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after which nothing else appeared to be removed. The discs from nearly all the 
reactions exhibited a deep purple colouration, indicative of the presence of the 
oxidised form of leucocrystal violet analogue 28 (Table 11). This was a cause 
for optimism, as it would negate the need to subject the discs to oxidative 
conditions to generate the desired crystal violet analogue 35.  
The presence of crystal violet analogue 35 in the PVC discs was confirmed by 
UV-Vis absorbance spectroscopy: the absorbance maxima were observed at, 
or close to, 593 nm. Unfortunately, the FT-IR spectra still contained prominent 
peaks in the azide region in every case, so it was not possible to say whether 
any of crystal violet analogue 35 present was covalently bound. Moreover, a 
1H NMR spectrum was obtained in DMF-d7 for one of the samples which 
appeared to contain a higher concentration of crystal violet analogue 35. It was 
not possible, however, to detect any peaks that might have been attributable 
to the presence of a triazole proton in the aromatic region of the spectrum.316 
The PVC films were subjected to oxidative conditions (chloranil in acetonitrile) 
to convert any of the reduced form of crystal violet analogue 35 that might still 
be present. The polymer samples were then washed by immersion in solutions 
of acetone:water (3:2). This solvent system was chosen because it can both 
induce swelling of the PVC samples and dissolve crystal violet analogue 35. It 
was felt that if crystal violet analogue 35 did not leach from the polymer in a 
solution that caused swelling, then this would be strong evidence to suggest 
that it was in fact covalently bound. 
Sadly, extensive leaching of crystal violet analogue 35 from the polymer 
samples was observed, even after ten wash cycles in some instances. With 
no further ideas for proving that any crystal violet analogue 35 was covalently 
bound to the polymer, this area of research was not pursued any further. 
With hindsight, perhaps it was not reasonable to expect that all the polymer 
bound azide could undergo a reaction purely due to steric demand. It may be 
impossible for leucocrystal violet analogue 28 to penetrate the bulk polymer, 
or for it to react with two azide moieties in close proximity. The latter issue 
could perhaps be overcome by reducing the percentage of surface-bound 
azide relative to chloride. It then becomes even more difficult to quantify to any 
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extent the amount of azide that is present, though. In any case, it has not been 
possible to show that the azide moieties are uniformly distributed throughout 
the polymer, so this is still no guarantee of success.      
2.3 Ethyl violet as an alternative to crystal violet? 
The use of crystal violet as an antibacterial agent, either when illuminated or 
in the dark, is very well documented in the literature and is discussed 
extensively in the introduction. There are, however, issues relating to the 
toxicity of crystal violet: it is known to persist in the environment and is a potent 
carcinogen.135 Though this is not envisaged as being a problem in cases 
where the compound is embedded in a polymer matrix,270-272 there is clearly 
scope for elucidating less hazardous alternatives. 
The commercially available compound ethyl violet has a very similar structure 
to crystal violet, with the only difference being the exchange of the methyl 
groups attached to the amine in crystal violet with ethyl groups (Figure 25).  
 
Figure 25. Ethyl violet. 
In 2001, Mellish et al.317 described the synthesis of a variety of methylene blue 
analogues, where the dimethyl- substituents were replaced with longer alkyl 
chains. The group observed that the photosensitising ability of the compounds 
was reduced as the alkyl chain length increased. The differences observed 
were small when the alkyl chain length was four carbons or less. For longer 
alkyl chain lengths, the photosensitising ability of the corresponding 
compounds was greatly reduced. Interestingly, in the study conducted, all the 
compounds except for methylene blue were excluded from the nucleus of the 
tumour cells they were incubated with, thus reducing the mutagenic potential 
of these compounds. 
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Importantly, unlike crystal violet, ethyl violet has not been classified as a 
hazardous compound. One might reasonably assume that its potential as a 
mutagen would be less than that of crystal violet, due to it being more 
hydrophobic and based on the observations of Mellish et al.317 In essence, 
ethyl violet might prove to be a better alternative to crystal violet in the future 
due to it being a less hazardous substance, even if its efficacy as a 
photosensitiser was shown to be less than that of crystal violet. 
In the following sections, the efficacy of ethyl violet as a photosensitiser is 
assessed. Its photobactericidal activity was compared to that of crystal violet 
in the light, and in the dark. 
2.3.1 Preparation and characterisation of dye-incorporated polymer 
samples 
Initially, crystal violet and ethyl violet were incorporated into medical grade 
silicone using a “swell-encapsulate-shrink” technique, previously reported by 
Ozkan et al.271 A sheet of silicone was cut into 1 cm × 1 cm squares, which 
were immersed in solutions of each dye (1 × 10−3 M) in chloroform for three 
days in the dark. After this time, the samples were rinsed with distilled water, 
dried with paper towels, and allowed to air dry in the dark overnight (Figure 
26). 
 
Figure 26. Polymer samples after the incorporation process. 
The dye-incorporated samples were analysed by FT-IR and UV-Vis 
absorbance spectroscopy. In addition, leaching tests were performed in PBS 
solution. 
The FT-IR spectra of the silicone samples incorporated with ethyl violet and 
crystal violet were obtained, and compared to the spectrum of an unmodified 
control sample. The spectra were identical in appearance, which indicates that 
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no significant chemical change occurs during the incorporation process. 
Moreover, new peaks corresponding to the presence of crystal/ethyl violet 
were not observed. One can therefore conclude that the physical and chemical 
properties of the bulk polymer are largely unaffected by the introduction of 
crystal/ethyl violet. 
The UV-Vis absorbance spectra of the samples were obtained, and are shown 
below (Figure 27). The peaks corresponding to the presence of ethyl violet 
and crystal violet are poorly resolved, due to the low percentage of light 
transmission through the intensely coloured polymer samples. For this reason, 
it is impossible to ascertain the consistency of dye uptake of samples from the 
same incorporation batch and of samples subjected to the same conditions in 
different batches.  In addition, the spectrum of the polymer sample containing 
ethyl violet is red-shifted relative to that of the one with crystal violet 
incorporated, but it is not possible to determine an absorbance maximum for 
either. 
 
Figure 27. UV-Vis absorbance spectra of the dye-incorporated polymer samples. 
The polymer samples incorporated with crystal/ethyl violet were immersed in 
PBS solution for a period of one week. The UV-Vis spectra of the resultant 
solutions were recorded after this time, as well as at various time intervals in-
between. After one week, no loss of crystal/ethyl violet from the polymer into 
solution due to leaching was observed. 
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2.3.2 Antibacterial activity of dye-incorporated polymer samples 
The following study was carried out by Sandeep Sehmi. The antibacterial 
activity of the polymer samples was tested against E. coli, a Gram-negative 
bacterium. As expected, the unmodified control samples exhibited no activity 
after incubation in the dark for five hours or after five hours of illumination with 
a 6000-lux white light source. The samples containing crystal/ethyl violet had 
no appreciable effect on the numbers of bacterial colonies after incubation in 
the dark for five hours. The samples incorporated with ethyl violet (~1 log 
reduction in CFU) proved to be less efficacious than those that contained 
crystal violet (~1.5 log reduction in CFU), when exposed to the white light 
source (Figure 28). 
 
Figure 28. The number of E. coli CFU per mL on the surfaces of the polymer samples after white light illumination, 
or incubation in the dark for 5 hours. D = dark, L = light; CV = crystal violet, EV = ethyl violet. 
In this section, ethyl violet has been shown to be less effective at preventing 
the colonisation of polymer surfaces by E. coli than crystal violet. Though this 
result is disappointing, the ability of ethyl violet to function as a photosensitiser 
has been demonstrated and, as previously discussed, it may prove to be a 
less toxic, more environmentally friendly alternative to crystal violet in future 
applications where this is desirable. 
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2.4 Assessment of the antibacterial activity and physical 
properties of silicone incorporated with different porphyrins 
The use of porphyrins in photodynamic therapy and, to a lesser extent, in the 
preparation of antibacterial surfaces is extremely well documented, and is 
discussed extensively in the introduction. It was apparent that in nearly all 
instances, the antibacterial activity was assessed for only one or two 
porphyrins in the same microbiological assay. It is thus difficult to infer what 
chemical modifications could be used to improve the antibacterial activity of a 
porphyrin. 
In the following sections, the syntheses of several different analogues of meso-
tetraphenylporphyrin (TPP) 42 are described. The porphyrins were 
incorporated into medical grade silicone via a swell-encapsulate-shrink 
process. For the resultant polymers, FT-IR, UV-Vis, and fluorescence spectra 
were obtained. Unfortunately, no microbiologists were available to test the 
antibacterial activity of the films before this thesis was written. 
2.4.1 Synthesis of related analogues of meso-tetraphenylporphyrin (TPP) 
The structures of 8 different porphyrins, identified as synthetic targets and all 
closely related to TPP 42, are shown below (Figure 29). 
 
Figure 29. Compounds 42-50 that were identified as synthetic targets. 
Initially, TPP 42 was prepared by reacting pyrrole with benzaldehyde in 
refluxing propionic acid.318 The desired product was obtained in yields of 18-
19%, which are in accordance with the reported literature values (Scheme 56). 
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Scheme 56. Synthesis of TPP 42. 
The reaction between TPP 42 and various metal salts afforded the resultant 
metalloporphyrins in reasonably good yields (Table 12). 
 
Table 12. Synthesis of metalloporphyrins 43-47. 
The reaction between Zn(OAc)2 or Cu(OAc)2 with TPP 42 was found to 
proceed much more rapidly than the analogous reaction between TPP 42 and 
Ni(acac)2, Pd(OAc)2 or PtCl2. This is because complexes of Cu(II) and Zn(II) 
are almost invariably tetrahedral, whereas group 10 metal (II) complexes are 
nearly always square planar. It is well known that d8 square planar complexes 
are highly stable as the unfilled d(x2 – y2) orbital is strongly anti-bonding, and 
the filled d orbitals are virtually non-bonding in nature (Figure 30). 
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Figure 30. Crystal field splitting diagram of a square planar complex. 
It was found that the isolation of NiTPP 45 proved to be somewhat 
troublesome due to its relatively low solubility in toluene. It was quickly 
established that filtering a mixture of NiTPP 45 and Na2SO4 in toluene, 
obtained in the aqueous crude work up, resulted in a substantial loss of the 
desired product. The drying step was not carried out in future experiments and 
thus good yields were obtained. 
Having successfully synthesised a set of metalloporphyrins, attempts to 
prepare three different tetraphenylporphyrins with varying degrees of 
fluorination were begun. Initially, the porphyrin syntheses were attempted 
using the conditions of Adler et al.318 (Table 13). It was quickly discovered that 
these conditions were not suitable for the syntheses of the more soluble 
porphyrins, meso-tetra(pentafluorophenyl)porphyrin (F20TPP) 48 and meso-
tetra(2,4,6-trifluorophenyl)porphyrin (F12TPP) 49, which were not isolated. On 
the other hand, the method employed afforded meso-tetra(4-
fluorophenyl)porphyrin (F4TPP) 50 in a yield of 24%. It was discovered, 
however, that the product was highly insoluble in chloroform, as well as in 
other solvents, so it was not possible to obtain NMR spectra for this compound. 
This observation is in agreement with the results published that were 
previously by Fleischer et al.319 in 1973. 
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Table 13. Attempted synthesis of the fluorinated tetraphenylporphyrins 48-50 by the method of Adler et al.318 
The method of Adler et al.318 is generally preferred for ease of purification of 
the desired product, but can only be used to access a relatively limited number 
of porphyrins. In addition, the reaction conditions that are employed are fairly 
harsh. The method of Dommaschk et al.,320 based on the work of Lindsey et 
al.,321 was tried with boron trifluoride as the acid-catalyst. These conditions are 
much milder and so it is possible to synthesise a greater range of porphyrins. 
The desired porphyrins, F20TPP 48 and F12TPP 49, were synthesised, and 
obtained in yields of 17% and 20% respectively (Table 14). 
 
Table 14. Synthesis of F20TPP 48 and F12TPP 49 by the method of Dommaschk et al.
320 
Unfortunately, F12TPP 49 was only successfully prepared once. Future 
attempts to make this compound proved to be fruitless, and so it was only used 
in the preliminary optimisation studies of the incorporation process. 
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For each of the porphyrins dissolved in chloroform (1 × 10−5 M), UV-Vis 
absorbance and fluorescence spectra were recorded and are shown below 
(Figures 31 and 32). 
 
Figure 31. UV-Vis absorbance spectra of porphyrins 42-50 dissolved in chloroform. 
The UV-Vis absorbance spectra of each of the above porphyrins can be 
considered in terms of two separate sections: the near UV region containing a 
high intensity Soret or B band, which corresponds to an S0 → S2 transition; 
and the visible region that contains one or more lower intensity Q bands, which 
correspond to the S0 → S1 transition.322  
The spectra of the more symmetric metalloporphyrins contain up to two visible 
Q bands, whereas for the less symmetric free-base porphyrins up to four Q 
bands can be observed. This is because the electronic dipole transitions in the 
x and y directions are equivalent for metalloporphyrins. The electronic 
absorptions of PtTPP 47 are subject to a significant hypsochromic shift. This 
is predominantly a result of increased metal dπ to porphyrin π* back-bonding, 
which increases the HOMO-LUMO gap of the system. This effect is also seen, 
to a lesser extent, in the spectra of the copper, nickel, and palladium 
tetraphenylporphyrins (44, 45, and 46), when compared to the spectrum of 
ZnTPP 43.323,324 
The fluorinated tetraphenylporphyrins 48-50 gave spectra that were not 
markedly different to the spectrum of TPP 42. There were two oddities, though, 
the first being that the peak that was expected at roughly 550 nm was only 
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clearly visible in the spectrum of F4TPP 50. The second observation was that 
the extinction coefficient obtained for F12TPP 49 in chloroform was markedly 
lower than that of the other fluorinated variants (48 and 50) and TPP 42. There 
is no obvious reason for these unusual findings; however, they are of little 
consequence. 
 
Figure 32. Fluorescence spectra of porphyrins 42-48 dissolved in chloroform. 
The fluorescence spectrum of each of the samples was obtained (Figure 32). 
While the fluorescence spectra of the polymer films that were incorporated 
with TPP 42 and ZnTPP 43 contained two clear peaks, the polymer samples 
containing the other metalloporphyrins 44-47 were virtually inactive. In the 
case of PtTPP 47, and to a lesser extent PdTPP 46, the presence of a heavy 
metal atom results in increased spin-orbit coupling, which makes spin-
forbidden ISC to an excited triplet state more favourable.325 In addition, ISC is 
relatively favourable for CuTPP 44 due to the fact that it is a paramagnetic 
species.325 The excited triplet state molecule can transfer its energy to another 
nearby molecule, such as oxygen or water, to generate ROS; alternatively, it 
can undergo phosphorescence or some other non-radiative energy transfer in 
order to return to the ground state. On the other hand, the excited singlet state 
of NiTPP 45 is low in energy, which means that the molecule can return to 
ground state via internal conversion.326 Intriguingly, the polymer film that was 
incorporated with the free-base porphyrin, F20TPP 48, gave rise to a spectrum 
with three fluorescence peaks, despite the fact that only two peaks were 
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anticipated. It is felt that this is due to peak splitting, which results from vibronic 
coupling; however, it is strange that this effect hasn’t been noted previously.327 
2.4.2 Preparation and characterisation of porphyrin-incorporated 
polymer films 
To begin with, optimisation studies were carried out to establish the best 
conditions for the incorporation process. The experiments were carried out 
with TPP 42 dissolved in toluene, which was chosen because it can both 
solubilise the porphyrins that had been synthesised and effect the swelling of 
silicone. In addition, all the experiments were carried out in the dark, to prevent 
photocatalytic oxidation of the porphyrins in solution. Firstly, the effect of 
porphyrin concentration was investigated: solutions containing different 
amounts of TPP 42 were prepared, and 1 cm × 1 cm silicone films were 
immersed in these solutions for three days. The resultant films were rinsed 
with distilled water, before being air-dried in the dark for one day. An image of 
the resultant films is shown below (Figure 33). 
 
Figure 33. Silicone films that had been exposed to solutions of TPP 42 of varying concentration for three days. 
When the concentration of the porphyrin solution was less than 4 × 10−5 M, 
the porphyrin was not visible in solution. The incorporation process appeared 
to work best for the silicone film that was exposed to a 5 × 10−3 M solution of 
TPP 42; therefore, this concentration was selected for all further experiments. 
Having identified the most suitable concentration, the effect of immersion time 
was investigated. In this case, 1 cm × 1 cm silicone films were submerged in 
5 × 10−3 M porphyrin solutions for varying periods of time, after which they 
were washed and dried as described above. An image of the films that were 
produced is shown (Figure 34). 
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Figure 34. Silicone films that had been exposed to solutions of TPP 42 for varying periods of time. 
By looking at the above image, it is not altogether obvious what the optimal 
immersion time is; however, on closer inspection, it does seem that longer 
immersion times give rise to greater dye uptake (Figure 35). On that basis, it 
was decided that the incorporation time would be three days for all further 
experiments. 
 
Figure 35. Silicone films that had been exposed to solutions of TPP 42 for longer periods of time. 
The optimised conditions were used to incorporate the previously synthesised 
porphyrins 42-50 into 1 cm × 1 cm silicone films. In this instance, fifteen 
polymer squares were immersed in the same solution of porphyrin in toluene 
(5 × 10−3 M) for three days. Unfortunately, several problems were encountered 
at various stages of the incorporation process. It was immediately found that 
both NiTPP 45 and F4TPP 50 were very poorly soluble in toluene. Once the 
incorporation process was complete, a number of samples, including the ones 
incorporated with TPP 42, were observed to have extensive porphyrin 
aggregation (Figure 36). Moreover, samples that were incorporated with the 
same porphyrin were found to exhibit obvious visual differences, indicating 
that the process was inconsistent. 
 
Figure 36. Silicone films that had been exposed to different porphyrin solutions for three days. 
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It was hypothesised that one issue might be the fluxional temperature within 
the lab. To test this, two 1 cm × 1 cm silicone films were immersed in identical, 
yet separate, solutions of TPP 42 in toluene. One experiment was kept in the 
fridge, while the other was kept on the bench. No appreciable difference 
between the two resultant samples was observed, although dye uptake 
appeared to be greater for the experiment that was carried out on the bench 
(Figure 37). 
 
Figure 37. Silicone films that had been immersed in solutions of TPP 42, which had been left in the fridge (left) and 
on the bench (right), for three days. 
It was noticed that toluene was ineffective at solubilising some dyes, so a new 
solvent system needed to be considered. Moreover, doubts were had about 
the effectiveness of the washing process, and whether this was a cause of 
some of the problems that were being encountered. Finally, the incorporation 
process appeared to be markedly more uniform when only one silicone film 
was immersed in a porphyrin solution, and that things tended to go wrong 
when multiple samples were immersed in the same solution at the same time. 
To try to resolve the first two issues, four experiments were devised to 
ascertain whether chloroform would be a more suitable solvent system than 
toluene for the incorporations, and whether the washing process had a 
negative effect. To start with, two 1 cm × 1 cm silicone films were immersed in 
separate solutions of TPP 42 in chloroform, while another two samples were 
immersed in separate solutions of the same porphyrin in toluene. Of the four 
silicone films that were incorporated with TPP 42, two that were subjected to 
different incorporation conditions were washed with distilled water before 
drying, while the remaining two samples were only dried (Figure 38). 
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Figure 38. Silicone films that were incorporated with TPP 42 via different procedures. From left to right: toluene, no 
wash; toluene, washed; chloroform, no wash; and chloroform, washed. 
Clearly, the sample that had been immersed in a solution of TPP 42 in 
chloroform, and rinsed with distilled water once the incorporation process was 
terminated, appeared to have the most uniform dye distribution. These 
conditions were thus used to for the preparation of a batch of fifteen silicone 
samples that were immersed in the same incorporation solution at the same 
time. Unfortunately, the resultant films displayed signs of porphyrin 
aggregation, as TPP 42 was unevenly distributed on the surface (Figure 39). 
 
Figure 39. The fifteen 1 cm × 1 cm silicone films that were incorporated with TPP 42. 
Having established that the incorporation of every polymer sample had to be 
done individually, and that chloroform appeared to be a more suitable solvent 
system than toluene, new experiments were designed to incorporate 1 cm × 1 
cm silicone films with porphyrins 42-48. The porphyrin concentration was 
lowered from 5 × 10−3 M to 1 × 10−3 M, to preserve precious material in case 
this set of experiments did not go according to plan. It was felt that using this 
concentration would still give a sufficient level of dye uptake, as can be seen 
above (Figure 38). Thankfully, the dye-incorporated polymer films that were 
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obtained from these experiments exhibited no signs of porphyrin aggregation, 
and samples that were incorporated with the same compound appeared to 
display similar colouration, at least by eye (Figure 40). 
 
Figure 40. Silicone films that had been exposed to different porphyrin solutions for three days. 
The FT-IR spectra of the porphyrin-incorporated silicone samples were 
obtained, and compared to the spectrum of an unmodified control sample. The 
spectra were identical in appearance, which indicates that no significant 
chemical change occurs during the incorporation process. Moreover, new 
peaks corresponding to the presence of porphyrins 42-48 were not observed. 
One can therefore conclude that the physical and chemical properties of the 
bulk polymer are largely unaffected by the introduction of porphyrins 42-48. 
The UV-Vis absorbance spectra of the samples were obtained, and are shown 
below (Figure 41). The sample containing fluorinated porphyrin 48 is intensely 
absorbing, whereas the samples containing the other porphyrins 42-47 are 
very weakly absorbing. In fact, the samples containing ZnTPP 43 and NiTPP 
45 have barely discernible absorbance maxima. Of the samples that do give 
rise to spectra with clearly defined absorbance maxima, the UV-Vis spectra 
correlate closely with the previously obtained spectra for each of the 
porphyrins dissolved in chloroform.  
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Figure 41. UV-Vis absorbance spectra of 1 cm × 1 cm silicone films incorporated with porphyrins 42-48. 
The fluorescence spectra of the samples were obtained (Figure 42). Except 
for ZnTPP 43, every porphyrin-incorporated sample gave rise to a 
fluorescence spectrum which was almost identical to that which was recorded 
for each of the porphyrins when dissolved in chloroform. For the sample that 
was incorporated with ZnTPP 43, the anticipated peak at 600 nm was non-
existent, while the peak at 650 nm now appeared to have a shoulder peak at 
roughly 640 nm. Moreover, a broad peak at around 710 nm was observed, 
which wasn’t seen previously. It can be concluded that the properties of ZnTPP 
43 have been altered by the incorporation process, or by virtue of it being 
encapsulated within silicone. 
 
Figure 42. Fluorescence spectra of 1 cm × 1 cm silicone films incorporated with porphyrins 42-48. 
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Having prepared and analysed a series of silicone films incorporated with 
porphyrins 42-48, the next stage is to run microbiological experiments to 
ascertain their effectiveness at killing bacteria both in the light and in the dark. 
Unfortunately, due to time constraints and a lack of available trained 
microbiologists, these studies have been put on hold for the foreseeable 
future. 
2.5 Attempted formation of polyurethane with a covalently 
attached crystal violet analogue via a polymerisation reaction 
Previously, attempts to covalently link small molecules to a pre-functionalised 
polymer surface, via a 1,3-dipolar cycloaddition reaction, were unsuccessful 
(See section 2.2). Issues were encountered when the modified polymer was 
dissolved in the reaction solvent, or when the reaction was attempted 
heterogeneously. In this section, the attempted synthesis of a polymer from 
monomeric units, with the simultaneous covalent attachment of an 
appropriately functionalised crystal violet analogue, is described. 
In 2014, Felgenträger et al.252 described the preparation of a polyurethane 
coating containing a covalently attached porphyrin, 5-(4-hydroxyphenyl)-
10,15,20-triphenylporphyrin. The polyurethane was prepared by dissolving the 
porphyrin in a mixture of polyvalent alcohols, which was then combined with a 
“hardener”, presumably diisocyanates of some kind. In addition, Chung et 
al.328,329 describe the preparation of polyurethanes with a variety of covalently 
bound dyes by a similar method. They react poly(tetramethylene glycol) 
(poly(THF)), 4,4’-methylenebis(phenylisocyanate) (MDI), and 1,4-butanediol 
in the presence of commercially available dyes such as rhodamine and 
fluorescein to afford the resultant dye-incorporated polymers. These studies 
were the inspiration for considering the covalent attachment of a crystal violet 
analogue. 
2.5.1 Attempted preparation of an amine-functionalised crystal violet 
analogue 
The synthesis of two PEGylated amine-functionalised crystal violet analogues 
had already been described by Szent-Gyorgyi et al.297 in 2008. A synthetic 
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route based on their methodology was devised and is shown below (Scheme 
57). 
 
Scheme 57. Proposed synthetic route towards an amine-functionalised crystal violet analogue. 
The first step involved an SN2 reaction between 4-hydroxybenzaldehyde and 
ethyl bromobutyrate in acetonitrile. The desired aryl aldehyde 51, was 
obtained in yields of up to 94% (Scheme 58).330 
 
Scheme 58. Synthesis of aryl aldehyde 51. 
The reaction of aryl aldehyde 51 with 2 equivalents of N,N-dimethylaniline to 
give the corresponding leucocrystal violet analogue 52, using the conditions 
of Szent-Gyorgyi et al.,297 was capricious. The numbers of equivalents of all 
the reagents were frequently adjusted, as was the concentration. After 
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numerous attempts the desired leucocrystal violet analogue 52 was obtained 
in a yield of 32% (Scheme 59). 
 
Scheme 59. Synthesis of leucocrystal violet analogue 52. 
Attempts to cleave the ester group were unsuccessful in acetone with both 
NaOH(aq) and KOH(aq), using the procedure of Szent-Gyorgyi et al.297 In 
addition, the reaction was tried in ethanol with KOH(aq) but again the desired 
product was not obtained. 
2.5.2 Preparation of a modified polyurethane film 
Initially, a commercially available polyurethane-making kit was used, which 
included a mixture of poly-alcohols, and a “hardener”. The intention was to 
optimise the amount of dye required to generate a polymer film without any 
aggregation of the dye, but with sufficient colouration so that it would be 
expected to exhibit antibacterial activity in the presence of a light source.  
To the poly-alcohol mixture was added commercially available crystal violet. 
The amount of crystal violet that was used was varied, and ranged between 
0.01%-0.30% by mass. The polyurethane was made by adding the hardener 
to the poly-alcohol mix, before pouring the resultant mixture into a silicone ice 
cube tray and allowing the desired polymer film to form. Although the polymers 
generated were robust and consistently had the same properties, aggregation 
of crystal violet was observed in every experiment. As the exact composition 
of the polyurethane-making kit was not known, it was decided that a more 
rigorous approach would involve preparation of the polymer from known 
starting materials. 
The conditions of Chung et al.328,329 were used, but modified slightly owing to 
availability of equipment. The chain-extender, 1,4-butanol, was added to a 
mixture of poly(THF) and MDI in THF (instead of DMF). The amounts of each 
component were varied, and are noted in the table below (Table 15).  
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Table 15. The various conditions that were used for the preparation of different polyurethane films. The relative 
numbers of equivalents of each component are indicated. 
The resultant mixture from each experiment was poured into segments of a 
silicone ice cube tray, instead of into a petri dish; the solvent was then allowed 
to evaporate in air which resulted in the generation of the desired polymer film, 
as opposed to carrying out this process in a vacuum oven. None of the polymer 
films that were produced were fit for purpose: they were either too brittle or 
soft, or both. Moreover, some of these experiments were repeated and the 
properties of the films generated were seen to vary substantially. 
Considering the difficulties encountered up until this point, and having had little 
success with trying to synthesise the desired crystal violet analogue, no further 
experiments were tried and this project was abandoned. 
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3 Conclusions and future work 
The syntheses of alkyne-functionalised analogues of methylene blue, toluidine 
blue O, and crystal violet, were investigated. It was not possible to synthesise 
any analogues of methylene blue or toluidine blue O. One of the major 
problems with the attempted synthesis of methylene blue analogues was the 
susceptibility of every product to oxidation, making their purification difficult. 
The attempted alkylation of 10-acetyl-3,7-diaminophenothiazine 3 proved to 
be particularly troublesome, and the synthesis was abandoned at this point. In 
2014, Murray et al.331 synthesised methylene blue analogue 59 by reacting 2-
amino-5-(dimethylamino)phenylthiosulfonic acid 57 with tertiary aniline 58 
(Scheme 60). One might synthesise, and use, an alkyne-functionalised tertiary 
aniline in place of tertiary aniline 58, and expect a similar outcome. 
 
Scheme 60. Synthesis of methylene blue analogue 59, as described by Murray et al.331 
By using the same methodology, it might be possible to access a range of 
toluidine blue O analogues. In this case, arylthiosulfonic acid 60 would need 
to be synthesised (Scheme 61). 
 
Scheme 61. Proposed synthesis of toluidine blue analogue 62. 
The syntheses of three different crystal violet analogues 35-37 are described. 
Of the four, three contain alkyne substituents that should allow them to 
participate in further chemical reactions. It was hypothesised that these 
compounds might be able to undergo a copper-catalysed 1,3-dipolar 
cycloaddition reaction with an azide-functionalised polymer surface; however, 
it was not possible to prove that crystal violet analogue 35 was covalently 
attached to azide-functionalised PVC. To overcome this issue in the future, 
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one might consider synthesising a suitable polymer precursor containing a 
crystal violet analogue. The subsequent polymerisation of this monomeric unit 
would give a material that contained covalently attached crystal violet moieties. 
The added advantage of such an approach would be that the amount of crystal 
violet could be controlled by performing co-polymerisation reactions with 
varying amounts of the crystal violet-containing monomer unit (Scheme 62).  
 
Scheme 62. A hypothetical co-polymerisation reaction between a monomer (MON) containing crystal violet (CV), 
and another with no crystal violet moiety. 
Despite setbacks with regards to covalently attaching crystal violet analogues 
35-37 to a polymer surface, microbiological studies were conducted to assess 
their efficacy as light-activated antibacterial agents when they were 
incorporated into polyurethane, which was achieved by a swell-encapsulate-
shrink process. The polyurethane film that was incorporated with crystal violet 
analogue 35 effected the lethal photosensitisation of S. aureus after three 
hours of white light illumination (Figure 43).  
 
Figure 43. Crystal violet analogue 35. 
A mini-project was devised to investigate whether ethyl violet was more 
effective as a light-activated antibacterial agent than crystal violet. The 
superiority of crystal violet was demonstrated; however, should the toxicity of 
ethyl violet towards mammalian cells be shown to be significantly less than 
that of crystal violet in the future, it might prove to be a better alternative. 
A separate project was devised to investigate the effect of subtle structural 
changes on the light-activated antibacterial activity of a range of synthetic 
porphyrins. The porphyrins were synthesised according to literature 
procedures, and were incorporated into medical grade silicone via a swell-
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encapsulate-shrink process. The antibacterial activity of the resultant polymer 
films has not yet been assessed. Eventually, the physical properties of the 
porphyrin-incorporated films should be studied, if any of the films prove be 
effective at killing bacteria. The relative photostability of the biologically active 
porphyrins when physically incorporated into silicone would be of particular 
interest. 
Finally, attempts were made to synthesise an amine-functionalised crystal 
violet analogue that could, in theory, be added to a polymerisation reaction to 
generate polyurethane with covalently attached crystal violet moieties. 
Problems were encountered with the synthesis of a suitably functionalised 
crystal violet analogue, and with the generation of the polyurethane film. 
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4 Experimental 
4.1 Techniques, materials, and instrumentation 
Commercially available chemicals were used without any further purification, 
unless stated otherwise. When dry solvents were used, they were either 
obtained from commercial vendors, or from the anhydrous solvent system set 
up in UCL. Thin-layer chromatography (TLC) was conducted using pre-coated 
aluminium backed plates (Merck, Silica Gel 60 F254). TLC plates were 
visualised under UV light and/or by dipping the TLC plate into a solution of 
vanillin, or alkaline KMnO4, solution followed by heating. Flash column 
chromatography was performed using silica gel (Merck Kieselgel 60). All yields 
quoted refer to isolated yields. 
1H and 13C NMR spectra were measured on the following Bruker instruments: 
Avance 300, Avance III 400, DRX500, and Avance III 600 Cryo (as specified). 
Chemical shift values are recorded in parts per million (ppm); coupling 
constants are recorded in Hz. Mass spectra were measured on a Finnigan 
MAT 900 XP or a Waters Autosampler Manager 2777C connected to Waters 
LCT Premier XE. IR spectra were measured on a Bruker ALPHA FT-IR 
spectrometer operating in ATR mode. Melting points were measured using a 
Reichert-Jung Thermovar hot-stage microscope apparatus and are 
uncorrected. UV-Vis spectra were measured on a Perkin Elmer Lambda 25 
spectrometer. X-ray photoelectron spectroscopy (XPS) was performed using 
a Thermo Scientific K-alpha spectrometer. Photographs were taken using a 
Sony Xperia E4 5-megapixel camera. Water droplet contact angles were 
measured using a First Ten angstroms 1000 device with a side mounted rapid 
fire camera casting 3 µL water droplet on the surface of each sample and 5 
replicates on fresh samples were performed. 
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4.2 Procedures for the synthesis of organic compounds and 
associated data 
3,7-Dinitrophenothiazine (1)285  
The procedure from a Wista Laboratories Ltd. patent 
was used.285 To a mixture consisting of phenothiazine 
(5.00 g, 25.1 mmol, 1.00 eq.), DCM (25 mL) and acetic 
acid (10 mL) was added NaNO2 (5.19 g, 75.3 mmol, 3.00 eq.). The reaction 
was stirred at r.t. for 10 minutes prior to the addition of DCM (25 mL), acetic 
acid (10 mL) and NaNO2 (5.19 g, 75.3 mmol, 3.00 eq.). To ensure that efficient 
stirring could continue, acetic acid (30 mL) was added. The reaction mixture 
was stirred at r.t. for 3 hours. The resultant solid precipitate was filtered and 
washed with ethanol (250 mL), water (250 mL) and ethanol (250 mL). The 
solid was recrystallised from DMF to give 3,7-dinitrophenothiazine 1 as a 
purple solid (3.79 g, 13.1 mmol, 52%). mp > 240 °C; νmax/cm−1 3328 (NH), 
1604, 1564, 1539, 1480, 1298, 1265, 1235, 1140, 1125; δH (500 MHz, DMSO-
d6) 10.13 (1H, s, NH), 7.88 (2H, dd, J = 8.8 and 2.5 Hz, H2), 7.80 (2H, d, J = 
2.5 Hz, H4), 6.75 (2H, d, J = 8.8 Hz, H1); δC (125 MHz, DMSO-d6) 145.1 (C3), 
142.5 (CS), 124.8 (C2), 121.8 (C4), 116.7 (CN), 114.7 (C1). Data is consistent 
with the literature values.285 
10-Acetyl-3,7-dinitrophenothiazine (2)285 
The procedure from a Wista Laboratories Ltd. patent 
was used.286 To a mixture consisting of 3,7-
dinitrophenothiazine 1 (2.00 g, 6.91 mmol, 1.00 eq.), 
DMF (5 mL) and acetic anhydride (6.5 mL, 69 mmol, 10 eq.) was added 
triethylamine (3.9 mL, 28 mmol, 4.0 eq.). The reaction mixture was heated to 
105 °C and allowed to stir for 3 hours, before being cooled to r.t. and stirred 
for a further 1 hour. The resultant product was isolated by filtration and washed 
with methanol (3 × 40 mL). The desired product 2 was obtained as a light 
yellow solid (1.72 g, 5.19 mmol, 75%). mp 228-229 °C (lit.332 221-223 ºC); 
νmax/cm−1 3100 (CH), 1685 (C=O), 1517, 1461, 1340, 1312, 1288, 1252, 1209, 
1122; δH (600 MHz, CDCl3) 8.35 (2H, d, J = 2.5 Hz, H4), 8.26 (2H, dd, J = 8.8 
and 2.5 Hz, H2), 7.69 (2H, d, J = 8.8 Hz, H1), 2.30 (3H, s, CH3); δC (150 MHz, 
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CDCl3) 168.3 (C=O), 146.4, 143.3 and 136.7 (CN, CS and C3), 127.8 (C1), 
123.5 (C4), 123.1 (C2), 23.1 (CH3). Data is consistent with literature values.285 
10-Acetyl-3,7-diaminophenothiazine (3)285  
The procedure from a Wista Laboratories Ltd. patent 
was used.285 To a solution of 10-acetyl-3,7-
dinitrophenothiazine 2 (1.00 g, 3.02 mmol, 1.00 eq.) in 
ethanol (25 mL) was added SnCl2.2H2O (6.81 g, 30.2 mmol, 10.0 eq.). The 
resultant solution was heated under reflux for 5 hours. The reaction mixture 
was cooled to r.t. before being poured into ice water (~100 mL). The pH of the 
resultant solution was adjusted to 7 using 5% aq. NaHCO3 (100 mL), before 
being extracted with ethyl acetate (3 × 100 mL). The combined organic 
extracts were washed with brine (3 × 200 mL), dried over MgSO4, and 
concentrated in vacuo to give the title compound 3 as a blue-purple solid (517 
mg, 1.91 mmol, 63%). mp 189-191 °C (lit. value not given); νmax/cm−1 3323 
and 3200 (NH), 1727 (C=O), 1651, 1615, 1592, 1481, 1368, 1334, 1278, 1224, 
1136, 1058, 1013; δH (500 MHz, DMSO-d6) 7.16-7.10 (2H, m, H1), 6.61 (2H, 
s, H4), 6.49-6.47 (2H, m, H2), 5.31-5.23 (2H, m, NH2), 2.01 (3H, s, CH3); δC 
(100 MHz, DMSO-d6, 100 °C) 168.5 (C=O), 146.4 (C3), 132.1, 128.4 and 
126.7 (CN, CS and C1), 112.0 and 111.1 (C2 and C4), 21.7 (CH3). Data is 
consistent with the literature values.285 
N-Benzylaniline (6)333  
Method A: The procedure of Gray et al.287 was used. To a 
solution of aniline (0.11 mL, 1.2 mmol, 1.0 eq.) and K2CO3 
(162 mg, 1.17 mmol, 1.00 eq.) in acetonitrile (4 mL, 
degassed by bubbling argon through the solution for 10 minutes before use) 
was added benzyl bromide (0.14 mL, 1.2 mmol, 1.0 eq.) dropwise under argon. 
The reaction mixture was heated at 80 ºC for 20 hours under argon, before 
being cooled to r.t., filtered to remove any solid impurities, and concentrated 
in vacuo. The crude product was purified by flash column chromatography 
(SiO2, petroleum ether:diethyl ether 99:1) to give the desired product 6 as a 
white solid (28 mg, 0.15 mmol, 13%). Method B: The procedure of Srivastava 
et al.288 was used. To a solution of aniline (0.11 mL, 1.2 mmol, 1.0 eq.) and 
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K2CO3 (162 mg, 1.17 mmol, 1.00 eq.) in DMSO (0.50 mL, degassed by 
bubbling argon through the solution for 10 minutes before use) was added 
benzyl bromide (0.14 mL, 1.2 mmol, 1.0 eq.) dropwise under argon. The 
reaction mixture was stirred at 80 °C for 18 hours under argon, before being 
cooled to r.t. and diluted with chloroform (10 mL). The mixture was filtered to 
remove any solid impurities. The filtrate was poured into water (10 mL) and 
the organic layer was separated. The aqueous layer was extracted with 
chloroform (3 × 10 mL). The combined organic extracts were washed with 
brine (30 mL), dried over Na2SO4, and concentrated in vacuo. The crude 
product was purified by flash column chromatography (SiO2, petroleum 
ether:diethyl ether 99:1) to give the desired product 6 as a white solid (52 mg, 
0.28 mmol, 24%). Rf 0.15 (petroleum ether:diethyl ether 99:1); mp 37-39 °C 
(lit.333 37-40 ºC); νmax/cm−1 3417 (NH), 3052, 3023 and 2926 (CH), 1600, 1511, 
1492, 1449, 1328, 1302, 1277, 1180, 1151, 1118, 1105, 1079, 1065, 1027; δH 
(500 MHz, CDCl3) 7.39-7.33 (4H, m, H2’-3’), 7.30-7.26 (1H, m, H4’), 7.20-7.16 
(2H, m, H3), 6.74-6.71 (1H, m, H4), 6.66-6.64 (2H, m, H2), 4.34 (2H, s, CH2), 
4.04 (1H, br s, NH); δC (125 MHz, CDCl3) 148.1 (C1), 139.4 (C1’), 129.3 (C3), 
128.0 and 127.5 (C2’ and C3’), 127.2 (C4’), 117.6 (C4), 112.8 (C2), 48.3 (CH2). 
Data is consistent with the literature values.333  
Methyl 4-aminobenzoate (13)334  
The procedure of Takamatsu et al.291 was used. To a solution 
of 4-aminobenzoic acid (1.00 g, 7.29 mmol, 1.00 eq.) in 
methanol (20 mL) was added concentrated H2SO4 (5 mL) 
dropwise. The reaction mixture was heated under reflux for 38 hours before 
being cooled to r.t. and concentrated in vacuo. This was followed by dilution 
with water (15 mL) and adjustment of the pH to 3 using 2M aq. NaOH (20 mL). 
The resultant solid was separated by filtration and washed with water (50 mL) 
to give the desired product 13 as an off-white solid (775 mg, 5.13 mmol, 70%). 
mp 110-112 °C (lit.334 111-113 ºC); νmax/cm−1 3464 and 3369 (NH), 3247 (CH), 
1678 (C=O), 1593, 1568, 1520, 1435, 1313, 1284, 1180, 1167, 1121; δH (500 
MHz, CDCl3) 7.87-7.85 (2H, m, H2), 6.66-6.63 (2H, m, H3), 3.86 (3H, s, CH3); 
δC (125 MHz, CDCl3) 167.1 (C=O), 150.8 (C4), 131.6 (C2), 119.8 (C1), 113.8 
(C3), 51.6 (CH3). Data is consistent with the literature values.334  
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Methyl 4-(formamido)benzoate (15)335  
A mixture of acetic anhydride (1.3 mL, 27 mmol, 4.0 eq.) 
and formic acid (0.5 mL, 27 mmol, 4.0 eq.) was heated to 
60 °C for 2 hours in a round-bottomed flask equipped with 
a drying tube. The mixture was cooled to r.t. before the addition of methyl 4-
aminobenzoate 13 (500 mg, 3.31 mmol, 1.00 eq.) in DCM (5 mL) dropwise. 
The reaction mixture was stirred for 20 hours at r.t. before being concentrated 
in vacuo. An excess of diethyl ether (ca. 70 mL) was added and any solid 
precipitate was removed by filtration. The filtrate was concentrated in vacuo. 
Water (50 mL) was added, which resulted in the precipitation of a solid, which 
was isolated by filtration. The solid was washed with water (3 × 50 mL) to 
afford the desired product 15 as an off-white solid, which was a mixture of 
rotamers in a 3:1 ratio (380 mg, 2.12 mmol, 64%). mp 120-122 °C (lit.335 119-
122 ºC); νmax/cm−1 1692 (ester C=O), 1602 (formamide C=O), 1437, 1275, 
1179, 1113; δH (500 MHz, DMSO-d6) 10.54 (0.75H, br s, O=CH), 10.47 (0.25H, 
d, J = 11.4 Hz, O=CH), 8.97 (0.25H, d, J = 11.0 Hz, NH), 8.36 (0.75H, s, NH), 
7.93 (1.5H, d, J = 8.7 Hz, H2), 7.90 (0.5H, d, J = 8.6, H2), 7.71 (1.5H, d, J = 
8.7 Hz, H3), 7.32 (0.5H, d, J = 8.6 Hz, H3), 3.82 (3H, s, CH3); δC (125 MHz, 
DMSO-d6) 165.7 (OC=O), 162.6 (HNC=O, minor), 160.2 (HNC=O, major), 
143.0 (C4, minor), 142.5 (C4, major), 130.8 (C2, minor), 130.4 (C2, major), 
124.4 (C1), 118.2 (C3, major), 116.4 (C3, minor), 51.9 (CH3). Data is 
consistent with the literature values.335  
Methyl 4-(methylamino)benzoate (14)287  
To a solution of methyl 4-(formamido)benzoate 15 (500 mg, 
2.79 mmol, 1.00 eq.) in dry THF (25 mL, degassed by bubbling 
argon through the solution for 10 minutes before use) was 
added BH3.THF (1M in THF, 14 mL, 14 mmol, 5.0 eq.) dropwise at 50 °C under 
argon. The reaction mixture was stirred at 50 °C under argon for 1 hour. The 
reaction mixture was cooled to r.t. and quenched by the dropwise addition of 
methanol (20 mL). Once quenched, the resultant solution was concentrated in 
vacuo. The crude product was purified by flash column chromatography (SiO2, 
petroleum ether:ethyl acetate 9:1) to give the desired product 14 as a white 
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solid (385 mg, 2.33 mmol, 84%). Rf 0.15 (petroleum ether:ethyl acetate 9:1); 
mp 96-98 °C (lit.287 96-97 ºC); νmax/cm−1 3389 (NH), 1684 (C=O), 1598, 1563, 
1532, 1436, 1343, 1311, 1274, 1193, 1170, 1106; δH (500 MHz, CDCl3) 7.90-
7.87 (2H, m, H2), 6.57-6.54 (2H, m, H3), 4.20 (1H, br s, NH), 3.86 (3H, s, 
OCH3), 2.89 (3H, s, HNCH3); δC (125 MHz, CDCl3) 167.4 (C=O), 152.9 (C4), 
131.5 (C2), 118.2 (C1), 111.1 (C3), 51.5 (OCH3), 30.1 (HNCH3). Data is 
consistent with the literature values.287 
N-Methyl-N-benzyl-4-(carbomethoxy)aniline (16)336  
The procedure of Srivastava et al.288 was used. To a 
solution of methyl 4-(methylamino)benzoate 14 (200 
mg, 1.21 mmol, 1.00 eq.) in DMSO (3 mL) was added 
K2CO3 (167 mg, 1.21 mmol, 1.00 eq.). This was 
followed by the dropwise addition of benzyl bromide (0.14 mL, 1.2 mmol, 1.0 
eq.). The reaction mixture was stirred at 80 °C for 24 hours and cooled to r.t., 
before being poured into water (30 mL). The mixture was extracted with 
chloroform (3 × 10 mL). The combined organic extracts were washed with 
brine (30 mL), dried over MgSO4, and concentrated in vacuo. The crude 
product was purified by flash column chromatography (SiO2, petroleum 
ether:diethyl ether 9:1) to give the desired product 16 as a white solid (177 mg, 
0.693 mmol, 57%). Rf 0.10 (petroleum ether:diethyl ether 9:1); mp 82-84 °C 
(lit.336 67-68 ºC); νmax/cm−1 1687 (C=O), 1598, 1523, 1453, 1431, 1381, 1351, 
1321, 1276, 1182, 1123, 1005; δH (500 MHz, CDCl3) 7.90-7.88 (2H, m, H3), 
7.35-7.32 (2H, m, H3’), 7.28-7.25 (1H, m, H4’), 7.20-7.18 (2H, m, H2’), 6.72-
6.69 (2H, m, H2), 4.63 (2H, s, CH2), 3.86 (3H, s, OCH3), 3.13 (3H, s, NCH3); 
δC (125 MHz, CDCl3) 167.4 (C=O), 152.7 (C1), 137.8 (C1’), 131.4 (C2), 128.7 
(C3’), 127.2 (C4’), 126.4 (C2’), 117.4 (C4), 110.9 (C3), 55.9 (CH2), 51.5 
(OCH3), 38.7 (NCH3). Data is consistent with the literature values.336 
Bis(4-(dimethylamino)phenyl)methanol (20)295  
To a slurry of LiAlH4 (3.54 g, 93.2 mmol, 5.00 eq.) in THF 
(50 mL) was added bis(4-
(dimethylamino)phenyl)methanone (5.00 g, 18.6 mmol, 
1.00 eq.) in THF (50 mL) at 0 °C dropwise. The resultant reaction mixture was 
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stirred at r.t. for 1 hour before diluting with THF (100 mL). The mixture was 
cooled to 0 °C and water (3.5 mL) was added very cautiously, followed by the 
addition of 15% aq. NaOH (3.5 mL) and water (10.5 mL). The resultant slurry 
was stirred for a further 30 minutes at r.t. before addition of Na2SO4, filtration, 
and concentration in vacuo. The crude product was recrystallised from 
benzene to afford the desired product 20 as a pink solid (3.97 g, 14.7 mmol, 
79%).  mp 106-108 °C (lit.337 103-104 ºC); νmax/cm−1 3404 (OH), 2837 (CH), 
1613, 1517, 1345, 1225, 1165, 1043; δH (500 MHz, DMSO-d6) 7.10 (4H, d, J 
= 8.7 Hz, H2), 6.63 (4H, d, J = 8.8 Hz, H3), 5.46 (1H, d, J = 3.9 Hz, HOCH), 
5.40 (1H, d, J = 4.1 Hz, OH), 2.81 (12H, s, CH3); δC (125 MHz, DMSO-d6) 
149.5 (C4), 134.4 (C1), 127.2 (C2), 112.3 (C3), 74.0 (HOCH), 40.6 (CH3); m/z 
(CI) found 270 ([M]+, ~85%), 253 ([M – OH]+, 100%); Accurate mass calc. for 
C17H22N2O [M]+ 270.1732, found 270.1730, Δ 0.7ppm. Data is consistent with 
the literature values.295 
N-Methyl-N-phenylpropargylamine (21)338  
The procedure of Srivastava et al.288 was used. To a solution 
of N-methylaniline (5.00 g, 46.7 mmol, 1.00 eq.) in DMSO (75 
mL) was added K2CO3 (6.45 g, 46.7 mmol, 1.00 eq.). This was 
followed by the dropwise addition of propargyl bromide solution (80 wt.% in 
toluene, 5.2 mL, 47 mmol, 1.0 eq.). The reaction mixture was heated to 80 °C 
and allowed to stir for 20 hours before being cooled to r.t. and poured into 
water (750 mL). The mixture was then extracted with chloroform (3 × 250 mL). 
The combined organic extracts were washed with brine (3 × 250 mL), dried 
over MgSO4, and concentrated in vacuo. The crude product was purified by 
flash column chromatography (SiO2, petroleum ether:diethyl ether 19:1) to 
give the desired product 21 as a pale yellow oil (5.09 g, 35.1 mmol, 75%). Rf 
0.30 (petroleum ether:diethyl ether 19:1); νmax/cm−1 3289 (CH), 1600, 1504, 
1357, 1242, 1199, 1114, 1034; δH (500 MHz, CDCl3) 7.29-7.26 (2H, m, H3), 
6.88-6.86 (2H, m, H2), 6.83-6.80 (1H, m, H4), 4.06 (2H, m, CH2), 2.98 (3H, s, 
CH3), 2.18-2.17 (1H, m, C≡CH); δC (125 MHz, CDCl3) 149.0 (C1), 129.1 (C3), 
118.3 (C4), 114.3 (C2), 79.3 (C≡CH), 72.0 (C≡CH), 42.5 (CH3), 38.6 (CH2); 
m/z (EI) found 144 ([M – H]+, 100%); Accurate mass calc. for C10H11N [M]+ 
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145.0886, found 145.0880, Δ 4.2ppm. Data is consistent with the literature 
values.338 
4-(Trimethylsilylethynyl)toluene (23)339  
A mixture of CuI (44 mg, 0.23 mmol, 0.025 eq.), Pd(PPh3)2Cl2 
(322 mg, 0.459 mmol, 0.0500 eq.), triethylamine (40 mL, 
degassed for 10 min by bubbling argon through the solution 
before use) and 4-iodotoluene (2.00 g, 9.17 mmol, 1.00 eq.) was stirred for 5 
minutes before the dropwise addition of trimethylsilylacetylene (1.5 mL, 11 
mmol, 1.2 eq.) at r.t. under argon. The reaction mixture was heated under 
reflux for 18 hours under argon, before quenching with 1 M aq. HCl (300 mL). 
The aqueous solution was filtered to remove any solid impurities, before being 
extracted with petroleum ether (3 × 100 mL). The combined organic extracts 
were washed with water (100 mL) and brine (100 mL), dried over MgSO4, and 
concentrated in vacuo. The crude product was purified by flash column 
chromatography (SiO2, petroleum ether) to give the desired product 23 as an 
off-white solid (1.53 g, 8.13 mmol, 89%). Rf 0.25 (petroleum ether); mp 30-32 
ºC (lit. value not given); νmax/cm−1 2959 (CH), 2157 (C≡C), 1507, 1250; δH (500 
MHz, CDCl3) 7.37 (2H, d, J = 8.1 Hz, H3), 7.11 (2H, d, J = 8.1 Hz, H2), 2.35 
(3H, s, ArCH3), 0.26 (9H, s, SiCH3); δC (125 MHz, CDCl3) 138.6 (C1), 131.9 
(C3), 128.9 (C2), 120.1 (C4), 105.4 (C≡CSi), 93.2 (C≡CSi), 21.5 (ArCH3), 0.0 
(SiCH3). Data is consistent with the literature values.339 
1-Bromomethyl-4-(trimethylsilylethynyl)benzene (24) 
To a solution of 4-(trimethylsilylethynyl)toluene 23 (500 mg, 
2.66 mmol, 1.00 eq.) and N-bromosuccinimide (473 mg, 
2.66 mmol, 1.00 eq.) in benzotrifluoride (10 mL, degassed 
by bubbling argon through the solution for 10 minutes before use) was added 
dibenzoyl peroxide (64 mg, 0.27 mmol, 0.10 eq.) under argon. The reaction 
mixture was heated under reflux for 24 hours under argon, under irradiation 
by an W6-IQ Group White 150 W Security Pir Transmitter Flood Light. The 
reaction mixture was cooled to r.t. and concentrated in vacuo. The crude 
product was purified by flash column chromatography (SiO2, petroleum ether) 
to give the desired product 24 as a colourless oil (425 mg, 1.59 mmol, 60%). 
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Rf 0.15 (petroleum ether); νmax/cm−1 2959 (CH), 2158 (C≡C), 1506, 1249, 
1221, 863-842, 760, 732, 634, 606, 557; δH (500 MHz, CDCl3) 7.44 (2H, d, J 
= 8.3 Hz, H3), 7.33 (2H, d, J = 8.2 Hz, H2), 4.47 (2H, s, CH2), 0.26 (9H, s, 
SiCH3); δC (125 MHz, CDCl3) 138.0 (C1), 132.3 (C2), 128.9 (C3), 123.3 (C4), 
104.5 (C≡CSi), 95.3 (C≡CSi), 32.9 (CH2), -0.1 (SiCH3). m/z (CI) found 187 ([M 
– Br]+, 100%).  
N-(4-Ethynylbenzyl)-N-methylaniline (22) 
For the first step, the procedure of Srivastava et al.288 was 
used. To a solution of N-methylaniline (500 mg, 4.67 
mmol, 1.00 eq.) in DMSO (7.5 mL) was added K2CO3 
(645 mg, 4.67 mmol, 1.00 eq.), followed by 1-bromomethyl-4-
(trimethylsilylethynyl)benzene 24 (1.25 g, 4.67 mmol, 1.00 eq.). The reaction 
mixture was heated to 80 °C and stirred for 20 hours before being cooled to 
r.t. and poured into water (75 mL). The mixture was then extracted with 
chloroform (5 × 25 mL). The combined organic extracts were washed with 
brine (3 × 25 mL), dried over MgSO4, and concentrated in vacuo to afford the 
trimethylsilyl-protected product, which was not isolated. The crude product 
was mixed with K2CO3 (215 mg, 1.56 mmol, 0.333 eq.) in methanol (10 mL) 
and DCM (10 mL) at r.t. for 22 hours. The mixture was then diluted with water 
(100 mL) before being extracted with chloroform (3 × 25 mL). The combined 
organic extracts were washed with brine (3 × 25 mL), dried over MgSO4, and 
concentrated in vacuo. The crude product was purified by flash column 
chromatography (SiO2, petroleum ether:diethyl ether 49:1) to afford the 
desired product 22 as a white solid (847 mg, 3.83 mmol, 82%). Rf 0.30 
(petroleum ether:diethyl ether 49:1); mp 57-59 ºC; νmax/cm−1 3254 (CH), 1595, 
1504, 1373, 1344, 1296, 1253, 1210, 1118, 1035; δH (500 MHz, CDCl3) 7.46 
(2H, d, J = 8.2 Hz, H3’), 7.25-7.20 (4H, m, H3 and H2’), 6.75-6.73 (3H, m, H2 
and H4), 4.54 (2H, s, CH2), 3.06 (1H, s, C≡CH), 3.03 (3H, s, CH3); δC (125 
MHz, CDCl3) 149.5 (C1), 140.1 (C1’), 132.3 (C3’), 129.2 and 126.7 (C3 and 
C2’), 120.6 (C4’), 116.8 (C4), 112.4 (C2), 83.6 (C≡CH), 76.9 (C≡CH), 56.6 
(CH2), 38.6 (CH3); m/z (EI) found 221 ([M]+, ~80%), 115 ([M – C7H8N]+, 100%); 
Accurate mass calc. for C16H15N [M]+ 221.1204, found 221.1200, Δ 2.3ppm. 
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Tris(4-dimethylaminophenyl)methane (27)340  
To a solution of N,N-dimethylaniline (500 mg, 4.13 mmol, 
1.00 eq.) in methanol (5 mL) was added bis(4-
(dimethylamino)phenyl)methanol 20 (1.12 g, 4.13 mmol, 
1.00 eq.), followed by p-toluenesulfonic acid (78 mg, 0.41 
mmol, 0.10 eq.). The reaction mixture was stirred at r.t. 
for 24 hours. The resultant product was isolated by filtration and washed with 
methanol to afford the desired product 27 as a pale purple solid (1.25 g, 3.35 
mmol, 81%). mp 184-186 °C (lit.340 177-179 ºC); νmax/cm−1 1611, 1514, 1346, 
1163, 1060; δH (500 MHz, CDCl3) 7.00 (6H, d, J = 8.7 Hz, H2), 6.68 (6H, d, J 
= 8.5 Hz, H3), 5.31 (1H, s, Ar3CH), 2.92 (18H, s, CH3); δC (125 MHz, CDCl3) 
148.9 (C4), 133.8 (C1), 130.0 (C2), 112.7 (C3), 54.1 (Ar3CH), 40.9 (CH3); m/z 
(CI) found 373 ([M]+, ~95%), 253 ([M – C8H10N]+, 100%); Accurate mass calc. 
for C25H31N3 [M]+ 373.2518, found 373.2512, Δ 1.7ppm. Data is consistent with 
the literature values.340 
4,4'-((4-(Methyl(prop-2-yn-1-yl)amino)phenyl)methylene)bis(N,N-
dimethylaniline) (28) 
To a solution of N-methyl-N-phenyl-propargylamine 21 
(2.85 g, 19.6 mmol, 1.00 eq.) in methanol (30 mL) was 
added bis(4-(dimethylamino)phenyl)methanol 20 (5.30 
g, 19.6 mmol, 1.00 eq.), followed by p-toluenesulfonic 
acid (373 mg, 1.96 mmol, 0.100 eq.). The reaction 
mixture was stirred at r.t. for 24 hours. The resultant 
product was isolated by filtration and washed with methanol to afford the 
desired product 28 as a pale purple solid (2.06 g, 5.18 mmol, 26%). mp 136-
138 °C; νmax/cm−1 1610, 1514, 1443, 1346, 1188, 1060; δH (500 MHz, CDCl3) 
7.03-6.99 (6H, m, H3 and H2’), 6.76 (2H, d, J = 8.7 Hz, H3’), 6.68 (4H, d, J = 
8.2 Hz, H2), 5.31 (1H, s, Ar2CH), 4.02 (2H, d, J = 2.4 Hz, CH2), 2.95 (3H, s, 
H2CNCH3), 2.92 (12H, s, N(CH3)2), 2.17 (1H, t, J = 2.4 Hz, C≡CH); δC (125 
MHz, CDCl3) 148.8 (C1), 147.1 (C4’), 135.3 (C1’), 133.6 (C4), 129.9 (C3 and 
C2’), 114.1 (C3’), 112.6 (C2), 79.5 (C≡CH), 72.0 (C≡CH), 54.1 (Ar2CH), 42.6 
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(CH2), 40.8 (N(CH3)2), 38.7 (H2CNCH3); m/z (CI) found 397 ([M]+, 100%); 
Accurate mass calc. for C27H31N3 [M]+ 397.2518, found 397.2520, Δ 0.5ppm. 
4,4'-((4-((4-Ethynylbenzyl)(methyl)amino)phenyl)methylene)bis(N,N-
dimethylaniline) (29) 
To a solution of N-(4-Ethynylbenzyl)-N-methylaniline 
22 (500 mg, 2.26 mmol, 1.00 eq.) in methanol (5 mL) 
was added bis(4-(dimethylamino)phenyl)methanol 20 
(611 mg, 2.26 mmol, 1.00 eq.), followed by p-
toluenesulfonic acid (43 mg, 0.23 mmol, 0.10 eq.). 
The reaction mixture was stirred at r.t. for 24 hours. The resultant product was 
isolated by filtration and washed with methanol to afford the desired product 
29 as a pale purple solid (412 mg, 0.870 mmol, 38%). mp 156-158 °C; 
νmax/cm−1 3283 (CH), 1611, 1515, 1330, 1207, 1117; δH (500 MHz, CDCl3) 7.43 
(2H, d, J = 8.2 Hz, H3’’), 7.19 (2H, d, J = 8.4 Hz, H2’’), 6.99-6.95 (6H, m, H3 
and H2’), 6.67-6.62 (6H, m, H2 and H3’), 5.28 (1H, s, Ar2CH), 4.46 (2H, s, 
CH2), 3.04 (1H, s, C≡CH), 2.95 (3H, s, H2CNCH3), 2.90 (12H, s, N(CH3)2); δC 
(125 MHz, CDCl3) 148.8 (C1), 147.8 (C4’), 140.4 (C1’’), 133.9 and 133.6 (C4 
and C1’), 132.3 (C3’’), 130.0 and 129.9 (C3 and C2’), 126.8 (C2’’), 120.5 (C4’’), 
112.6 and 112.3 (C2 and C3’), 83.6 (C≡CH), 76.8 (C≡CH), 56.9 (CH2), 54.0 
(Ar2CH), 40.8 (N(CH3)2), 38.6 (H2CNCH3); m/z (EI) found 473 ([M]+, 100%); 
Accurate mass calc. for C33H35N3 [M]+ 473.2831, found 473.2830, Δ 0.2ppm. 
Bis(4-dimethylaminophenyl)phenylmethane (30)341  
The procedure of Szent-Gyorgyi et al.297 was used. To a 
solution of benzaldehyde (200 mg, 1.88 mmol, 1.00 eq.) and 
ZnCl2 (514 mg, 3.77 mmol, 2.00 eq.) in ethanol (5 mL, 
degassed by bubbling argon through the solution for 10 
minutes before use) was added N,N-dimethylaniline (0.46 
mL, 3.8 mmol, 2.0 eq.). The reaction mixture was heated under reflux for 20 
hours under argon, before being cooled to r.t. and concentrated in vacuo. The 
residue was dissolved in water (50 mL) and ethyl acetate (20 mL). The layers 
were separated and the aqueous layer was extracted with ethyl acetate (2 × 
20 mL). The combined organic extracts were washed with water (3 × 20 mL), 
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dried over MgSO4, and concentrated in vacuo. The crude product was purified 
by flash column chromatography (SiO2, petroleum ether:diethyl ether 9:1) to 
afford the desired product 30 as a pale green solid (254 mg, 0.769 mmol, 
41%). Rf 0.05 (petroleum ether:diethyl ether 9:1); mp 92-94 ºC (lit.341 92-93 
ºC); νmax/cm−1 2878 and 2801 (CH), 1610, 1516, 1442, 1349, 1189, 1059; δH 
(500 MHz, DMSO-d6) 7.26-7.23 (2H, m, H3), 7.16-7.13 (1H, m, H4), 7.08 (2H, 
d, J = 7.6 Hz, H2), 6.90-6.87 (4H, m, H2’), 6.45-6.41 (4H, m, H3’), 5.31 (1H, s, 
Ar2CH), 2.84 (12H, s, CH3); δC (125 MHz, DMSO-d6) 148.8 (C4’), 145.4 (C1), 
132.3 (C1’), 129.4 (C2’), 128.9 (C2), 128.0 (C3), 125.7 (C4), 112.4 (C3’), 54.2 
(Ar2CH), 40.3 (CH3); m/z (EI) found 330 ([M]+, 100%), 253 ([M – C6H5]+, ~70%); 
Accurate mass calc. for C23H26N2 [M]+ 330.2096, found 330.2085, Δ 3.3ppm. 
Data is consistent with the literature values.341 
4-(Prop-2-yn-1-yloxy)benzaldehyde (31)298  
The procedure of Hoogendoorn et al.298 was used. To a solution 
of 4-hydroxybenzaldehyde (1.00 g, 8.19 mmol, 1.00 eq.) in 
acetone (30 mL) was added K2CO3 (1.58 g, 11.5 mmol, 1.40 eq.). The resultant 
slurry was stirred for 30 minutes at r.t. prior to the addition of propargyl bromide 
(80 wt.% in toluene, 1.8 mL, 16 mmol, 2.0 eq.). The reaction mixture was 
heated under reflux for 2 hours before being cooled to r.t. and concentrated in 
vacuo. The residue was dissolved in water (100 mL) and the resultant solution 
was extracted with ethyl acetate (3 × 100 mL). The combined organic extracts 
were washed with brine (100 mL), dried over MgSO4, and concentrated in 
vacuo to afford the title compound 31 as a white solid (1.24 g, 7.74 mmol, 
95%). Rf 0.25 (petroleum ether:ethyl acetate 4:1); mp 76-78 ºC (lit.342 76-78 
ºC); νmax/cm−1 3205, 2832, 2808 and 2749 (CH), 2122 (C≡C), 1677 (C=O), 
1601, 1574, 1504, 1426, 1395, 1379, 1301, 1248, 1168, 1006; δH (500 MHz, 
CDCl3) 9.90 (1H, s, HC=O), 7.87-7.84 (2H, m, H2), 7.11-7.08 (2H, m, H3), 4.78 
(2H, d, J = 2.4 Hz, CH2), 2.57 (1H, t, J = 2.4 Hz, C≡CH); δC (125 MHz, CDCl3) 
190.8 (HC=O), 162.4 (C4), 132.0 (C2), 130.7 (C1), 115.3 (C3), 77.6 (C≡CH), 
76.4 (C≡CH), 56.0 (CH2). Data is consistent with the literature values.298 
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4-((4-Ethynylbenzyl)oxy)benzaldehyde (32) 
For the first step, the procedure of Hoogendoorn et 
al.298 was used. To a solution of 4-
hydroxybenzaldehyde (594 mg, 4.87 mmol, 1.00 eq.) 
in acetone (15 mL) was added K2CO3 (942 mg, 6.81 
mmol, 1.40 eq.). The resultant slurry was stirred at r.t. for 30 minutes prior to 
the addition of 1-bromomethyl-4-(trimethylsilylethynyl)benzene 24 (1.15 g, 
4.87 mmol, 1.00 eq.) in acetone (5 mL). The reaction mixture was heated 
under reflux for 22 hours before being cooled to r.t. and concentrated in vacuo. 
The residue was dissolved in water (50 mL) and the solution was extracted 
with ethyl acetate (3 × 50 mL). The combined organic extracts were washed 
with brine (50 mL), dried over MgSO4, and concentrated in vacuo to afford the 
trimethylsilyl-protected product, which was not isolated. The crude product 
was mixed with K2CO3 (222 mg, 1.61 mmol, 0.333 eq.) in methanol (10 mL) 
and DCM (10 mL) at r.t. for 24 hours, before concentration in vacuo. The 
residue was dissolved in water (150 mL) and the solution was extracted with 
ethyl acetate (3 × 50 mL). The combined organic extracts were washed with 
brine (50 mL), dried over MgSO4, and concentrated in vacuo. The crude 
product was purified by flash column chromatography (SiO2, petroleum 
ether:ethyl acetate 4:1) to afford the desired product 32 as a white solid (530 
mg, 2.24 mmol, 46%). Rf 0.25 (petroleum ether:ethyl acetate 4:1); mp 127-129 
ºC; νmax/cm−1 3224 (CH), 1676 (C=O), 1594, 1505, 1461, 1377, 1313, 1261, 
1207, 1156, 1016; δH (600 MHz, CDCl3) 9.90 (1H, s, HC=O), 7.86-7.84 (2H, 
m, H2), 7.54-7.53 (2H, m, H3’), 7.40 (2H, d, J = 7.9 Hz, H2’), 7.08-7.06 (2H, 
m, H3), 5.16 (2H, s, CH2), 3.11 (1H, s, C≡CH); δC (150 MHz, CDCl3) 190.9 
(HC=O), 163.4 (C4), 136.9 (C1’), 132.6 and 132.2 (C2 and C3’), 130.4 (C1), 
127.4 (C2’), 122.2 (C4’), 115.2 (C3), 83.3 (C≡CH), 77.8 (C≡CH), 69.8 (CH2); 
m/z (CI) found 237 ([M]+, 100%); Accurate mass calc. for C16H13O2 [M + H]+ 
237.0910, found 237.0911, Δ 0.1ppm. 
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4,4’-((4-(Prop-2-yn-1-yloxy)phenyl)methylene)bis(N,N-dimethylaniline) 
(33) 
To a solution of 4-(prop-2-yn-1-yloxy)benzaldehyde 31 
(200 mg, 1.25 mmol, 1.00 eq.) in ethanol (5 mL, 
degassed by bubbling argon through the solution for 10 
minutes before use) was added acetyl chloride (0.18 mL, 
2.5 mmol, 2.0 eq.) followed by N,N-dimethylaniline (0.33 
mL, 2.6 mmol, 2.1 eq.) at r.t. under argon. The reaction mixture was heated 
under reflux under argon for 24 hours before being cooled to r.t. and diluted 
with water (50 mL). The resultant solution was extracted with DCM (3 × 10 
mL). The combined organic extracts were washed with water (2 × 10 mL) and 
brine (10 mL), dried over MgSO4, and concentrated in vacuo. The crude 
product was purified by flash column chromatography (SiO2, petroleum 
ether:ethyl acetate 4:1) to afford the desired product 33 as a white solid (300 
mg, 0.780 mmol, 62%). Rf 0.25 (petroleum ether:ethyl acetate 4:1); mp 122-
124 ºC; νmax/cm−1 3248, 2896, 2855 and 2793 (CH), 1607, 1515, 1451, 1334, 
1225, 1162, 1123, 1062, 1027; δH (500 MHz, CDCl3) 7.07-7.04 (2H, m, H2’), 
6.99-6.96 (4H, m, H3), 6.89-6.87 (2H, m, H3’), 6.67 (4H, d, J = 8.5 Hz, H2), 
5.33 (1H, s, Ar2CH), 4.65 (2H, d, J = 2.4 Hz, CH2), 2.91 (12H, s, CH3), 2.50 
(1H, t, J = 2.4 Hz, C≡CH); δC (150 MHz, CDCl3) 155.8 (C4’), 149.0 (C1), 138.7 
(C1’), 133.1 (C4), 130.4 (C2’), 130.0 (C3), 114.5 (C3’), 112.7 (C2), 78.9 
(C≡CH), 75.5 (C≡CH), 56.0 (CH2), 54.3 (Ar2CH), 40.9 (CH3); m/z (ES+) found 
385 ([M]+, 100%); Accurate mass calc. for C26H29N2O [M + H]+ 385.2280, found 
385.2266, Δ 3.6ppm. 
Tris(4-(dimethylamino)phenyl)methylium 2,3,5,6-tetrachloro-4-
hydroxyphenolate (34) 
A modified procedure of Szent-Gyorgyi et 
al.297 was used. To a solution of leucocrystal 
violet 27 (200 mg, 0.535 mmol, 1.00 eq.) in 
ethyl acetate (10 mL) was added chloranil 
(263 mg, 1.07 mmol, 2.00 eq.). The reaction 
mixture was heated under reflux for 1 hour before being cooled to r.t. and 
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filtered. The solid was washed with cold (0 ºC) ethyl acetate and diethyl ether 
to afford the title compound 34 as a green solid (321 mg, 0.518 mmol, 97%). 
νmax/cm−1 1585, 1359, 1176; δH (600 MHz, CDCl3) 7.33 (6H, d, J = 9.1 Hz, H2), 
6.87 (6H, d, J = 9.1 Hz, H3), 3.28 (18H, s, CH3); δC (150 MHz, CDCl3) 178.4 
(Ar3C+), 155.7 (C4), 139.9 (C2), 126.8 (C1), 112.5 (C3), 40.8 (CH3); m/z (ES+) 
found 372 ([M]+, 100%); Accurate mass calc. for C25H30N3 [M]+ 372.2440, 
found 372.2438, Δ 0.5ppm; λmax = 589 nm (ε = 76,860). 
Bis(4-(dimethylamino)phenyl)(4-(methyl(prop-2-
ynyl)amino)phenyl)methylium 2,3,5,6-tetrachloro-4-hydroxyphenolate 
(35) 
A modified procedure of Szent-Gyorgyi et 
al.297 was used. To a solution of 
leucocrystal violet analogue 28 (200 mg, 
0.503 mmol, 1.00 eq.) in ethyl acetate (10 
mL) was added chloranil (248 mg, 1.01 
mmol, 2.00 eq.). The reaction mixture was heated under reflux for 1 hour 
before being cooled to r.t. and filtered. The solid was washed with cold (0 ºC) 
ethyl acetate and diethyl ether to afford the title compound 35 as a purple solid 
(290 mg, 0.451 mmol, 90%). νmax/cm−1 1683, 1579, 1471, 1360, 1169; δH (600 
MHz, CDCl3) 7.36-7.33 (6H, m, H2 and H2’), 6.96 (2H, d, J = 8.8 Hz, H3’), 6.90 
(4H, d, J = 8.8 Hz, H3), 4.29 (2H, d, J = 2.2 Hz, CH2), 3.32 (12H, s, N(CH3)2), 
3.28 (3H, s, H2CNCH3), 2.35 (1H, t, J = 2.2 Hz, C≡CH); δC (150 MHz, CDCl3) 
178.6 (Ar2C+), 156.1 (C4), 154.2 (C4’), 140.3 and 139.3 (C2 and C2’), 127.9 
(C1’), 127.0 (C1), 113.0 and 112.9 (C3 and C3’), 77.7 (C≡CH), 73.4 (C≡CH), 
42.2 (CH2), 40.9 (N(CH3)2), 39.0 (H2CNCH3); m/z (ES+) found 396 ([M]+, 
100%); m/z (ES−) found 248 ([M]−, ~10%), 247 ([M]−, ~50%), 245 ([M]−, 100%), 
243 ([M]−, ~80%); Accurate mass calc. for C27H30N3 [M]+ 396.2440, found 
396.2445, Δ 1.3ppm; λmax = 590 nm (ε = 88,230). 
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Bis(4-(dimethylamino)phenyl)(4-((4-
ethynylbenzyl)(methyl)amino)phenyl)methylium 2,3,5,6-tetrachloro-4-
hydroxyphenolate (36) 
A modified procedure of Szent-Gyorgyi 
et al.297 was used. To a solution of 
leucocrystal violet analogue 29 (200 mg, 
0.422 mmol, 1.00 eq.) in ethyl acetate 
(10 mL) was added chloranil (208 mg, 
0.845 mmol, 2.00 eq.). The reaction mixture was heated under reflux for 1 hour 
before being cooled to r.t. and filtered. The solid was washed with cold (0 ºC) 
ethyl acetate and diethyl ether to afford the title compound 36 as a dull green 
solid (299 mg, 0.416 mmol, 98%*). νmax/cm–1 1574, 1475, 1353, 1161; δH (600 
MHz, CDCl3) 7.49 (2H, d, J = 7.4 Hz, H3’’), 7.33-7.28 (6H, m, H2 and H2’), 
7.19 (2H, d, J = 8.0 Hz, H2’’), 6.87 (6H, br s, H3 and H3’), 4.81 (2H, s, CH2), 
3.34 (3H, s, H2CNCH3), 3.30 (12H, s, N(CH3)2), 3.09 (1H, s, C≡CH); δC (150 
MHz, CDCl3) 178.4 (Ar2C+), 155.9 (C4), 155.1 (C4’), 143.6 (CO anion), 140.1 
and 139.8 (C2 and C2’), 137.4 (C1’’), 132.9 (C3’’), 127.4 and 126.8 (C1 and 
C1’), 126.5 (C2’’), 121.6 (C4’’), 119.5 (CCl anion), 112.7 and 110.6 (C3 and 
C3’), 83.2 (C≡CH), 77.8 (C≡CH), 56.3 (CH2), 40.8 (N(CH3)2), 39.8 (H2CNCH3); 
m/z (ES+) found 472 ([M]+, 100%); m/z (ES−) found 248 ([M]−, ~10%), 247 
([M]−, ~50%), 245 ([M]−, 100%), 243 ([M]−, ~80%); Accurate mass calc. for 
C33H34N3 [M]+ 472.2753, found 472.2729, Δ 5.1ppm; λmax = 590 nm (ε = 
97,590). *This compound contained ethyl acetate as an impurity (<3% by 
mass).  
Bis(4-(dimethylamino)phenyl)(4-(prop-2-ynyloxy)phenyl)methylium 
2,3,5,6-tetrachloro-4-hydroxyphenolate (37) 
A modified procedure of Szent-Gyorgyi et 
al.297 was used. To a solution of 
leucocrystal violet analogue 33 (200 mg, 
0.520 mmol, 1.00 eq.) in ethyl acetate (10 
mL) was added chloranil (256 mg, 1.04 
mmol, 2.00 eq.). The reaction mixture was heated under reflux for 1 hour 
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before being cooled to r.t. and filtered. The solid was washed with cold (0 ºC) 
ethyl acetate and diethyl ether to afford the title compound 37 as a dull green 
solid (251 mg, 0.398 mmol, 77%). νmax/cm–1 1682, 1578, 1355, 1161, 1009; δH 
(600 MHz, CDCl3) 7.37 (4H, d, J = 8.6 Hz, H2), 7.33 (2H, d, J = 8.7 Hz, H2’), 
7.16 (2H, d, J = 8.7 Hz, H3’), 6.97 (4H, d, J = 8.6 Hz, H3), 4.86 (2H, d, J = 2.4 
Hz, CH2), 3.37 (12H, s, CH3), 2.64 (1H, t, J = 2.4 Hz, C≡CH); δC (150 MHz, 
CDCl3) 177.6 (Ar2C+), 162.5 (C4’), 156.9 (C4), 140.9 (C2), 137.5 (C2’), 132.6 
(C1), 127.3 (C1), 115.3 (C3’), 113.7 (C3), 77.5 (C≡CH), 76.9 (C≡CH), 56.4 
(CH2), 41.2 (CH3); m/z (ES+) found 383 ([M]+, 100%); m/z (ES−) found 248 
([M]−, ~10%), 247 ([M]−, ~50%), 245 ([M]−, 100%), 243 ([M]−, ~50%); Accurate 
mass calc. for C26H27N2O [M]+ 383.2123, found 383.2120, Δ 0.8ppm; λmax = 
611 nm (ε = 66,840), and 459 nm (ε = 21,020). 
Diazide-PEG-400 (38)301 
The procedure of Susumu et al. was used.301 To a 
solution of PEG-400 (5.00 g, 12.5 mmol, 1.00 eq.) in dry 
THF (15 mL, degassed by bubbling argon through the solution for 10 minutes 
before use) was added mesyl chloride (2.2 mL, 29 mmol, 2.3 eq.). The mixture 
was cooled to 0 °C prior to the dropwise addition of triethylamine (4.4 mL, 31 
mmol, 2.5 eq.) under argon. The reaction mixture was then allowed to warm 
to r.t. and stirred overnight. After 18 hours, the reaction mixture was diluted 
with water (15 mL) and sodium bicarbonate (893 mg, 10.6 mmol, 0.850 eq.) 
was added. This was succeeded by addition of sodium azide (2.23 g, 34.4 
mmol, 2.75 eq.) and removal of THF by distillation under argon. The reaction 
was heated to reflux under argon for 24 hours before being cooled to r.t. and 
extracted with chloroform (5 × 10 mL). The combined organic extracts were 
dried over MgSO4 before being concentrated in vacuo. The crude product was 
purified by flash column chromatography (SiO2, chloroform:methanol 20:1) to 
give the desired product 38 as a pale yellow oil (4.89 g, 10.9 mmol, 87%). Rf 
0.75 (chloroform:methanol 10:1); νmax/cm–1 2866 (CH), 2097 (N≡N), 1452, 
1286, 1101; δH (500MHz, CDCl3) 3.69-3.65 (33.5H, m, OCH2), 3.39 (4H, t, J = 
5 Hz, N3CH2); δC (125MHz, CDCl3) 70.7-70.0 (OCH2), 50.7 (N3CH2). Data is 
consistent with the literature values.301 
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Mono-azide, mono-amine-PEG-400 (39)301  
The procedure of Susumu et al.301 was used. To a 
round-bottomed flask was added diazide-PEG-400 38 
(5.00 g, 11.1 mmol, 1.00 eq.), ethyl acetate (75 mL) and hydrochloric acid (1M 
in water, 30 mL). The mixture was degassed by bubbling argon through the 
solution for 10 minutes prior to the addition of triphenylphosphine (3.21 g, 12.2 
mmol, 1.10 eq.) in ethyl acetate (50 mL) via addition funnel at 0 °C under 
argon. Once the addition was complete, the reaction mixture was warmed to 
r.t. and stirred for 20 hours under argon. The organic and aqueous layers were 
separated, and the aqueous layer was washed with ethyl acetate (2 × 50 mL). 
The aqueous layer was then transferred to a round-bottomed flask and KOH 
(12.5 g, 222 mmol, 20.0 eq.) was added slowly. The mixture was stirred until 
all the KOH had dissolved. The aqueous mixture was then extracted with ethyl 
acetate (5 × 50 mL). The combined organic extracts were washed with brine 
(50 mL), before being dried over MgSO4 and concentrated in vacuo to afford 
the desired product 39 as a pale yellow oil (2.43 g, 5.73 mmol, 52%). Rf 0.10 
(chloroform:methanol 5:1); νmax/cm–1 2865 (CH), 2100 (N≡N), 1454, 1298, 
1094; δH (500MHz, CDCl3) 3.69-3.63 (34H, m, OCH2), 3.56 (2H, t, J = 5.3 Hz, 
H2NCH2), 3.39 (2H, t, J = 5.2 Hz, N3CH2), 2.91-2.87 (2H, m, NH2); δC (125MHz, 
CDCl3) 70.8-70.1 (OCH2), 50.8 (N3CH2), 41.7 (H2NCH2). Data is consistent 
with the literature values.301 
1-(ω-amino-PEG)-4-(N-methyl-N-phenyl)methylene-1,2,3-triazole OR 1-
(ω-amino-PEG)-5-(N-methyl-N-phenyl)methylene-1,2,3-triazole OR 2-(ω-
amino-PEG)-4-(N-methyl-N-phenyl)methylene-1,2,3-triazole (40) 
A solution of N-methyl-N-phenyl-
propargylamine 21 (50 mg, 0.34 mmol, 1.0 
eq.) and mono-azide, mono-amine-PEG-400 
39 (147 mg, 0.344 mmol, 1.00 eq.) in DCM (1 
mL) was degassed by bubbling argon through the solution for 10 minutes. To 
this solution was added CuBr(PPh3)3 (16 mg, 17 μmol, 0.050 eq.), and the 
reaction mixture was stirred at r.t. for 24 hours under argon. The mixture was 
then concentrated in vacuo, and the crude product was purified by flash 
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column chromatography to afford the desired product 40 as a mixture of two 
unidentifiable structural isomers in a 2:1 ratio as a yellow oil (175 mg, 0.306 
mmol, 89%*). δH (600 MHz, CDCl3) 7.57 (0.67H, s, H8), 7.47 (0.33H, m, H8), 
7.24-7.21 (2H, m, H2), 6.81-6.79 (2H, m, H3), 6.74-6.71 (1H, m, H1), 4.64 (2H, 
s, H6), 4.55 (1.33H, t, J = 5.2 Hz, H9), 4.47 (0.67H, t, J = 5.0 Hz, H9), 3.89 
(1.33H, t, J = 5.2 Hz, H10), 3.83-3.81 (0.67H, m, H10), 3.70-3.51 (20H, m, 
H11-14), 3.03 (2H, s, H5), 3.01 (1H, s, H5); δC (150 MHz, CDCl3) 149.2 (C4), 
145.3 (C7), 129.3 (C2), 123.1 and 122.9 (C8), 117.2 (C1), 113.1 (C3), 70.7-
70.3 (C11, C12 and C13), 69.6 (C10), 50.3 (C9), 48.7 (C6), 38.8 and 38.7 (C5 
and C14); m/z (EI) found 451 ([M]+, ~25%), 422 ([M – CH3N]+, ~85%), 159 ([M 
– C12H26N3O5]+, 100%), 144 ([M – C12H27N4O5]+, ~70%), 120 ([M – 
C14H27N4O5]+, ~70%), 107 ([M – C15H28N4O5]+, ~60%); Accurate mass calc. for 
C22H37N5O5 [M]+ 451.27947, found 451.27939, Δ 0.2ppm. *This compound 
contained minor, unidentifiable impurities. 
Meso-tetraphenylporphyrin (42)343,344 
The procedure of Adler et al.318 was used. To propionic 
acid (400 mL) under reflux were added freshly distilled 
pyrrole (6.9 mL, 100 mmol, 1.0 eq.) and benzaldehyde 
(10 mL, 100 mmol, 1.0 eq.) simultaneously. The reaction 
mixture was heated under reflux in the dark for 30 
minutes before being cooled to r.t.  and filtered. The filter 
cake was washed copiously with methanol to afford the title compound 42 as 
a purple solid (2.88 g, 4.68 mmol, 19%). Rf 0.75 (chloroform); mp > 240 ºC; 
νmax/cm−1 3314 (NH), 3054 and 3019 (CH), 1593, 1573, 1555, 1471, 1440, 
1400, 1347, 1249, 1219, 1177, 1071; δH (600 MHz, CDCl3) 8.86 (8H, s, β-H), 
8.23-8.22 (8H, m, H3), 7.80-7.75 (12H, m, H2 and H4), −2.77 (2H, s, NH); δC 
(150 MHz, CDCl3) 142.3 (C1), 134.7 (C3), 127.8 (C4), 126.8 (C2), 120.3 
(meso-C); m/z (EI) found 614 ([M]+, 100%); Accurate mass calc. for C44H30N4 
[M]+ 614.2465, found 614.2465, Δ 0.1ppm; λmax = 412 nm (ε = 235,210), 506 
nm (ε = 21,800), 583 nm (ε = 7,190), and 657 nm (ε = 2,410). Data is consistent 
with the literature values.343,344 
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Zinc meso-tetraphenylporphyrin (43)345  
The procedure of He et al.345 was used. To a solution of 
meso-tetraphenylporphyrin 42 (200 mg, 0.325 mmol, 
1.00 eq.) in chloroform (30 mL) was added zinc acetate 
(90 mg, 0.49 mmol, 1.5 eq.) in methanol. The reaction 
mixture was stirred at r.t. in the dark for 1 hour, before 
being added to water (100 mL). The layers were 
separated and the aqueous layer was extracted with chloroform (2 × 20 mL). 
The combined organic extracts were washed with water (20 mL) and brine (20 
mL), dried over Na2SO4, and concentrated in vacuo. The resultant solid was 
washed thoroughly with methanol to afford the title compound 43 as a dark 
pink solid (153 mg, 0.226 mmol, 69%). Rf 0.70 (chloroform); mp >240 ºC; 
νmax/cm−1 1593, 1523, 1484, 1439, 1337, 1203, 1174, 1157, 1066; δH (600 
MHz, CDCl3) 8.96 (8H, s, β-H), 8.24-8.23 (8H, m, H3), 7.80-7.74 (12H, m, H2 
and H4); δC (150 MHz, CDCl3) 150.3 (α-C), 142.9 (C1), 134.6 (C3), 132.1 (β-
C), 127.6 (C4), 126.7 (C2), 121.3 (meso-C); m/z (ES+) found 709 ([M + 
CH3OH]+, ~90%), 677 ([M + H]+, 100%); Accurate mass calc. for C44H29N4Zn 
[M + H]+ 677.1684, found 677.1684, Δ 0.1ppm; λmax = 421 nm (ε = 252,820), 
550 nm (ε = 19,570), and 593 nm (ε = 4,060). Data is consistent with the 
literature values.345 
Copper meso-tetraphenylporphyrin (44)345  
The procedure of He et al.345 was used. To a solution of 
meso-tetraphenylporphyrin 42 (200 mg, 0.325 mmol, 
1.00 eq.) in chloroform (30 mL) was added copper 
acetate (89 mg, 0.49 mmol, 1.5 eq.) in methanol. The 
reaction mixture was heated under reflux for 3 hours in 
the dark before being cooled to r.t. and added to water 
(100 mL). The layers were separated and the aqueous layer was extracted 
with chloroform (2 × 20 mL). The combined organic extracts were washed with 
water (20 mL) and brine (20 mL), dried over Na2SO4, and concentrated in 
vacuo. The resultant solid was washed thoroughly with methanol to afford the 
title compound 44 as a light purple solid (160 mg, 0.237 mmol, 73%). Rf 0.80 
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(chloroform); mp >240 ºC; νmax/cm−1 1596, 1538, 1520, 1488, 1439, 1345, 
1204, 1176, 1156, 1070, 1002; δH (600 MHz, CDCl3) 7.65-7.50 (br m); δC (150 
MHz, CDCl3) 136.1 (C3), 127.2 (C4), 126.5 (C2); m/z (EI) found 675 ([M]+, 
100%); Accurate mass calc. for C44H28N4Cu [M]+ 675.1604, found 675.1606, 
Δ 0.3ppm; λmax = 414 nm (ε = 239,290), and 539 nm (ε = 21,500). Data is 
consistent with the literature values.345  
Nickel meso-tetraphenylporphyrin (45)345  
The procedure of He et al.345 was used. To a solution of 
meso-tetraphenylporphyrin 42 (200 mg, 0.325 mmol, 
1.00 eq.) in toluene (30 mL) was added nickel 
acetylacetonate (125 mg, 0.488 mmol, 1.50 eq.). The 
reaction mixture was heated under reflux for 72 hours in 
the dark before being cooled to r.t. and added to water 
(100 mL). The layers were separated and the aqueous layer was extracted 
with toluene (20 mL). The combined organic extracts were washed with water 
(20 mL) and brine (20 mL), and concentrated in vacuo. The resultant solid was 
washed thoroughly with methanol to afford the title compound 45 as a purple 
solid (150 mg, 0.223 mmol, 69%). Rf 0.80 (chloroform); mp >240 ºC; νmax/cm−1 
3053 and 3021 (C-H), 1598, 1576, 1439, 1350, 1177, 1070, 1005; δH (600 
MHz, CDCl3) 8.75 (8H, s, β-H), 8.02-8.01 (8H, m, H3), 7.71-7.68 (12H, m, H2 
and H4); δC (150 MHz, CDCl3) 142.7 (α-C), 141.0 (C1), 133.8 (C3), 132.3 (β-
C), 127.9 (C4), 127.0 (C2), 119.1 (meso-C); m/z (EI) found 670 ([M]+, 100%); 
Accurate mass calc. for C44H28N4Ni [M]+ 670.1662, found 670.1663, Δ 0.2ppm; 
λmax = 415 nm (ε = 238,590), and 528 nm (ε = 22,030). Data is consistent with 
the literature values.345 
Palladium meso-tetraphenylporphyrin (46)346  
The procedure of Nishibayashi et al.346 was used. A 
solution of meso-tetraphenylporphyrin 42 (200 mg, 
0.325 mmol, 1.00 eq.) and palladium acetate (292 mg, 
1.30 mmol, 4.00 eq.) in chloroform (30 mL, degassed by 
bubbling argon through the solution for 10 minutes prior 
to use) was heated under reflux in the dark and under 
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argon for 96 hours. The reaction mixture was then cooled to r.t. before being 
added to water (100 mL). The layers were separated and the aqueous layer 
was extracted with chloroform (3 × 20 mL). The combined organic extracts 
were washed with brine (60 mL), dried over Na2SO4, and concentrated in 
vacuo. The resultant solid was washed thoroughly with methanol to afford the 
title compound 46 as a dark red solid (173 mg, 0.241 mmol, 74%). Rf 0.75 
(chloroform); mp >240 ºC; νmax/cm−1 1595, 1439, 1351, 1311, 1174, 1073, 
1010; δH (600 MHz, CDCl3) 8.82 (8H, s, β-H), 8.19 (8H, m, H3), 7.79-7.73 
(12H, m, H2 and H4); δC (150 MHz, CDCl3) 141.9 and 141.7 (α-C and C1), 
134.2 (C3), 131.1 (β-C), 127.9 (C4), 126.9 (C2), 121.9 (meso-C); m/z (CI) 
found 722, 721, 720, 719, 718, 717 and 715 ([M + H]+, ~50%, ~95%, ~50%, 
100%, ~80%, ~40% and ~5%); Accurate mass calc. for C44H29N4102Pd [M + 
H]+ 715.1443, found 715.1440, Δ 0.5ppm; λmax = 417 nm (ε = 210,710), and 
524 nm (ε = 19,170). Data is consistent with the literature values.346 
Platinum meso-tetraphenylporphyrin (47)345  
A solution of meso-tetraphenylporphyrin 42 (200 mg, 
0.325 mmol, 1.00 eq.) and platinum chloride (130 mg, 
0.488 mmol, 1.50 eq.) in benzonitrile (40 mL, degassed 
by bubbling argon through the solution for 10 minutes 
prior to use) was heated under reflux in the dark and 
under argon for 18 hours. The reaction mixture was then 
cooled to r.t. before being added dropwise to methanol (600 mL). The resultant 
precipitate was separated and the filter cake was washed thoroughly with 
methanol to afford the title compound 47 as a red solid (200 mg, 0.248 mmol, 
76%). Rf 0.80 (chloroform); mp >240 ºC; νmax/cm−1 1595, 1440, 1357, 1315, 
1174, 1074, 1015; δH (600 MHz, CDCl3) 8.76 (8H, s, β-H), 8.16-8.15 (8H, m, 
H3), 7.81-7.72 (12H, m, H2 and H4); δC (150 MHz, CDCl3) 141.5 (C1), 141.0 
(α-C), 134.0 (C3), 130.8 (β-C), 128.0 (C4), 126.9 (C2), 122.4 (meso-C); m/z 
(EI) found 807, 806, 805, 804, 803 and 802 ([M]+, ~95%, 100%, ~70%, ~15% 
and ~10%); Accurate mass calc. for C44H29N4190Pt [M]+ 802.1908, found 
802.1907, Δ 0.1ppm; λmax = 402 nm (ε = 218,760), 510 nm (ε = 24,590), and 
539 nm (ε = 5,410). Data is consistent with the literature values.345 
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Meso-tetra(pentafluorophenyl)porphyrin (48)347  
The procedure of Dommaschk et al.320 was used. To 
a solution of pentafluorobenzaldehyde (1.2 mL, 10 
mmol, 1.0 eq.) and freshly distilled pyrrole (0.69 mL, 
10 mmol, 1.0 eq.) in dry DCM (400 mL, degassed by 
bubbling argon through the solution for 10 minutes 
prior to use) was added BF3.Et2O (0.41 mL, 3.3 
mmol, 0.33 eq., 1 M solution in THF). The reaction 
mixture was heated under reflux in the dark and under argon for 48 hours 
before the addition of chloranil (615 mg, 2.50 mmol, 0.250 eq.). The reaction 
mixture was then heated under reflux for a further 3 hours in the dark in air, 
before being cooled to r.t. and concentrated in vacuo. The crude product was 
purified by flash column chromatography (SiO2, petroleum ether:chloroform 
3:2) to afford the title compound 48 as a purple solid (419 mg, 0.430 mmol, 
17%). Rf 0.55 (petroleum ether:chloroform 3:2); mp >240 ºC; νmax/cm−1 3319 
(NH), 1650, 1497, 1435, 1343, 1147, 1078, 1046; δH (600 MHz, CDCl3) 8.93 
(8H, s, β-H), −2.92 (2H, s, NH); δC (150 MHz, CDCl3) 146.6 (dm, J = 248 Hz, 
C2 or C3 or C4), 142.5 (dm, J = 258 Hz, C2 or C3 or C4), 137.7 (dm, J = 254 
Hz, C2 or C3 or C4), 131.3 (br s, α-C or β-C), 115.6 (tm, J = 19.7 Hz, C1), 
103.8 (s, meso-C); δF (282 MHz, CDCl3) −136.4-136.6 (m, F2), -151.2 (t, J = 
20.9 Hz, F4), −161.2-161.4 (m, F3); m/z (ES+) found 975 ([M + H]+, 100%), 
976 ([M + 2H]+, ~50%); Accurate mass calc. for C44H10F20N4 [M + H]+ 
975.0664, found 975.0668, Δ 0.4ppm; λmax = 412 nm (ε = 235,210), 506 nm (ε 
= 21,800), 583 nm (ε = 7,190), and 657 nm (ε = 2,410). Data is consistent with 
the literature values.347 
Meso-tetra(2,4,6-trifluorophenyl)porphyrin (49) 
The procedure of Dommaschk et al.320 was used. To a 
solution of 2,4,6-trifluorobenzaldehyde (1.00 g, 6.25 
mmol, 1.00 eq.) and freshly distilled pyrrole (0.43 mL, 
6.3 mmol, 1.0 eq.) in dry DCM (250 mL, degassed by 
bubbling argon through the solution for 10 minutes 
before use) was added BF3.Et2O (0.25 mL, 2.1 mmol, 
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0.33 eq., 1 M solution in THF). The reaction mixture was heated under reflux 
in the dark and under argon for 48 hours before the addition of chloranil (384 
mg, 1.56 mmol, 0.250 eq.). The reaction mixture was then heated under reflux 
for a further 3 hours in the dark in air, before being cooled to r.t. and 
concentrated in vacuo. The crude product was purified by flash column 
chromatography (SiO2, petroleum ether:chloroform 3:2) to afford the title 
compound 49 as a purple solid (256 mg, 0.308 mmol, 20%). Rf 0.30 (petroleum 
ether:chloroform 3:2); mp >240 ºC; νmax/cm−1 1677, 1635, 1594, 1563, 1481, 
1439, 1352, 1257, 1232, 1172, 1115, 1037; δH (600 MHz, CDCl3) 8.90 (8H, s, 
β-H), 7.20-7.17 (8H, m, H3), −2.84 (2H, s, NH); δC (150 MHz, CDCl3) 169.7 (s, 
α-C or β-C), 163.8 (dt, J = 251.5 Hz and 14.8 Hz, C4), 162.6 (ddd, J = 249.7 
Hz, 15.1 Hz and 14.7 Hz, C2), 140.9 (s, meso-C), 115.1 (td, J = 21.6 Hz and 
4.7 Hz, C1), 105.5 (s, α-C or β-C), 100.5 (td, J = 24.1 Hz and 5.0 Hz, C2); δF 
(282 MHz, CDCl3) −105.0 (d, J = 6.5 Hz, F2), −105.9 (t, J = 8.5 Hz, F4); m/z 
(EI) found 828 ([M – 2H]+, 100%); λmax = 413 nm (ε = 207,270), 508 nm (ε = 
14,830), 584 nm (ε = 4,580), and 655 nm (ε = 2,300). 
Meso-tetra(4-fluorophenyl)porphyrin (50) 
The procedure of Adler et al.318 was used. To propionic 
acid (40 mL), being heated under reflux, was added 
freshly distilled pyrrole (0.69 mL, 10 mmol, 1.0 eq.) and 
4-fluorobenzaldehyde (1.1 mL, 10 mmol, 1.0 eq.) 
simultaneously. The reaction mixture was heated 
under reflux in the dark for 30 minutes before being 
cooled to r.t.  and filtered. The filter cake was washed copiously with methanol 
to afford the title compound 50 as a purple solid (429 mg, 0.624 mmol, 24%). 
λmax = 419 nm (ε = 241,670), 514 nm (ε = 17,250), 549 nm (ε = 7,290), 589 nm 
(ε = 5,660), and 646 nm (4,030). Only UV-Vis data were obtained for this 
compound due to its low solubility in all solvents tried. 
Ethyl 4-(4-formylphenyl)butyrate (51)348  
The procedure of Fraga-Dubreuil et al.330 was used. 
To a suspension of 4-hydroxybenzaldehyde (1.00 g, 
8.19 mmol, 1.00 eq.) and K2CO3 (1.70 g, 12.3 mmol, 
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1.50 eq.) in acetonitrile (25 mL) was added ethyl 4-bromobutyrate (1.2 mL, 8.2 
mmol, 1.0 eq.). The reaction mixture was heated under reflux for 18 hours 
before being cooled to r.t., filtered and concentrated in vacuo. To the residue 
was added diethyl ether (250 mL), and the resultant suspension was filtered 
through Celite®. The filtrate was concentrated in vacuo to afford the desired 
product 51 as a pale yellow oil (1.82 g, 7.70 mmol, 94%). Rf 0.30 (petroleum 
ether:ethyl acetate 7:3); νmax/cm−1 2980 and 2741 (CH), 1728 (aldehyde C=O), 
1687 (ester C=O), 1598, 1577, 1509, 1472, 1375, 1312, 1251, 1156, 1110, 
1029; δH (600 MHz, CDCl3) 9.88 (1H, s, HC=O), 7.84-7.82 (2H, m, H3’), 7.00-
6.98 (2H, m, H2’), 4.15 (2H, q, J = 7.1 Hz, H2CCH3), 4.10 (2H, t, J = 6.1 Hz, 
H4), 2.53 (2H, t, J = 7.2 Hz, H2), 2.15 (2H, tt, J = 7.2 Hz and 6.1 Hz, H3), 1.26 
(3H, t, J = 7.1 Hz, CH3); δC (150 MHz, CDCl3) 191.0 (HC=O), 173.1 (C1), 164.0 
(C1’), 132.1 (C3’), 130.1 (C4’), 114.9 (C2’), 67.2 (C4), 60.7 (H2CCH3), 30.7 
(C2), 24.5 (C3), 14.4 (CH3). Data is consistent with the literature values.348  
Ethyl 4-(4-(bis(4-dimethylamino)phenyl)methyl)phenoxy)butyrate (52 ) 
A modified procedure of Szent-Gyorgyi et 
al.297 was used. To a solution of ethyl 4-(4-
formylphenyl)butyrate 51 (3.00 g, 12.7 mmol, 
1.00 eq.) and ZnCl2 (5.19 g, 38.1 mmol, 3.00 
eq.) in ethanol (30 mL, degassed by bubbling 
argon through the solution for 10 minutes before use) was added N,N-
dimethylaniline (4.8 mL, 38 mmol, 3.0 eq.) at r.t. under argon. The reaction 
mixture was heated under reflux for 24 hours prior to the addition of a second 
portion of N,N-dimethylaniline (1.6 mL, 13 mmol, 1.0 eq.). The reaction mixture 
was heated under reflux for a further 24 hours, before being cooled to r.t. and 
concentrated in vacuo. The residue was dissolved in a mixture of water (300 
mL) and DCM (100 mL) and the layers were separated. The aqueous layer 
was extracted with DCM (2 × 100 mL). The combined organic extracts were 
washed with water (100 mL) and brine (100 mL), dried over Na2SO4, and 
concentrated in vacuo. The crude product was purified by flash column 
chromatography (SiO2, petroleum ether:ethyl acetate 7:3), followed by 
recrystallization from ethanol to afford the title compound 52 as a white solid 
(1.85 g, 4.02 mmol, 32%). Rf 0.30 (petroleum ether:ethyl acetate 7:3); mp 72-
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74 ºC; νmax/cm−1 2897 and 2804 (C-H), 1731 (C=O), 1608, 1508, 1470, 1444, 
1357, 1317, 1241, 1157, 1123, 1105, 1056, 1019; δH (600 MHz, CDCl3) 7.04-
7.02 (2H, m, H3’), 6.99-6.97 (4H, m, H2’’), 6.80-6.78 (2H, m, H2’), 6.68-6.67 
(4H, m, H3’’), 5.33 (1H, s, Ar2CH), 4.15 (2H, q, J = 7.2 Hz, H2CCH3), 3.97 (2H, 
t, J = 6.1 Hz, H4), 2.92 (12H, s, NCH3), 2.51 (2H, t, J = 7.3 Hz, H2), 2.10 (2H, 
tt, J = 7.3 Hz and 6.1 Hz, H3), 1.26 (3H, t, J = 7.2 Hz, H2CCH3); δC (150 MHz, 
CDCl3) 173.5 (C1), 157.1 (C1’), 149.0 (C4’’), 137.8 (C4’), 133.3 (C1’’), 130.4 
and 130.0 (C3’ and C2’’), 114.1 (C2’), 112.7 (C3’’), 66.7 (C4), 60.6 (H2CCH3), 
54.3 (Ar2CH), 40.9 (NCH3), 31.0 (C2), 24.8 (C3), 14.4 (H2CCH3); m/z (ES+) 
found 461 ([M + H]+, 100%); Accurate mass calc. for C29H37N2O3 [M + H]+ 
461.2804, found 461.2801, Δ 0.7ppm.  
4.3 Procedures for surface modifications, incorporations, 
leaching experiments, and other miscellaneous experiments 
4.3.1 Incorporation of crystal violet analogues into polyurethane 
A dip-coating technique, previously described by Noimark et al.,270 was used. 
A sheet of polyurethane was cut into 1 cm × 1 cm squares, which were 
immersed in aqueous solutions containing the crystal violet analogues (1 × 
10−3 M) for 96 hours in the dark. After this time, the samples were removed 
from solution, rinsed with distilled water, and dried with paper towels. 
4.3.2 Preparation of a PVC film 
To vigorously stirring THF (150 mL) was added PVC powder (5.00 g, from 
BDH, MW ~ 100,000) slowly, and with gentle heating to prevent aggregation. 
Once all the solid had dissolved, the solution was poured into a suitably sized 
glass container and the THF was allowed to evaporate slowly in air, which took 
roughly one week. The resultant film was cut into discs using a standard sized 
hole punch and used without any further purification. The consistency of the 
preparation process was confirmed by FT-IR spectroscopy. 
4.3.3 Modification of PVC with sodium azide 
A modified procedure of Sacristán et al.315 was used. To a solution of sodium 
azide (0.1 M) in a mixture of DMF:water (6:1, 7 mL for every 2 discs) was 
added PVC film (cut into discs using a hole punch) and the resultant mixture 
James Rudman 
143 
 
was stirred vigorously and heated to 60 ºC for 2 days. The PVC discs were 
then immersed in a solution of acetone:water (6:4, 5 mL for every 2 discs) for 
1 day, and this process was repeated 3 times with fresh acetone:water 
solutions. The discs were then dried with paper towels, before finally being 
dried under vacuum for 1 day. Analysis of the FT-IR spectrum was used to 
confirm the presence of the covalently attached azide (observed between 
2100-2115 cm−1).    
4.3.4 Incorporation of crystal/ethyl violet into medical grade silicone 
The “swell-encapsulate-shrink” technique, previously described by Ozkan et 
al.,271 was used. A sheet of medical grade silicone (MED82-5010-40, Polymer 
Systems Technology Ltd.) was cut into 1 cm × 1 cm squares, which were 
immersed in toluene for 24 hours in the dark. They were then rinsed with 
distilled water and dried with paper towels, before being allowed to air dry in 
the dark for 24 hours. The squares were then immersed in solutions of 
crystal/ethyl violet in chloroform (1 × 10−3 M) for 72 hours in the dark, before 
being rinsed with distilled water, dried with paper towels, and air dried in the 
dark for 24 hours. 
4.3.5 The extent of dye leaching from medical grade silicone 
incorporated with crystal/ethyl violet 
A 1 cm × 1 cm sample containing crystal/ethyl violet was immersed in PBS 
solution (2.5 mL) for 168 hours in the dark. The UV-Vis absorbance of the PBS 
solution was obtained after 30 minutes, 1 hour, 2 hours, 4 hours, 6 hours, 24 
hours, 48 hours, 72 hours, 96 hours and 168 hours. 
4.3.6 Incorporation of porphyrins into medical grade silicone 
A “swell-encapsulate-shrink” technique was used.271 A sheet of medical grade 
silicone (MED82-5010-40, Polymer Systems Technology Ltd.) was cut into 1 
cm × 1 cm squares, which were immersed in a solution of a porphyrin (1 × 10−3 
M) in chloroform for 72 hours in the dark. The resultant films were rinsed with 
distilled water, dried with paper towels, and air dried in the dark for 24 hours. 
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